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Diary 
Please note that from May the evening, unless otherwisw 
stated, meetings wi ll be held at the RPS, 66-68 East 
Smithfield, London E 1 W I AW, starting with 
refreshments at 5.00 pm. The RPS is expected to have 
moved to its new headquarters by May 2015. 
Monday 18 May 2015 
Joint meeting with the Friends of the Archives, 
Society of Apothecaries to view displays of the 
Museum of the RPS at its new headquarters at 
66-68 East Smithfield, London ElW l AW. 
Refreshments at 5.00 for 5.30. Details with the 
meeting notice. 
Monday 12 October 2015 
'Joseph Banks' by Andrew Sankey. At new RPS 
headquarters at 58 East Smithfield, London EI W 
IAW, 5.00 for 5.30. 
November 2015 
Joint Meeting with Medway School of Pharmacy. 
Detai ls to be confirmed. 
British Society for the History of 
Medicine, 26th Congress 2-5 September 
2015, Leeds 
BSHP Conference 2015 
The 20 15 Conference will be held from Friday 27 March 
to Sunday 29 March in Sunderland. The cost wi ll be held 
at £300, as last year. 
The Conference will be at the Best Western Roker 
Hotel, Roker Terrace, Sunderland, Tyne And Wear, 
SR6 9ND. This is a ea front hotel about I mile from 
the city centre. There is no pre-arranged acti vi ty for 
Saturday afternoon. 
The mam theme will be ' The Apotheca,y ' to 
commemorate the Apothecarie Act of 1815. 
Pharmacy student 
Laura Ghiggino, will give the Bumby Award Lecture 
on 'Medicine in 1914' and there arc papers on 
Sunderland and New Zealand, as well as posters . 
Enquiries or requests to provide posters to Shirley 
Ellis as oon as possible please: 
sh irleyel I is@sh i rlel I is. p I us.corn 
International Congress for the History of 
Pharmacy, Tuesday 8 to Friday 11 
September 2015, Istanbul, Turkey 
The 42nd international Congress will be held at the 
Istanbul University Convention Center on the theme of 
the 'Exchange of Phannaceutical Knowledge Between 
East and West'. Further information and booking fonm 
are available at www.42ichp.org. 
International Society for the History of Pharmacy 
The 2014 ISHP newsletter is avai lable at 
www.histphann.org/IGGP0 o20 cwslctter 15 2014.pdf 
The congress will be held at Wectwood Hall , Leeds 
on the themes 'The good, the bad and the unknown 
(people, events and discoveries)' and First World 
War Medicine. Preliminary information is available 
at http://www.bshm.org.uk/Congrcss.asp?ID=5 
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A Survey of Artificial Pharmaceutical 
'Stones' - Part 1 
Christopher J Duffin and Rachael Pymm 
Sutton, Surrey and Egham, Surrey 
Rocks, minerals, fossils and earths have a history of use 
in the lapidary traditions of all the major world 
civilisations, from classical times extending, in some 
cases, to the present day. 1 In addition to these 
geopharmaceuticals, a significant number of ' stones' or 
calculi of various descriptions, some real and some 
fabulous, harvested from the bodies of living organisms 
figured in the prescribing practices of Eur?pean 
apothecaries and physicians, as well as havmg a 
prominent position in folk medicine; bezoar stones are a 
good example.2 A third group of hard, durable materials 
that have been used therapeutically includes artificial or 
synthetic ' stones' that have been produced as part of the 
apothecaries ' art. This paper seeks to give an overview 
of these preparations, some of which were the wares of 
mountebanks and quacks, and others of which were 
incorporated into official pharmacopoeias. 
Lapis de Goa 
The Lapis de Goa or 'Goa Stone' was a popular artificial 
stone invented by the late 17th century Jesuit missionary to 
Goa, Gaspar Antonio (c. 1531-1610), in response to 
declining availability and quality of local bezoar stones. 
The Goa Stone was made up of musk, oriental bezoar, 
ambergris, red and white coral, emerald, topaz, ruby, 
sapphire, jacinth, small pearls, fossil shark's teeth, terra 
sigillata, stones from Cananor and calcined deer horn. 
These materials were comminuted, mixed into a fine paste, 
and then coated with a layer of gold leaf A more detailed 
history of this artificial stone has been provided elsewhere.3 
Prescribed as an alexipharmic (antidote against poisons), 
sudorific (sweat inducer), diaphoretic, cardiac tonic, mild 
astringent and a general cordial or invigorant, it was 
commonly used to treat a wide variety of fevers, including 
those associated with plague and gout, as well as being 
employed in the treat:Jnent of small pox, measles, fevers in 
children, and muscle spasm. The costly nature of the 
individual ingredients made the Goa Stone an expensive 
tl1crapy; this obviously made it worth selling counterfeits, 
as the presence of fine-grained sandstone replacements in 
John Burges' late 18th century materia medica collection 
indicates.4 
Other Bezoar Substitutes 
The high cost of importing bezoar stones from India and 
south-east Asia resulted in tl1e production of artificial 
substitutes. Two types of Mineral Bezoar appeared during 
the I 7tl1 century. The first was naturally occurring and 
sometin1es referred to as lapis bezoar foss ilis, lapis bezoar 
minera/e siculus, term sicula or Sicilian earth. The Sicilian 
Cistercian botanist, Paolo Silvio Boccone ( 1633- 1704), 
commented in 1669 that the 'professors and curious of 
Sicily' had long used large, white or grey, walnut-shaped 
stones with internal layering for 'Malignant fevers, 
Smallpox, Wom1s, as a Medicament against disease 
proceeding from rot or from excessive fermentation of the 
blood'.5 
The second type was entirely artificial; Pierre Pomet 
(1658-1699) indicated that Mineral Bezoar was 'made of 
Butter of Antimony, prepar'd with Spirit of Nitre' -
following distillation in a retort, the white residue was then 
calcined.6 Possibly the invention of the supposed 15th 
century alchemist, Basil Valentine ( c. 1394-1450), this 
preparation was esteemed as a diaphoretic. 
The closely related Jovial Bezoar (Bezoar of Jupiter or 
Bezoardicumjoviale), was also antimony-based, involving 
the melting of regulus of antimony (purified antimony) 
with tin and 'corrosive sublimate' (mercuric chloride) and 
then distilled to make a butter-like material. This was then 
dissolved in Spirit of Nitre (nitric acid) and distilled further. 
The remnant was dried to form the Bczoar, which was later 
powdered, washed and diluted in Spirit of Wine ( aqueous 
solution of ethanol) before being administered, like the very 
similar Antihecticum poterii, against diseases of the lungs, 
liver, uterus, smallpox, gonorrhoea, apoplexies, epilepsy, 
'dimness of sight' , giddiness, jaundice, dropsy and ulcers -
all conditions that were believed to be eased by inducing 
copious perspiration.7 Bezoardicum lunale ~ezoar o~ the 
Moon) was prepared in a similar way, but with fine silv~r 
replacing the tin; it was ascribed similar diaphoretlc 
properties. 
Moraccolocius Stone 
The Moraccolocius Stone, and the three subsequent 
artificial stones described below, is the subject of a single-
sided pamphlet or broadside dated October 24th 1622 and 
issued by 'Professor' Iacobus Maximinus, undoubtedly a 
pseudonym;8 these stones do not seem to be mentio.ned in 
any other contemporary literature. Headed with .an 
impressive crest and surrounded by an ornate decorat:Jve 
border, the sheet was probably an advertis~g leaflet 
produced by a mountebank or quack; an extensive search 
for further publications under this name h.as p~ov~ 
unfruitful. The author signs himself as 'your lovmg frien? . 
The only physical details provided for the Moraccolocms 
stone is that it was white in colour. Scrapings of the stone 
dissolved in white wine were recommended as a gargle for 
'canker in the mouth or throat, and all evils that come of 
Blood or rhewme' ; three applications were deemed 
sufficient to give relief ('with God's helpe'). When powder 
from the stone was dispersed in half a pint of beer or .ale, it 
was supposedly 'good for a stopping, or a stuffing m ~ e 
stomack with any kind of flegme or glart, or heart-bunung 
or heart-aking ', where glart is an archaic synon)'.111 of 
phlegm, one of the four humours. In addition to this, the 
stone could be used to treat toothache, 'and all rotten and 
stinking teeth ' ; the patient was encouraged to put the stone 
into the hole or aching tooth, allowing it to 'bnng forth the 
worm and the rhewme', by which action it 'maketh the 
mouth sweete' . The reference to bringing forth wonns 
refers to the long-held belief that small gnawi1~g wo~~s 
inside the teeth caused dental caries and penodontitls. 
Dating back to the 'Legend of the Worm' record~d i~ 500.0 
BC on an ancient Sumerian clay tablet, this idea is 
remarkable for its inclusion in the medical beliefs of a 
wide range of cultures - from China, India, Japan and 
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Egypt. In Europe, the idea can be traced back to Scribonius 
Largus (dates unknown, but 1st century AD), who was 
Court Physician to the Emperor Claudius, who he 
accompanied to England in 43 AD. In his book De 
compositione medicamentorum, which contains a list of 
271 prescriptions, Largus recommends 'fumigations made 
with the seeds of hyoscyamus scattered on burning 
charcoal', followed by rinsing the mouth in hot water in 
order to expel the tooth worms.9 
Safonya Stone 
This 'famous ... straw-coloured stone' was recommended 
for podiatric problems thus: 
it is very good for the comes in your foete and eares, soaking 
your comes in warme water and then pare them, and shave 
some powder of the stone, and it helps them sodainly, the 
powder being layd thereto. IO 
Permission to sell a variety of topical preparations was 
granted in 1542 to 'every person being the king's [i.e. 
Henry VIII's] subject having knowledge and experience' 
of medicinal sirnples, provided they charged for 
ingredients only (and not for consultation). Such people 
could 'practice use and minister in and to any outward 
sore, wound swelling or disease'. This became known as 
the 'Quack's Charter' and led to exorbitantly high prices 
for individual drugs. 11 Supposed cures abounded for 
common ailments including corns and ulcers. 
The Safonya stone was also recommended in this 
pamphlet as being effective against dermal parasites: 
Make this stone into powder, and mixe it with Oyle of Bayes, 
and it wi ll ki ll the itch, and make no Lice shall trouble any one 
if the body be anointed therewith. These stones of have beene 
proeuved, and have ho I pen many one in this Citie of London'. 
Amothist Stone 
The third stone advertised by Maximinus is described as 
being red in colour. The name is remarkably close to that 
of the purple-hued variant of quartz, whose colour is due to 
iron impurities, and sometimes the presence of transition 
elements in the crystal lattice. Before appreciable reserves 
were discovered in South America, and Europe began 
receiving shipments during the 16th century, amethyst ~as 
counted as being a precious stone, almost on a par with 
diamond, being produced mainly in Sri Lanka. It was 
believed to be particularly effective against intoxication and 
drunkenness, either taken in powdered form or worn 
prophylactically as part of a finger ring. Additional benefi_ts 
were believed to be its properties as an astringent, and m 
helping to treat haemorrhage12 (probably by sympathet:Jc 
magic, on account of its range of colours). These 
therapeutic applications differ considerably from the claims 
made for Amothist, which was deemed to be 
good for the paine in the buck.le bone [an archaism referring 
variously to the hip bone, astragalus or knuckle], or shms, 
take the stone, beat it to powder and mixe it with Swme 
grease, and anoint it by the fire very well, and it is present 
helpe, it takes away the paines and swellings '. 
Alternatively, this ointment could be treated as a 'p.laiste_r' 
which, when laid on the stomach or navel, especially 111 
children, 'brings away the Wom1es, both Chest-wormes 
and other, in four and twenty houres'. 
In addition, scrapings of the stone di olved in four 
spoons full of water could be snuffed into the nostrils or 
held in the mouth. The patient was then commended to ' let 
the rhewme voyd out' in order to ease headache, sore eyes, 
hearing problems and 'the Megrin,'. 13 The latter term is a 
late Middle English version of the French word, migraine, 
which could also refer to depression. The Megrim was also 
known as Hemicrania, being characterised by 'a vehement 
pain in one half of the Head.14 Ambroise Pare ( 1510?- 1590) 
suggested the cause of the disease was 'putride vapours 
arising to the head from the ventricle, wombe, or other 
inferior member' or, alternatively (and somewhat 
ironically) inhaling 'some noisome vapour or moak, as of 
Antimony, Quick-silver or the like', in addition to possible 
contributions from drunkenness, gluttony and the eating of 
'vaporous meates' .15 
Finally, recalling the uses of true amcthy t, amothist 
was commended by Maximinus as being 'very good to 
staunch blood' when applied directly onto the wound, or 
worn as an amulet about the ncck.16 
Safaris Stone 
The final synthetic stone advertised by Maximinus is the 
purple-coloured Safaris Stone. Sewn into a si lk bag and 
worn about the neck, the author asserted that, in 20 days, it 
would help with a variety of diseases whose common 
denominator was involuntary tremor - palsy, ague, cramp 
and 'shaking of the Joynts'. 
Figure I. Contraycrva. From Pomct ( 1748) A ( ·011111/ctc 
History of Drugs. Plate I 0. 
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A blue variety of the same stone, powdered and 
suspended in PossetA1e and taken first thing in the morning 
for four consecutive days, was recommended as being 
good for the greene sickness, and procureth urine, and causeth 
the stone to voyde, and doth expel the wynde in the body. 17 
This list of diseases includes many that were a source 
of much discomfort, as well as being quite widespread in 
early modem times; dysuria and renal calculi were 
common candidates for a whole raft of hopeful cures. 18 
Lapis Contrayerva 
John Jacob Berlu (dates unknown, but late 17th century) 
introduces this as a 'made stone" containing Contrayerva 
root, pearls, coral, amber, crab's eyes and several other 
Table 1. Table to show variation in composition of lapis contrayerva. 
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ingredients 'which after 'tis gilded over, smeUeth strong 
of the root". 19 
Contrayerva (Fig. 1, p.3), a small plant belonging to 
one of several species of Dorstenia, has scaly, knobbly 
rhizomes which are also known as Drake Root or 
Drakens Radix on account of its introduction into Europe 
in around 1581 by Sir Francis Drake (circa 1540-1596).20 
The name means 'against poison' and indigenous tribes 
of the Amazon use it to treat both snakebite and the 
poisonous bites of various insects. Various South 
American peoples are recorded as consuming it as a salad 
plant, placing strips of it under the soles of their feet 
during winter time, and feeding goats with it so that they 
are stimulated to produce bezoar stones.21 It is used 
widely in modem day Venezuela, Argentina, Mexico, 
Trinidad, and especially Brazil where it is often 
employed against fevers and a wide range of other 
conditions. When introduced into apothecary's shops in 
Paris (1602) it was used extensively in plague remedies; 
Nathaniel Hodges utilised it during the Great Plague of 
London in 1665.22 
The composition of Lapis contrayerva is the subject of 
some variation (Table 1, p. 4). The simplest involves 
mixing five ounces of Contrayerva root with one and a 
half pounds of the powder of crab's claws (chelae 
cancrorum).23 In addition to these two basic ingredients, 
Nathaniel Hodges lists extract of Virginia Snake Root, 
Angelica, Tormentil, Red Coral, Antimony, Saffron, 
Oriental Bezoar, Ambergris and Viper skin jelly in his 
version of the composition.24 Another recipe incorporates 
pearls, coral, amber, crab's eyes (oculi cancrorum), 
oriental bezoar, black tips of crab's claws, 'Gelly of 
Hart's Hom, made with Dragon-water, a little tinctur'd 
with saffron' ground finely in a mortar, worked into balls 
and then dried.25 Joseph Browne (dates unknown, active 
1700-1721) gives several recipes for the stone which he 
says resulted from the popularity of the root in various 
~erapies against plague. He lists a number of ingredients 
mvolved in the production of the stone, some of which 
are omitted entirely from the recipes for which later he 
provides details: Rock Crystal (quartz), Zedoary, Bistort, 
Carline Thistle, Butterbur, Elecampane, Mastic, Musk, 
Scordium and Scorzonera, and the white of an egg.26 
Am_ong the nine recipes he gives are two that give 
d1stmctively coloured stones - one white and one red. He 
recommends the latter in cases of smallpox and purple 
fever. The English natural history writer, Henry Barham 
( circa 1660-1726) noted that he often added Arrow-root 
to ~sown version of Lapis contrayerva.27 
years, in 1751, Sir John Hill (1714-1775) recorded that 
the standard and recommended means of storage was in 
powdered fonn as Pu/vis Contrayerva Compositus.30 
Shortly afterwards, he had arrived at the opinion that it 
was 'better to give it alone than in that mixture of crab's 
claws and other useless ingredients' and that 
administering it in the fonn of a tincture w~ best of all.31 
~apis ~ontrayerva was praised for its various properties, 
mcludm~ as a c?rdial, tonic, alexipharmic, sudorific, 
stomachic, and stunulant, and it was used in 'all sorts of 
Malignant Fevers, and pestilential Distempers, resists 
Poisons and the bites of venomous Creatures' toothache 
to 'strengthen the Stomach, dispel Flatulenci~s and helJ 
Digestion', typhoid fever, smallpox, diphtheria, 
'gangrenous sore throats., indigestion, colic, weakness 
of the stomach, as well as being 'good in nervous 
cases'. 32 It was even used to promote sweating in horses 
and as part of the treatment for 'contagious distemper 
amongst Cows' (Anthrax?).33 
In at least one remarkable instance a specimen of Lapis 
contrayerva has survived in a cabinet of materia medica 
for over 300 years. The specimen forms part of a 
teaching collection made by the Yeronese chcmi t 
Giovanni Francesco (anglicised to John Francis) Yigani 
( circa 1650-1713), and is currently stored in the Long 
Room at Queens' College, Cambridge. Vigani was 
elected to the first ever Chair of Chemistry in 1702, 
teaching at Queens', St Catharine' and Trinity Colleges 
in Cambridge until 1708.34 The specimen of Lapis 
contrayerva has the fonn of a white, finely granular, 
flecked, chalk-like stick, measuring around 2 cm 111 
length and broken at one end (Fig. 2). 
Figure 2. Specimen of lapis contrayen'a from drawer F 
23 of the early eighteenth century matcria mcdica cabinet 
of John Francis Yigani. By kind pem1ission of the President 
Like the Goa Stone, Lapis contrayera was used 
ex_tensively as an alexipharmic (antidote); John Quincy 
(died l 722) variously mixed it with Gascoign's Powder, Lapis Alexiterius . 
~ithridatium, Saffron, Confection of Alkermes and Asserted by some as identical to Lapis contrayerm, Lap1s 
D1a~cordium in a range of alexiphannic medicines alexiterius is nevertheless a different preparation, but with 
dunng the late 17th and early 18th centuries.2s Some some ingredients in comm?n. Thorn~ Fuller ( 1654-1734: 
popular texts recommended its use, as with indigenous Fig. 3), the Cambridge-trained physician who practised 111 
peoples, against snakebite.29 Sevenoaks, Kent, specifies 111 his Phamwcopoew 
Joseph Miller's (1722) Botanicum officinale indicates e.xtemporanea ( 1722) that it contains amber, red coral, 
that Lapis contrayerva was the only means by which antimony, crab's eyes, crab's ~laws,. all powde1:e~ 
Contrayerva root was taken at the time, but within 30 together on a porphyry slab and mixed with ambergris. 
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Treacle Stone 
Joseph Browne's Antidotaria (1721) is the only source 
traced for this preparation.36 Used in the treatment of 
plague, one of its main ingredients was 'Hartman's 
Figure 3. Thomas Fuller (1654-1734). Line engraving 
by G. Vertue after I. Tymewell. Wellcome Libraiy, London. 
Table 2. Table to show variation in composition of lapis 
mirabilis. 
Schroeder Jungken Solleyscl Salmon 
1655 1697 1717 1710 
White vitriol X X X X 
Green \'itriol X X 
Sal nitris X X 
Sal oetrae X X 
Sal ammoniac X X 
Sugar X X 
Rock alum X X X X 
Camphor X X 
Bole Anneniac X X 
Litharn.e X 
Litharge of Gold X 
Litharge of Silver X 
Diaphoretick' or Flowers of Antimony. This is essentially 
sublimated antimony trioxide (Sbi03), a chemical 
subsequently discovered naturally occurring as the mineral 
VaJentinite. To this was added whole powdered viper, 
crab's eyes, cochineal, mother of pearl, white amber, 
orange peel, angelica, safilon, kermes berry (the scale 
insect, Kermes vermilio ), and roots of Bistort, Tormentil 
and Scorzonera. Scononera is a genus belonging to the 
Asteraceae, latex from the roots of which have proven 
analgesic properties and which has an extensive pedigree of 
use in European (especially Turkish), Chinese and 
Mongolian folk medicine.37 This list of ingredients was 
then mixed with Venice Treacle, itself a popular 
alexipharrnic and binding agent, before being worked into 
a 'Mass' which presumably acted as a source from which 
to scrape therapeutic powders. The eponymous treacle was 
believed to act magnetically, drawing poisons out of the 
body tissues. One of its most celebrated active ingredients 
was viper flesh; the addition of powdered whole viper in 
this recipe may have been seen as reinforcing the action of 
the Theriac by sympathetic magic (similia similibus 
curantur). 
Lapis mirabilis 
Lapis mirabilis, Lapis mirificus or the Wonderful Stone 
(Table 2) enjoyed considerable popularity in the 17th and 
18th centuries. It seems to have originated with the 
y£z£et e':.f aeu:m:Jeu!Jla ~ae Eafr[{a Se£ro·6ri-
Canf;rm1jJ manus n:fse {atJlrt!fzcu. 
:flft ammi l.,tes virfutrs munera mmtis 
. J1]jmiun'J}~'9' Jry~ Jcr:J!.a. J;cen.L . · 
,;,' "fin!- · .,...,,..,.":l!..:r-
Figure 4. Johann Schroeder (1600-1664). 
Wikimedia Commons. 
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Figure 5. Jacques Labessie de Solleysel (1617-1680). 
Wikimedia Commons. 
German Paracelsian physician, Johann Schroeder (1600-
1664; Fig. 4), who is perhaps most famous for isolating 
Arsenic in 1649 by heating white arsenic (As406) with 
charcoal. Schroeder moved around Europe a lot during 
his medical career, studying at Rostock, Copenhagen, 
Leiden and Caen; after serving as an army surgeon for 
Swedish forces in the Thirty Years War, he settled in 
Frankfurt, serving as physician to the Landgrave Hesse-
Darmstadt. It is probably while he was here that he wrote 
his Pharmacopoeia Medico-chymica first published in 
1649. His recipe for Lapis mirabilis consisted of white 
vitriol (ZnS04), green vitriol (FeS04), sal nitris (probably 
Na2C0 3), sal ammoniac (NHiCl), fine sugar, alum and 
camphor, finely powdered together and blended with 
olive oil to form a honey-like consistency, before being 
baked slowly into stony structures.38 It was used in the 
same way as Lapis salutis (see below). 
lead respectively) being introduced anew. The 
ingredients were boiled gently in water over an even heat 
from a smokeless fire such that the water evaporated 
leaving a hard residue. This stony material was then 
powdered into water when required and used to irrigate 
horses' eyes if they suffered from 'Rheums, Blows or 
Moon-eyes'. When applied either as a wash or as part of 
a compress directly to wounds or inflammation, 
especially on the back, Lapis mirabilis was judged to be 
'good to resist Corruption'.39 Solleysel's work formed 
the basis for many subsequent derivative farriery 
volumes. 
William Salmon (1644-1713; Fig. 6) used an identical 
recipe to that of Solleysel, and he suggested dispersing 
half an ounce of the powdered Stone in water from a 
Smithy ('Smith Forge Water'). The liquid could then be 
applied as a wash over old sores and minor wounds, or as 
part of a compress to reduce inflammation. As an 
eyewash or collyrie applied morning and evening, it was 
credited with the ability to reduce inflammation, heal 
ocular sores and ulcers, and prevent 'Fluxions of Rheum 
into the Eyes'.40 
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Representing pharmacy: The 
Pharmaceutical Society of Great 
Britain's first Diploma 
Dr Elizabeth Waters 
Department of Modern Languages and Cultures, 
University of Westminster, London 
Shortly after its launch in 1841, the Pharmaceutical 
Society of Great Britain approved its first Diploma, a 
black and white design intended to convey the 
profession's character and ethos. In the 19th century 
tradition it combined text and image. In fact image 
predominated and text was confined to a central 
medallion, shaped to hold the certificate and recipient's 
name. On either side of the medallion were imposing 
'imaginary portraits' of two classical authorities on 
medicine and materia medica. Avicenna on the left, 
author of the Canon of Medicine, in turban, tunic and 
cloak, pointed with a staff of Asclepius at a wreath of 
medicinal plants bordering part of the medallion's 
circumference; and on the right, Galen, the Greek 
physician, bare-headed in tunic and cloak, held a 
weighing scale. The medallion and its flanking figures 
rested on a pedestal, ornamented with a central bas relief 
of an alchemist at work in his laboratory and decorated in 
recessed side-panels with chemical and pharmaceutical 
vessels. A mortar and pestle, supported by the upper edge 
of the medallion, formed the Diploma's summit. 1 
Origins 
It was turf wars between medical practitioners for 
professional and economic advantage, compounded by 
the prospect of restrictive government legislation, which 
pushed chemists and druggists towards association. 
Pharmacy was to some extent the victim of its own 
success. In the 18th century, urbanisation and consumer 
revolution brought rapid growth, but a century later the 
marketplace in medical services had become too 
crowded for comfort. Less organised than the longer-
established apothecaries, physicians and surgeons, and 
less qualified and more closely connected with trade, the 
chemists and druggists faced an uncertain future. The 
leading metropolitan and provincial founders of the 
Phannaceutical Society believed that unity and 
professional education were the only guarantors of 
survival and long-term security,2 and the Diploma was a 
small but not insignificant part of the strategy by which 
they intended to achieve their aims. 
Cultural objects were important in the creation of 
professional identities, communicating and strength-
ening confidence and shared values. Medical men were 
prolific commissioners of portraits and works of 
sculpture for display in the private and public spaces of 
library and consulting room, college and hospital. 
Professional bodies, their numbers on the increase in 
Georgian and Victorian Britain, issued certificates and 
medals to mark and promote practitioner excellence, and 
more broadly to foster a reputation for competence and 
gentility. These artefacts were often illustrated and they 
frequently referenced noteworthy people and things from 
the past likely to enhance contemporary standing. The 
Diploma followed suit, presenting pharmacy as an 
honorable, historically-rooted calling, integral to the 
practice of modem scientific medicine. 
In an early issue of the Pharmaceutical Journal, its 
editor, Jacob Bell, traced the origins of the Diploma back 
to a meeting of provincial chemists called to discuss the 
future of the profession: someone had suggested that 
members of the Society receive a document, signed by 
President and Council, that might distinguish them from 
the incompetent and unqualified in the eyes of the 
public.3 Another story, or perhaps a different version of 
the same story, credited the editor himself with this idea.4 
Whatever the precise manner and sequence of the 
project's genesis, Jacob Bell was instrumental in taking it 
forward. By May 1841 a Diploma Committee had been 
set up under his leadership and a few months later 
produced for inspection a draft design along with style 
samples to illustrate the type of engraving envisaged.5 
Society members, busy metropolitan pharmacists for the 
most part, chose to squeeze the viewing of these art 
works in between their deliberations on superior quality 
filter paper and specimens of 'iodine of potassium, gum 
Figure 1. Jacob Bell, pharmacist, art lover and chair of the 
Diploma Committee. Photograph by Barrauds, London. 
Musetun of the Royal Pharmaceutical Society 
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mastic, dragon 's blood etc. '6 At the later stages of the 
Diploma's realisation, a proper sense of occasion was 
observed: the first certificate to come off the press in the 
spring of 1842 was symbolically presented to the 
Society's first President, William Allen. Certificates were 
impressively large in size (24 x 19.5 inches; 61 x 49.5 
cm) and printed on heavy, fine quality paper; the 
Diploma was published in the first bound volume of the 
cultural artefacts, 10 and the partnership between these 
two men had direct and specific impact on the style and 
content of their product. HP Briggs, elected Royal 
Academician in 1832, was a respected though never 
front-ranking artist, well-known in his life-time for 
historical paintings and portraiture. His paintings on 
early modem and Shakespearean themes posse sed 
detail, drama and sentiment in the Victorian manner, 
Pharmaceutical Journal, as its .-------------------------------, 
frontispiece. 7 
Designers: Jacob Bell, 
HP Briggs 
Jacob Bell was the son of a 
respected and successful Quaker 
pharmacist, a keen advocate of 
science and professionalisation, a 
member of the recently formed 
Chemical Society and a skillful 
organiser whose judgment the 
leaders of the Pharmaceutical 
Society were inclined to trust. In 
addition, they knew him to be a man 
with a 'taste for the fine arts'. 8 In his 
teens he had shown a gift for 
drawing, and his father, despite 
religious beliefs that committed 
adherents to disapproval of what 
they saw as worldly and frivolous 
pursuits, arranged private lessons 
and enrolled him in classes at a 
well-known Bloomsbury art school. 
AU his adult life, Jacob Bell 
delighted in creating caricatures and 
satirical drawings of everyday 
events for the private amusement of 
himself and his friends, but he 
recognised that painting was not his 
metier, and limited public practice 
to expanding his art collection and 
offering business advice to the 
artists among his acquaintances. 
Friendships formed at the 
Bloomsbury school with fellow 
pupils, Edwin Landseer and 
William Frith, who were both to 
become popular and influential 
Victorian painters, gained him 
extensive contacts in the art world, 
and cemented his renown among 
pharmaceutical colleagues for art 
appreciation and knowledge. 
Authorised to produce a diploma 
design, Jacob Bell secured Henry 
Perronett Briggs, his former private 
tutor, for the job. 9 Social networks L-----~====---------~--=-:--~~-:-~~ 
were important, as the historian . . . 
Ludmilla Jordanava has shown, in Figure 2. Draft of the Society's Diploma. MIIllature Etching,. ize of the original 
determining the context in which the 30 by 1912 inches.' Wellcome Library, London 
medical profession created its 
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while his portraits, mostly executed during the 1830s and 
early 1840s 11 (including one of Thomas Wheeler, 
Botanical Demonstrator and Master to the Society of 
Apothecaries) showed greater economy and restraint. 
The Diploma, an uncluttered design that gave pride of 
place to 'imaginary portraits', displayed the artist's 
talents at their most effective. 
Diploma Design 
The Diploma design drew on both heraldic and classical 
traditions. The right to bear arms, initially limited to royal 
and aristocratic houses, was extended in the early 17th 
century to public bodies, by which time the standard 
heraldic components - shield/escutcheon, crest, motto/ 
scroll and supporters - had become well established. The 
apothecaries were granted arms in 1617, one of the early 
beneficiaries of the more inclusive policy, and by the 
19th century coats of arms had become a familiar 
component of the everyday visual environment and an 
influence on other forms of public art. The Diploma with 
its two flanking figures, its central, shield-shaped 
medallion and mortar and pestle in crest position was a 
case in point. In other respects the design took visual 
inspiration from the fine arts. Its architectural features 
wreath and medallion were examples of the neo-classical 
motifs frequently used in public portraiture and sculpture 
at the time. Creators of works on medical themes sought 
accessories that specifically evoked the ancient art of 
physic and looked to the mythology of Greece, Rome 
and other ancient cultures for heroic imagery. Jn 1822, 
the College of Surgeons made Machaon and Podalirius 
the sons of Asclepius, the supporters in their coat of 
arms; the Medical Society of London employed the 
Egyptian goddess, Isis, as its symbol; and the Society of 
Apothecaries continued to illustrate its professional 
mat~rial with the scene of Apollo conquering the dragon 
of disease from the shield of its 17th century coat of 
arms. 12 The choice of Galen and Avicenna, - the key 
scholar/physicians of the Ancient and Medieval worlds-
and their placement amidst a densely symbolic 
arrangement of medical accessories followed this 
tradition of historical referencing. 
Oriental ism 
The Diploma design gives Avicenna precedence over 
Galen. He holds the staff of Asclepius and points to the 
wreath of medicinal plants, and his image is echoed in 
the turbaned alchyrnist on the pedestal's bas relief. 
Avicenna was less well known to the Victorian medical 
public than Galen, but his writings were still consulted 
for prescriptions and technical know-how at the 
beginning of the 19th century. By the 1840s 
pharmaceutical and chemical practitioners were findin~ 
new aspects of Arabic scholarship to esteem. Jacob Bell 
gave respectful mention to Avicenna's scientific 
achievements in his accounts of the history of pharmacy. 
Jonathan Pereira, the eminent pharmacologist who later 
in the decade became Jacob Bell's co-editor on the 
Pharmaceutical Journal, recognised the contributions of 
physicians across the Muslim world between the 8th and 
12th centuries _t~ the development of modem chemistry 
as well as medicme. John Forbes Royle, a physician who 
had worked for the East India Company before taking up 
an academic position at Kings College, London, also 
made the link between ancient pharmacy and the origins 
of the chemical sciences. The prominent pharmacist and 
chemist, Thomas Morson, in a lecture to a pharma-
ceutical meeting in June 1841, described the 'Arabians' 
as 'perhaps the most learned' of the ancients (though he 
took issue with their polypharmacy), and spoke 
glowingly of the 'glorious' age of Alchemy, arguing that 
in their search for gold and long life the alchemists had 
built the foundation of present-day chemical 
knowledge. 13 The inauguration of the Chemical Society 
in 1841, the same year as the Pharmaceutical Society, 
was illustrative of the fresh interest in the discipline that 
warranted new perspectives on Arabic medicine and its 
alchemic experimentation. 
The decision of Jacob Bell and HP Briggs to feature 
Avicenna in the Diploma should be seen in the context of 
a broad reappraisal of the Orient, shaped in part by the 
upswing in international trade and travel at the end of the 
Napoleonic wars and by growing awareness of Empire 
and lands to the East among all sections of the British 
population, artists included. One of the painters to show 
interest in Oriental themes was John Frederick Lewis, a 
friend of Edwin Landseer, who made the first of several 
visits to the Near East in 1837. 14 It seems likely that both 
Jacob Bell, living a few streets away from the Lewis 
household and moving in the same circles as the artist, 
and HP Briggs, a fellow Royal Academician, would have 
AVICENA 
-
Figure 3. Portrait of Avicenna.from a 16th century 
printed book. Wellcome Library, London 
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been aware at the very least of this new direction of his 
work. HP Briggs had himself painted a fine portrait of the 
Bengali reformer, Rajah Rammohun Roy, who visited 
England in the early I 830s as ambassador of the Mughal 
Emperor Akbar II. 15 The Mughal dynasty once ruled 
from the Central Asian city of Samarkand in 
Transoxania, not far from Avicenna's home town of 
Bukhara, and the Arabic physician in the Diploma 
evidently draws on the artist's first-hand knowledge of 
Persian dress. 16 
If the Diploma's choice of the two medical authorities 
reflected the well-established and newly-minted cultural 
vogues for neo-classicism and Orientalism, it was 
nevertheless bold and unusual. Representations of 
Avicenna and Galen, along with other scholars of the 
Graeco-Roman and Arabic schools, had appeared 
relatively frequently in Renaissance manuscripts and 
published books, but there is no trace of them in British 
medical artefacts in the first half of the 19th century, nor 
in the intervening period either. 
Materia medica 
The treatment of the wreath was also far from typical. 
Garlands of various types were commonplace in classical 
design and true to this form the medicinal plants that ran 
along the circumference of the medallion were drawn 
close together to give the effect of a continuous border. In 
other ways the wreath was a distinctly contemporary riff 
on the classical design. Instead of a decorative pattern of 
repetitive foliage, the artist created faithful facsimiles of 
the natural world, suggesting a series of specimens. In the 
1840s, botany was well established both as successful 
scientific discipline and popular leisure pursuit. It was a 
crucial component of the medical curriculum and of the 
horticultural aspirations of the middle and upper classes. 
Hefty books on vegetable materia medica and 
expensively produced botanical journals were published 
in brisk succession for these expanding markets. 17 
According to Jacob Bell, the wreath represented the 
connection between 'Botany and Materia medica', and 
the Diploma made the link manifest through its choice of 
artistic style. The attention to detail, pre-figuring the 
hyperrealism of the Pre-Raphaelites, would have allowed 
experienced medical and pharmaceutical viewers to 
identify the individual components of the wreath and 
read the message they embodied. The Diploma illustrated 
a materia medica that had stood the test of time. Of the 
wreath's key plants, the only recent additions were Jalap 
and Digitalis, introduced in the 17th and 18th cen~ 
respectively. Arabic medicine knew Acacia, ' 
Hyoscyamus, Papaver, Pinus, Mandragora, 18 Rheum, 
Rosa, Scammonium, Camphor, Senna and Tarax~cum, 
and all excepting the last three in this list had a history 
that went back to the Greeks. Not only had these 
remedies been in use for centuries, they still number~d 
among the most important and effective treatrnen~. m 
contemporary medicine. 19 Like the medical au~on~es, 
the wreath conveyed a story of pharmacy's histoncal 
lineage and contemporary relevance. Above all, the 
portraits and materia medica evoked the quest for 
scientific medicine and implied a central role for 
pharmacy in the march of progress. 
Interpretation 
Between them HP Briggs and Jacob Bell produced a 
handsome design that was a clever combination of 
convention and modernity, both in form and content. It 
was confidently innovative in style, at the same time 
paying tribute to the traditional iconography of public art. 
It presented pharmacists as heirs of the ancients -
scientific, educated, and responsible - and consequently 
worthy of a place in the medical community of the 
present day. Were it not for a short article, 'The 
Description of the Diploma of the Pharmaceutical 
Society,' published in the Pharmaceutical Journal at the 
end of 1841, the success of Jacob Bell and the Diploma 
Committee in fulfilling their brief would have appeared 
complete. 
Although the Diploma moved from first prop?sal to 
finished product with speed, its passage was evidently 
not without incident. Members asked questions that 
Jacob Bell felt he should answer and perhaps also raised 
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cnhc1sms that he was anxious to deflect. Victorian 
institutions did not often hold open discussions about 
public art works or leave records of their closed 
deliberations and the 'Description' offers an 
interpretation of the Diploma that is all the more 
interesting because its author was attempting to establish 
points of contact between different ways of seeing. 20 
Some of the information in the Description is 
relatively straightforward. The author names the 
Diploma's medical figures and medicinal plants and 
explains their inclusion. While the turbaned supporter 
was clearly Oriental, the other European, more precise 
identification was hampered by the lack of fixed cultural 
conventions on the defining features of medical 
authorities from the past; there were no means of 
distinguishing Galen from Dioscorides, or Avicenna 
from other Arabic physicians, simply by looking. 
Renaissance manuscripts and books sometimes resolved 
this problem by printing names beneath portraits and the 
Description served the same purpose. Similarly, since 
nineteenth century chemists and druggists, who dealt 
primarily with raw drugs, would not necessarily have 
recognised their fresh aerial parts, the list of the 
Diploma's medicinal plants, presented in an accessible 
format - using the nomenclature of commerce and 
pharmacy rather than botany21 - permitted more viewers 
to appreciate the wreath intellectually as well as 
aesthetically. 
Other information in the article evidently seeks to 
correct negative impressions, counter objections or allay 
anxieties, in particular those that might have arisen in 
response to the apparent references to alchemy in the 
decoration of the pedestal. Until the 17th and early 18th 
century, medical men considered alchemy a serious tool 
in the search for knowledge, but with the spread of 
Enlightenment ideas it gained the reputation of a pseudo-
science and Victorians, associating it with magic and 
occult practices, viewed it with deep suspicion. Jacob 
Bell and HP Briggs may not have given thought to the 
impression that their design might make on pharmacists, 
a pragmatic and empirical body of men, unfamiliar with 
the latest revisionist assessments of alchemy or the new 
artistic interest in the East, and more used to the direct 
and unambiguous communications of advertisement 
than the allegory and symbolism of public art. 
The 'Description' sought in a discreet way to reassure 
colleagues that the Diploma met criteria for scientific and 
professional artefacts, downplaying alchemy while at the 
same time insisting that allusions to it were scientifically 
respectable. The article described the four motifs of 
silver, antimony, air and water etched at the comers of the 
Diploma's central pedestal as 'symbols of the ancients' 
without mention of any alchemic connection. It 
recognised the figure in the bas relief as an alchemist but 
qualified the label in a number of ways. Firstly the use of 
the archaic spelling, 'alchymist' linked pharmacy with 
ancient rather than modem alchemy; secondly, the 
alchymist's place of work - he is 'working in his 
laboratory' - and his instruments - referred to as 
'apparatus' and held to be symbolic of 'Chemistry' -
linked ancient alchemy with scientific modernity. 
Finally, far from possessing the taint of ignorance or 
quackery, the alchymist is said to represent 
'philosophical (ie scientific) research' .22 
At a more mundane level, the article claimed that the 
weighing scales stood for 'Prescriptions accurately 
prepared', an attempt perhaps to suggest that classical 
symbols need not be taken literally and might relate to the 
present-day activities of modem chemists and druggists. 
In a flight of fantasy, the article went as far as to suggest 
that one of the four motifs, 'water ' or 'Aqua regis', might 
also be interpreted as a reference to Queen Victoria.23 
Jacob Bell was known for a love of mischievous pranks 
but this proposition was more likely to have been an 
earnest attempt to find common ground with his 
colleagues than a joke at their expense. The same gap in 
expectations about visual representation is evident over 
the treatment of the chemists' and druggists' commercial 
activities. According to the Description, the mortar and 
pestle representing 'Pharmacy' was to be understood as 
a pun on the word 'pound', connecting the action of the 
pharmacist preparing his medicines to the profit accruing 
from them.24 Contemporaries conversant with the visual 
codes of medical artefacts would have noticed other 
allusions, less convoluted and more integral to the overall 
Diploma design. By the 19th century only a tiny minority 
of medical men possessed private financial means and 
creators of medical artefacts took as given that their 
subjects were working professionals. Artists situated 
medical practitioners in scientific, even heroic contexts, 
taking care at the same time to acknowledge their 
remunerative work through accessories. The designers of 
the Diploma adopted this approach when they included 
weighing scales, medical staff, medicinal plants and 
chemical vessels, in addition to mortar and pestle. They 
had no need of a pun as well. Jacob Bell apparently 
preferred to put forward a retrospective rationale, which 
however strained was safer than a lecture on modem 
medical symbolism that risked patronising and offending 
colleagues. 
Contemporaries acknowledged Jacob Bell's social 
skills, charm and powers of persuasion. His article - n? 
doubt supplemented by interventions at Council 
meetings and private conversations - effectively 
dispelled any reservations that Society members might 
have had about the design's fitness for purpose. In any 
event, there is no further trace of criticism of the Diploma 
on record, all the evidence pointing in the other direction, 
towards its rapid acceptance by the professi_on. 
Oppositional groupings within the Pharmaceutical 
Society, highly critical of Jacob Bell for his alleged 
arrogance and incompetence25 and likely to have made 
the most of any disagreements on a project for whi~h ?e 
was responsible, did not mention the Diploma in therr list 
of grievances. Local chemists were eager to incorporate 
the design in their business material, even too eager on 
occasion, according to the Pharmaceutical Joumal.26 
And in 1844, the Society used the design as template for 
14 Pharm Hist (Lond) 2015; 45 (1): 
https://dx.doi.org/10.24355/dbbs.084-201801291213
its successful application for a coat of arms. The 
Diploma in other words established itself rapidly as one 
of the Society's main visual markers, respected and 
valued both by members and the public, and it remained 
in use for well over a hundred years, framed and visible 
on pharmacy walls, signifying membership and 
qualification, just as the anonymous chemist in 1840 had 
proposed. 
Conclusion 
The diploma design was a success on many fronts: it was 
practical, cost-effective, aesthetically pleasing, culturally 
appropriate, and professionally and conceptually 
acceptable. A single copy, over the career of its recipient, 
might be seen by hundreds of colleagues and thousands 
of customers. Undeniably elegant, the design met 
accepted artistic criteria for a document of its geme, and 
provided a succinct visual statement of the purpose and 
principles of the pharmaceutical profession, accessible 
on several levels. Over subsequent decades, knowledge 
of Latin and with it the history of pre-modem medicine 
continued to decline and Galen was rarely mentioned in 
medical textbooks, beyond the occasional reference to 
the medicinal preparations that bore his name or a 
footnote on the burning of his books. Interest in 
chemistry's early history quickly peaked and Avicenna 
was erased even more thoroughly as a cultural reference 
point. The association between medicinal plants and 
modem materia medica grew more tenuous. But the 
basic visual grarmnar that underpinned the design 
remained intact, and the Pharmaceutical Society had no 
reason to consider a revision. While the public might 
miss specific allusions, they understood the Diploma's 
promise of competence and trustworthiness, and medical 
men recognised its declaration of professionalism and 
commitment to science. 
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Drug shortages in World War I: 
How German pharmacy survived the 
years of crisis 
Prof. Axel Helmstadter and Dr Sven 
Siebenand 
Department of Pharmaceutical Chemistry Goethe 
University, Frankfurt/Main, Germany 
In Germany, political crisis and the outbreak of World 
War I a hundred years ago led to severe supply shortfalls 
in almost every economic area, as goods formerly 
imported from the enemy or overseas were no longer 
available. This was the case in the pharmaceutical 
industry as well as in every single pharmacy. So it seems 
interesting to explore how industry and pharmacies 
coped with the situation and what efforts were made to 
guarantee the best possible way of drug supply on 
different levels. Several strategies are obvious and can 
actually be identified. Those include all measurements of 
rationing as well as the search for raw materials or 
products able to substitute for missing goods as far as 
possible. In 1916, when shortcomings became more and 
more visible in every single pharmacy, the famous Swiss 
pharmacist and botanist Alexander Tschirch made 
several suggestions concerning, as he called it, 'war 
chemistry'' and 'war botany'2. It will be of further 
historical interest to know if, and how far, the creativity 
forced by wartime circumstances led to sustainable 
developments or inventions that survived the war and 
remained of value in times of peace and free trade. 
Wilhelm Sertiirner, had already worried about supply 
shortfalls due to the dependence on foreign raw 
materials.3 In fact, this scenario came true for the Merck 
company in wartime, despite having had extended 
stockpiles.4 So in October 1916, atropine production 
stopped, as Hyoscyamus species Merck usually imported 
from Africa were no longer available. At the same time 
production of cocaine, which was still used as a local 
anaesthetic, also ceased. It also turned out that the switch 
from ether to the more effective benzene as the main 
extraction medium in the 1890s was a disadvantage, as 
benzene was hardly available in wartime. 
As chemical synthesis had already made some 
progress in the early 20th century, it was obvious to look 
for synthetic routes based on domestic materials to 
substitute natural products. Attempts were made but with 
variable success. There are some cases where synthetic 
alternatives had already been available prior to the war 
and there are others where the deficit promoted chemical 
research that became effective decades later. In his book 
The war of invention, Guy Hartcup5 found different 
examples where necessities of war catalysed 
developments that were also highly useful in times of 
peace. Among many other examples he focuses on the 
development of synthetic local anaesthetics like 
procaine, which had been synthesised by Alfred Einhorn 
in 1898 and regularly used since 1904. This was 
originally a German development which could easily be 
used instead of cocaine which had a great deal of other 
disadvantages. According to Hartcup, synthetic local 
anaesthetics hitherto imported from Germany, were soon 
in short supply in the British Forces, which caused hectic 
Alkaloid production attempts to develop synthetic procedures in British 
In Germany of the early 20th century, most medicines for laboratories as well. 
patients were still individually prepared in local Camphor substitutes 
pharmacies, although industrial production of drug A compound widely used in industry and medicine was 
preparations had already begun. Tablets and even camphor, a natural product isolated from the East-Asian 
ampoules had been commercially available since the tree Cinnamomum camphora by distillation. In 1915, 
1880s and replaced more and more traditional and 90% of the world supply, amounting to 4000 tons, came 
handmade preparations, while solutions and semi- ~.-----------------------. 
solid preparations remained a domain of the 
pharmacist. So during World War I, German 
pharmacists had to rely on a sufficient supply of 
mdustrial products on one hand and of raw materials 
f~r their home-made preparations on the other. On a 
higher level, industry suffered from short supply of 
raw materials imported from abroad, for example 
solvents or medicinal plants of foreign origin. 
Alkaloids, for example were often extracted from 
rather exotic plants, at least from a central European 
perspective. The Merck Company, the main manu-
facturer of alkaloid pure substances and 
preparations, faced severe problems. The situation 
became even worse as the British Tabloid 
prep~tions (Burroughs Wellcome), with their L-----' 
relatively big market share in Germany, were no Figure. Hemlock (Conium macu/atum) plantation for coniine 
longer available so that the request for domestic 
d 
production at Merck, Darmstadt, 191 2. 
pro ucts additionally increased. It is interesting to 
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drugs' as substitutes for imported merucinal plants and 
only saw major problems in substituting rhubarb, 
Strychnos seeds and ipecacuanha root.2 All other herbs 
could be replaced by plants containing chemically or 
pharmacologically similar compounds. He strongly 
recommended the systematic organisation of the 
collection of herbs, wherever possible guided by a 
pharmacist. From 1917 onwards, this was done by the 
so-called 'Hortus-Gesellschaft'. For example, the society 
eruted 32 leaflets with information for collectors and a 
description of the most important merucinal plants. 
Collectors were primarily rusabled war veterans, 
housewives, railwaymen and school children. 14 This 
situation was paralleled in World War II, when collecting 
merucinal plants was regarded as a nationwide and highly 
relevant task for those not serving in the army. Pharmacists 
were also involved as experts and guides, but most 
collectors were school children between 10 and 14 years 
of age. 15 Domestic vegetable materials were also used to 
replace materials needed in daily pharmaceutical practice, 
for example wound dressing materials or even cork 
stoppers. Beech tree fungi (Fornes fomentarius; tinder 
fungus) served both purposes, their fibres could be woven 
into some kind of gauze or even compacted into stopper-
like plugs for bottles.16 
Glycerin and ointments 
Among the most severe shortcomings in wartime industry 
and daily life was the lack of fat and everything derived 
therefrom. Fat was primarily used for food purposes and 
was therefore no longer available for industrial production. 
Again, this concerned big business as well as the local 
pharmacy. The absence of fat caused severe shortages of 
products like soap or glycerin, the pharmacist missed 
ointment and suppository bases. Cacao butter as well as 
petroleum jelly came from abroad and fat in general was 
rare and allocated. So from 1916, the use of pork fat or lard 
for the preparation of ointments was forbidden. 17 
Substitutes were often of miserable quality and sometimes 
caused more harm than the rusease to be treated. The 
famous dennatologist Paul Gerson Unna (1850-1929) for 
example complained about ointments made of raw and 
rurty wool fat as a reason for keratoderma and allergic skin 
reactions. 18 
1n particular, the demand for glycerin, usually produced 
by hydrolytic cleavage of fat, became extremely high, not 
caused by merucinal needs but by the extended use of 
dynamite, nitroglycerine, in times of war. It has also been 
used as an anti-freezing agent and a lubricant in machinery 
and weaponry. The explosive material was tremendously 
important not only in the war, but also for industrialisation 
in general, to a great degree depending on the availability of 
metals. So it has been stated, that 
It is interesting to contemplate the effect of explosives on the 
development of civilisation in some parts of the world. Before 
the development of mining with high explosives, the principal 
economic desire of the human race, after food and survival, was 
the search for surface metaJs.19 
1n the 19th century hydrolysis of fats was the primary 
process for glycerin production, and was used for the 
Table: Rules for prescribing in wartime (from 
'Kriegsverordnungsregeln', Germany 1916)17 
Prescribe in small quantities only 
Do not prescribe cosmetic preparations like soap 
and hair tonics 
Do not prescribe oils also useful for alimentary 
purposes like olive oil, groundnut oil etc. 
Do not prescribe lard, completely forbidden for 
external use in ointments ( also to be pref-
erentially used as food) 
Prescribe only small quantities of alcohol, and only 
if necessary (alcohol was often being produced 
from potatoes) 
Be restrictive with bandaging materials, prefer-
entially to be used for military purposes 
Do not prescribe 
Nafalan (no longer available from Russia) 
Glycerine (to be preferably used for military 
purposes) 
Guttapercha (no longer available) 
Substitute the following products (by) 
Petroleum jelly (Eucerin, wool fat) 
Starch (talc) 
Boric acid (hydrogen peroxide) 
Potassium chloride (alum, hydrogen peroxide, 
soda) 
' Chamomile flowers (hay blossoms) 
Rubber merucinal products (glass syringes, etc.) 
manufacture of soap and stearin candles. As fat became 
scarce, people remembered a ruscovery made by Louis 
Pasteur in 1858. He had observed that glycerin developed 
in small amounts as a by-product of alcoholic fermentation. 
Thus, research concentrated on methods of increasing the 
yield of glycerin in fermentation processes. In Germany, 
two working groups succeeded. Firstly, Wilhelm Connstein 
and Karl Ludecke, and secondly, biochemist Carl 
Neuberg.20 He tried to explore the biochemistry of the 
fermentation process by stopping the reaction at different 
stages. Raising the pH of the fermentation broth by adrution 
of a certain amount of soruurn sulfite increased glycerin 
yields up to 20%. A patent was granted for Connstein and 
Ludecke in 1915 but was exclusively utilised by the 
German armed forces.21 They founded the so-called Proto) 
company, referring to the chemical nature of glycerin, also 
known as propanetriol. The main purpose of the company 
was the production of 800 to 1 OOO tons of glycerin for 
nitroglycerin production. It has been stated that every 
German missed 6 kg of sugar a year which were needed for 
glycerin production; the availability of sugar decreased 
from 25 to 17 kg a year per person in 191 7, simply 
reflecting the glycerin demand.22 
In order to save glycerin, substitutes were proposed for 
different, including pharmaceutical, purposes. They 
included solutions of soruurn and potassium lactate, 
marketed under the trade names perglycerin or 
Perkaglycerin. These had also been developed by Carl 
Neuberg who had observed during his fermentation sturues 
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from the island of Taiwan and I 0% from Japan and 
China.6 In wartime, it was widely used as a cardiovascular 
stimulant for wounded soldiers. Applied topically, it 
increases blood circulation and acts as a mild local 
anaesthetic. It was also used as a moth repellent and 
against mites in beekeeping. It was a common ingredient 
of the pharmaceutical equipment of the armed forces. In 
technology, the terpene was highly important as a 
plasticizer and raw material for celluloid production. 
Camphor synthesis was developed in the late 19th century 
and became technologically relevant from 1903 onwards.7 
In 1905, 10% of the camphor used was already of 
synthetic origin. In Germany, the Schering Company was 
one of the biggest producers of synthetic camphor. In the 
beginning this was not used for medicinal purposes as 
there were severe doubts about quality. First of all 
synthesis only led to the racemic product, while only one 
stereoisomer was used pharmaceutically. Then, by-
products derived from the synthetic pathway were 
suspected. Furthermore, the German Phamacopoeia 
required natural camphor, so the synthetic one was 
basically not allowed for use in therapy. From 1915 
onwards, the use of the synthetic derivative was regularly 
used at least in external preparations. During the following 
years, synthetic camphor also became unavailable as 
pinene usually derived from French and American 
turpentine oil was needed as starting material. Thus, 
rationing procedures were irnplemented8 and substitution 
products were developed which again were used primarily 
in external preparations. Those included fenchone or a 
mixture of eucalyptol and methyl salicylate, marketed 
under the trade mark Kampferol by the Gennan 
wholesaler Hageda.9 
Cignolin (Dithranol) 
While in the case of procaine and camphor synthetic 
procedures had already been available before 1914, 
wartime misery was the starting point for extended 
phannaceutical chemistry research that turned out 
successfully sooner or later. One example is the 
development of the antipsoriatic agent Cignolin, also 
called dithranol or anthralin, originally synthesized as a 
wartime substitute for chrysarobin, a first-line agent 
against psoriasis since its introduction in the 1850s. 
Chrysarobin is a main constituent of Araroba powder 
derived from the Brazilian tree Andira araroba. It is also 
called Bahia or Goa powder, names which refer to the 
tree:s countries of origin. In WWI it was no lon~er 
available as it had to be imported from South Amenca. 
According to a description from around 1900, 
chrysarobin is a more or less impure neutral principle 
extracted from Goa powder by boiling in benzene. It is losing 
ground as a remedy on account of the occasional recurrence 
in a more severe form of the maladies that it appears to cure, 
and also on account of its irritating and staining qualities. 
Erythema, with swelling and cuticular desquamation, with 
reddening of the conjunctiva, are the effects of its application 
to the face or scalp. Intensely painful inflammation may 
succeed, lasting several weeks. 10 
Thus, it was by far not an ideal therapeutic compound, 
and a substitute was urgently needed. The short supply as 
well as the therapeutic disadvantages prompted the 
Gennan dermatologist Eugen Galewski ( 1864-1935) to 
search an alternative in close cooperation with the Bayer 
company. Bayer and Galewski received the patent for the 
newly synthesised but chemically related derivative 
dithranol in December 1916. 11 The compound was more 
effective than the treatment options before and had fewer 
and milder side effects. So skin affections of the head and 
face became treatable and the staining effect was much 
weaker. 
Lobeline 
Besides camphor, preparations of Lobelia injlata were 
regularly used as a respiratory stimulant and in the 
treatment of asthma. The plant which was also called 
Indian tobacco grows in the Eastern part of North 
America in the Great Lakes region. It has traditionally 
been used as a tincture although the Merck Company 
marketed small amounts of an extract from 1883 until 
1927. For a long time the nature of the active ingredient 
remained unclear until the German chemist Heinrich 
Wieland (1877-1957) extracted and crystallised the 
alkaloid lobeline. Elucidation of its chemical structure 
lasted several years as no adequate supply of plant 
material was available during wartime. In 1921 the 
Gennan company Boehringer started to offer a 
preparation containing the pure alkaloid w~ch, however, 
had still to be isolated from the plant. This was much 
better tolerated than the whole extract containing by-
products which regularly caused_nausea and vomi_ting in 
patients. Wieland and two of ~s PhD students ~vest-
igated possibilities of a lobeline total ~ynthes1s_ and 
succeeded in 1927 .12 However, a technically swtable 
synthesis procedure was not developed ~til 19~7 w?en 
Boehringer started to market synthetic lobehne JUS 
before World War II. The product, which was sti ll largely 
used as a medicine in the Gennan army soon became the 
company's blockbuster and was marketed until the Y~ 
1980, being recommended as an agent for smoking 
cessation in the last decades.13 
Collecting domestic plants 
Camphor tree, Araroba powder and Lobelia_ herb were by 
far not the only plant materials no longer available after the 
War had begun. In fact, Germany was soo~ ~ut off from 
every kind of foreign supply of ~edicmal plants. 
Moreover, in some kind of enthu_s1'."15m for new~y 
developed synthetic drugs and medicmal progre~s. m 
general collection and domestic cultivation of medicmal 
plants had been neglected. Circumstances of l?e war ~~de 
it necessary to concentrate again o~ domestl~ med1cmal 
plants. German pharmacists received advice by_ ~e 
German Alexander Tschirch, a professor of botany h;1ng 
and working in Switzerland, who created the term war 
botany'. Tschirch regretted th~t l?e Ge~an 
harmaceutical industry had rejected his earlier ~ugge~tlon f O obtain twpentine and pinene from domestic comf~rs 
and their needles as raw material for camphor sf thesis. 
He suggested a variety of: as he called them, parallel 
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that lactates could imitate some of the physical properties of 
glycerin, primarily in terms ofviscosity.23 It was also useful 
as a lubricant in greasing mechanical weapons and was 
cheaper than the original glycerin. It was also useful for 
pharmaceutical purposes and as an ingredient of cosmetic 
preparations. It had some antiseptic properties, but was not 
useful for combination with soap, tanning agents and coal 
tar products. Another disadvantage was that it was also not 
available in unlimited quantities, as the production oflactic 
acid was also limited in wartime. 
One of the most prominent glycerin substitutes was 
ethylene glycol, whose physical properties were quite 
similar to those of the original. It was easily available from 
ethylene and was useful as a pharmaceutical excipient. 
Unlike Perkaglycerin it could also be used in combination 
with tar and tannic acid derivatives. The use of the 
substance persists up to the present day as an antifreeze 
agent for cars, well known under the trademark Glysantin 
(BASF).24 Sugar solutions were also partly able to 
substitute for glycerin and to serve pharmaceutical 
purposes. There were different syrup-like products useful 
for external preparations or enemas. 'Mollphorus' was a 
mixture of sucrose and invert sugar with high viscosity. In 
concentrated form it did not crystallise and was also stable 
against microbial deterioration.25 Other glycerin 
substitutes included preparations made of plant mucilage, 
such as from Agar-Agar, Carrageen, Althaea root, quinces 
or linseed. They were not universally useful and always 
needed preservatives like boric acid. Combinations were 
also offered like the trade-marked 'Glycerinova' 
containing mucilage, potassium lactate, and calcium 
chloride.26 Besides Glysantin, which almost totally 
replaced glycerin as a technical anti-freeze and lubricating 
agent, all these developments did not survive the war for a 
significant time. 
Malaria prevention and treatment 
From a today's perspective it might sound strange that 
fighting malaria was a major concern of German troops in 
the late 19th and early 20th century. However, the tropical 
disease was still relevant in Southern Europe and North 
Africa and troops positioned there regularly suffered from 
the disease at that time only treatable with quinine. 
Quinine had already been in short supply during the 
American Civil War and several suggestions for local 
substitutes were made. Those included the external use of 
turpentine oil or domestic medicinal plants like dogwood, 
poplar or tulip tree.27 During WWl malaria was still 
prevalent in Southern Europe, the Balkan states and 
Northern Africa. Among the German army, the malaria 
incidence was estimated to be 13% for troops positioned 
in the Balkans and 18% for those in Turkey.28 Originally 
quinine came from Britain via the Netherlands, a supply 
chain which was soon cut off. It seems however, that a 
significant amount of material persistently came over via 
the black market. For the German troops in Africa, at least 
in the beginning, sufficient amounts of quinine were 
available which, however, soon faded, while no further 
supply from the North could be expected. Thus, military 
pharmacists felt the need to extract quinine out of local 
Cinchona succirubra plants. We know details from a 
biographical sketch written by the German military 
pharmacist Rudolf Schulze, garrisoned in Dar es Salaam, 
East Africa.29 Already in 1915, he started to 
experimentally extract quinine from local resources and 
could soon process more than a ton of succirubra root. In 
the following years he had to use all his pharmaceutical 
creativity as a production facility had to be established 
under rather primitive conditions right out of nothing. In 
the beginning, solvents and glass materials were readily 
available but the extraction procedure became more and 
more complex. Soon he had to switch from glass balloons 
to wooden barrels or iron bins. Moreover, cinchona stocks 
as well as the whole production plant had to be removed 
several times and hidden from the approaching enemy. 
One day he entered an abandoned railway station and 
constructed an extractor using vacuum brake chambers of 
the railcars. Heat for the extraction process was delivered 
by the engine of a discharged locomotive. This worked for 
a while until again, the place had to be given up due to 
advancing hostile troops. At the end, Schulze was only 
able to produce a rather primitive decoction which was, 
however, still useful in treating malaria. All this, he stated, 
was obviously better than British quinine tablets which 
had been compressed so hard that no effect could be 
expected. From 1000 kg quinine preparations used in 
Schulze's East African military company, 300 kg had been 
derived from local, extemporaneous production. 
The need for quinine substitutes clearly stimulated the 
active search for synthetic antimalarials which had begun 
in the 19th century, but did not succeed until the 1920s, 
when the Bayer company launched plasmoquine followed 
by chloroquine in 1934.3° In his study on the history of 
synthetic antimalarials, David Greenwood stated: 
During the war, the shortage of quinine impaired the efficiency 
of the Gennan forces especially in the East Africa Campaign. 
It is doubtful if any of the synthetic antimalarials in use would 
have been developed had not Gennany been deprived of all 
sources of quinine during the First World War.31 
Not every military pharmacist had been so successful as 
Rudolf Schulze had been, whose efforts are certainly an 
outstanding example of pharmaceutical creativity in 
wartime. Although not being proven in detail, one might 
assume that in every single pharmacy professional knowl-
edge was used to maintain pharmaceutical services for the 
benefit of patients as far as possible. German pharmacists 
of the early 20th century were still used to making 
medicines rather than just relying on industrial products. 
Conclusions 
It can be concluded that during WW I, in pharmacy 
as in any other economic area, serious shortcomings 
had to be conquered. In particular, a shortage of 
imported medicinal plants and of fat seriously 
compromised pharmaceutical services. Thus, at . all 
levels of the supply chain, alternative product10n 
methods or substitution products had to be fou~d. 
Industry, for example, switched their production 
processes for glycerin or camphor. The staff of local 
pharmacies were still used to manufacturing and 
were more or less able to cope with the situation by a 
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great deal of professional creativity. It also seems 
probable that the decentralised structure of pharma-
ceutical services in Germany was an advantage in the 
way that stockpiles existed at each level of the supply 
chain and that pharmaceutical services did not largely 
depend on only a few big suppliers but were 
delivered by a great number of experienced 
professionals distributed all over the country. In the 
1919 annual report of the German Pharmaceutical 
Society it was indeed stated that an adequate supply 
could have been maintained during the four years of 
war. The author, however, seriously doubted if 
pharmacists could have succeeded for additional 
years. 32 While most procedures and products 
introduced as substitutes vanished in times of peace 
and free trade, wartime necessities catalysed some 
important developments like those of synthetic 
antimalarials or the total synthesis of alkaloids. Some 
products well known today like Glysantin or 
dithranol, are directly related to the economy of 
scarcity a hundred years ago. 
This paper was presented at the BSHP Annual Spring 
Conference, Birmingham, March 2015. 
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some to well-known physicians 18th cent (MS.8910). 
Strathclyde University Archives, Andersoman 
Library, 101 St James Road, Glasgow G4 O~S, 
Scotland. George Mackie Ltd, dispensing chenusts, 
Glasgow: prescription registers 1874-1958 (Ace 1419). 
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Thomas Skinner: A Pioneer in 
Homeopathic Pharmacy 
Dr. rer. nat. Heike Gypser 
Glees, Germany 
Although not a phannacist, the Scottish physician 
Thomas Skinner nevertheless became a pioneer in the 
field of homeopathic phannaceutics. The preparation of 
remedies was not his major interest - it came about when 
practising homeopathy following the rules of the founder 
ofhomeopathy, Samuel Hahnemann (1755-1843), who 
recommended that every physician hould prepare his 
own remedies. 1 This principle of 'self-made' remedies 
became for Hahnemann and many of his fellows an 
irrefutable rule for homeopathy. Therefore it was a 
logical consequence for Skinner to catch up on the 
manufacture of remedies. This lead to the development 
of a production process which was in use up to the end of 
the 20th century. 
Figure 1. Thomas Skinner. In Clarke Ill Reference 2. 
1:1omas Skinner was born August 11 th 1825 at 
Salisbury Road, Newington, Edinburgh, as the second 
son of the solicitor John Robert Skinner. After leaving 
sch?ol in 1849, he began the study of medicine at the 
Uruversity of Edinburgh and at the Royal College of 
Surg.eons of Edinburgh. In 1854 Skinner gained the first 
medical qualification and in 1857 he became MD at the 
University of St. Andrews. In the meantime he had 
become a private assistant to James Young Simpson 
(I 81 L- L 870) and he took up Simpson's enthusiasm for 
chloroform. His contribution to anaesthesia ended up in 
the invention of an inhaler ('Skinner's Mask') and a drop 
tube ('Skinner's Drop-bottle').2 
Figure 2. Skinner's Mask. In SkinnerT. Reference 2: 15. 
While working with Simpson he was involved in 
discussions about homeopathy, and Skinner took part in 
Simpson's criticism of the new healing system3 and later 
he wrote that he 
was one of the physicians in Liverpool who took an active 
part in persecuting or attempting to put down homoeopathy 
... so great was my abhorrence of homoeopathy. '4 
When practising in Liverpool Skinner, as a 
consequence of influenza, suffered from an almo t 
complete insomnia for about three years, which made 
him unable to work. He could not find any release until 
he met the homeopath Edward William Berridge ( 1844-
1920).s Despite his thoughts against homeopathy he 
consulted Berridge who cured him with a single do c of 
Sulphur. Deeply impressed by thi experience,6 kinner 
started to study Hahnemann's writing and began to 
practi e homeopathy ecretly until 'he had made hi 
ground sure'. After 25 years of 'old school' practice he 
totally changed and abandoned allopathic remedies 
completely. 7 Skinner became a very prominent hom-
eopath, obvious from his large number of publications.8 
He published the international journal The Orga~on, 
wherein he was supported by famous Amencan 
homeopaths that he met personally in 1876 in 
Philadelphia on the occasion of the first International 
Congress for Homeopathy.9 In Philadelphia kinner 
became acquainted with Bernhard Fincke ( 1821- 1906) 
ed · 10 who had invented a certain type of rem y preparation, 
which had been patented in 1869 by the U patent office. 
In J 881 Skinner moved to London where he carried 
out a large practice for a quarter of century. He was an 
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assistant physician to the London Homoeopathic 
Hospital, which still exists today. Skinner was of good 
health and died only two weeks after he had slipped on a 
banana skin on October 11 th 1906. 11 
From the very beginning when practising homeopathy 
Skinner preferred using remedies at higher potencies. 
This fact can be considered as a common trend 
' 
especially in American homeopathy. 12 The preparation of 
higher potency remedies cannot be done by following 
Hahnemann's instructions exactly. Hahnemann mainly 
used the C 30 and C 60 potencies, which means that the 
original remedy had been diluted at 1: 100 and succussed 3? or 60 times. For this he needed 30 and 60 potentizing 
vials. Due to the development in homeopathy higher 
potencies were shown to be very effective, and remedies 
from C 200 up to C 8000 had been successfully used. Of 
course it is not very economical preparing them the 
traditional way and using a new vial for every potentizing 
step. Fincke was the first to solve this problem by the 
C 
D 
C 
E 
B 
Figure 3. Skinner'sApparatus. Reference 14: 320. 
construction of an apparatus for the preparation of the 
so-called high potencies. Skinner knew about this new 
principle and he built his first apparatus, which he called 
a 'fluxion-attenuator' and made it public in 1880. (Figure 
3.) 
The function of the apparatus is based upon Fincke's 
'fluxion-process', which means a continuous flow of 
water through a vessel. 13 In this case water comes 
through a copper funnel (after a certain time it will be 
replaced by the tap) followed by a silver tube, a nozzle 
and ends in an attenuating glass, which will hold 190 
minims. The glass holds one minim of the remedy 
prepared in advance following certain instructions, 
which are special for each remedy. The water flows into 
the attenuating glass with a certain power and causes a 
perturbation that substitutes the percussion required by 
Hahnemann to be necessary for a profound mixture of 
remedy and dilution liquid. When 100 minims of water 
have run through the glass one potentising step was 
counted. This apparatus was built at home by Skinner's 
son and could have been made for about two or three 
pounds. 14 
Figure 4. Skinner'aApparatus. Reference 16: 47. 
At this point Skinner developed another apparatus 
which prepared the remedies in a different way, which 
meant the water supply was interrupted once the 
potentising glass was filled up. The apparatus was 
automatically powered by a water wheel (Figure 4). 
Whenever the glass is filled with 100 minims it upsets 
and throws off the content. A certain quantity of remedy 
remains adsorbed inside the glass to be used to continue 
the potentizing process. Here also a strong perturbation 
happens, equalling a succussion. Skinner called these 
new types ofremedies 'interrupted-flux.ion' remedies to 
make a clear difference between the two methods of 
preparation. The number of the potency reached is 
registered by an index from one to one million. If the 
apparatus ran properly it was possible to make '50 
centesirnal potencies15 per minute, 3,000 per hour, 
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72,000 per day, 100,000 in about 
thirty-three hours and the millionth in 
about fourteen days and a half, running 
night and day' .16 
Skinner used his apparatus to 
prepare remedies at the tenth, thirtieth, 
two-hundredth, five-hundredth, 
thousandth (1 m ), five-thousandth 
(5m), ten-thousandth (10m), twenty-
thousandth (20m) fifty-thousandth 
(50m), hundred-thousandth (Cm), 
five-hundred-thousandth (Dm) and 
millionth (Mm) potencies. 17 The 
remedies were labelled as F.C., 
meaning 'fluxion-centesirnal' . It was 
possible to buy the remedies at 'Alfred 
Heath & Co., Homoeopathic 
Chemists' in London and they were 
also delivered to the United States. is 
The machine was made so as to be 
inserted into an ordinary wash-hand 
basin, 19 making it practicable for other users. Several 
other machines had been in use besides Skinner's own. 
~ne was modified with some improvements by Skinner 
himself and went to Toronto, Canada, to Joseph Daniel 
Tyrrell (1855- 1929). In 1887 he offered to potentize 
every remedy for doctors being a member of the 
~ternational Hahnemannian Association20 and not being 
m possession ofa potentizer.21 Today the original Skinner 
apparatus is stored at the Faculty of Homeopathy in 
London. 
Another of Skinner's apparatuses was in use and 
modified by the American homeopathic pharmaceutical 
company 'Boericke & Tafel' of Phi1adelphia22 about 
190~. The owners were very satisfied with the remedies 
o?tamed by this type of machine after having tested 
different types of potentizers.23 The remedies had been 
proved outstanding. Therefore the construction of a new 
machine based upon the mechanism of Skinner's 
apparatus occurred around the 1920s. This time 
'Boe~cke & Tafel' asked a company to design the 
machine. 
. With this new apparatus it was possible to prepare six 
d1ffe_rent remedies at the same time. Every potentizing 
~up !s fixed in a separate and sealed chamber. The water 
is llljected through a syringe under high pressure into the 
cup containing a C 30. The cups rotate and spill out the 
water. To arrive at the 1 O M level it took about one day 
~ d for the CM more than four days and more than 100 
htres of distilled water. To distinguish the remedies from 
others, 'sk' (for Skirmer) was added to the name of the 
remedy.24 (Figure 5) 
_In later years the machine was validated and complied 
with FDA's Good Manufacturing Practice standards. 
From 1991 onward the machine was not in use any 
longer_b~cause the FDA requested a succussion for every 
potentizmg step. This was not possible to perform with 
the machine, which made the 'succussion' by the violent 
perturbation following the flux.ion-principle. 'Boericke 
Figure 5. The Skinner Machine Today. 
Private picture, Dr Gypser. 
& Tafel' had offered more than 500 high potency 
remedies. 24 
Conclusion 
It has been demonstrated how a homeopathic physician 
became a pioneer in homeopathic pharmaceutics by 
coincidence. Neither the pharmaceutical work, the 
manufacture of remedies nor economic reasons were 
Skinner's major interest. His only goal was obtaining 
well-acting remedies for curing the sick. 
Because of the prominent role ofhomeopathy in America 
and its physicians prescribing high potencies, it resulted 
in a pharmaceutical company getting involved with 
Skinner's remedies. In comparison to other automatically 
produced remedies they were found more effective o 
that the company focused all their work on the 
improvement of the original Skinner apparatu . The 
technical and cientific development conti nued and 
ended up with the construction of a machine that was 
working up to the end of the 20th century. kinner's 
remedies were used successfully in homeopathic 
treatment worldwide for about a hw1dred years and 
Skinner became one of the very few, besides 
Hahnemann, to play an important role in homeopathic 
pharmaceutics. 
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A Survey of Artificial Pharmaceutical 
'Stones' - Part 2 
Christopher J Duffin and Rachael Pymm 
Sutton, Surrey and Egham, Surrey 
Continued from Pharmaceutical Historian 2014; 44 (1): 
2-9. 
Lapis medicamentosus 
This stone, credited to Oswald Croll (circa 1563-1609), 
alchemist, champion of Paracelsianism and a member of 
Rudolph II's scientific circle in Prague, is subject to some 
variation in composition. Earlier recipes are based on 
Roman vitriol (cupric sulphate), white vitriol (zinc 
sulphate), alum, cerusse (lead carbonate), lapis 
calarninaris (zinc oxide or zinc carbonate) and an earth, 
such as Bole armeniac. Later accounts cite green vitriol 
(iron sulphate) in place of the blue, the use of common 
salt and salt of tartar (potassium carbonate), and Anatron 
of Sandiver. The latter ingredient, also known as Glass-
gall was a by-product of the glass-making industry; it 
was the scum rising to the surface of the melted glass, 
consisting of various fused salts ( especially various 
chloride and sulphate impurities) that do not combine 
with the silica. 1 Schroeder's lapis rubeus dictus is quite 
similar to Lapis medicamentosus, having litharge, sal 
ammoniac and albi puri (pure white sugar) as additional 
ingredients. 
Lapis medicamentosus enjoyed a wide range of 
applications, being 'laid to fasten the Teeth, preserve the 
Gums, heal and dry up Ulcers and Wounds, ... and in 
Compositions for sore Eyes.' It also supposedly dried up 
various discharges and was used in the treatment of 
erysipelas ('St Anthony's Fire' - a dermal streptococcal 
infection), itch ('Scabiem'), fistulas, and gangrene, as 
well as encouraging coagulation of the blood and 
preventing corruption of the lyrnph.2 It seems to have 
been something of a last resort in terms of its dental 
applications as mentioned above: John Pechey (1655-
1718), the London doctor who often came into conflict 
with the Royal College of Physicians over his 
apothecarial style, wrote that 'When the Gums are 
putrified and corrupted , and the Teeth being carious and 
loose, stink' or when 'deep and putrid Ulcers afflict the 
Gums ... stronger Medicines, and such as greatly resist 
Putrefaction, are to be used ... Lapis medicamentosus is 
very effectual in this case'. 3 
Lapis medicamentosus was also used in iitjections 'for 
stopping a gonorrhoea after the virulence has been 
expelled' .4 Jean Astruc (1684-1766; Fig. 1), Professor of 
Medicine at Montpellier and Paris, and pioneer of the 
study of sexually transmitted diseases, noted that two 
drachrns of Lapis medicamentosus mixed with dried 
roots of the Common Marshmallow (Althaea officinalis), 
'to be thrown daily up the Urethra, or Vagina, to take of 
the relicks of an habitual Gonorrhoea. But be very 
cautious that you imprison none of the virulency, which 
may bring on the tragedy afresh; therefore it is better to 
abstain from so hazardous a remedy'. In the male, 
Figure 1. JeanAstruc (1684-1766). Line engraving by L. 
Halbron, 1771, after C. Monnet. Weilcome Library, London. 
Charles Gabriel le Clerc ( 1644-1700; Physician in 
Ordinary, and Privy-Counsellor to Louis XIV) indicated 
that Lapis Medicamentosus dissolved in Plantain Water 
was to be injected directly into the penis. 5 
The German alchemist and physician, Adrian von 
Mynsicht (circa 1588-1638; Fig. 2), used Lapis 
Figure 2. Adrian von Mynsicht (circa 1588-1638), Line 
engraving by D. Dirickson. Weilcome Library, London. 
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medicamentosus as a simple in a surprising variety of 
preparations, including 
• With Gum Lacca (scarlet resinous secretion of some 
species of scale insects and mealybugs) and burnt alum 
dissolved in Water of Sage and Roses to form Tincture of 
Lacca, with which to treat scurvy and 'the laxity and 
rotenness of the Gums' . 
• With mercury, Rose Water and Plantain Water, all 
dissolved in Aqua Fortis (nitric acid). This was used 
topically against old ulcers and wounds, 'especially the 
old sordid Aphrodisia' , and was deemed effective at 
removing 'all Morphew [blemish or mark on the skin, 
often due to scurvy], Spots, Scurff and Pimples of the 
Face', as well as treating erysipelas and fistulas. His 
advice to ' take heed lest you touch the eyes or teeth' 
seems well placed! 
• With alum, green Elder bark, Mugwort, St John's 
Wart, Cinquefoil, Dwarf Elder, Dill, Maidenhair, salt and 
Guiacum, all boiled together in river water in order to 
provide a foot bath (Balneum medicamentosum sive 
Latia pedum) to treat scurvy and tumours of the foot. 
• With Virgin honey, alum, Tincture of Roses and a 
range of coloured and aromatic ingredients ( e.g. coral, 
myrrh, mastic, Dragon's Blood) to form a medical 
balsam that was applied to the gums 'when they are 
putrid, swelled, overgrown and black', to fasten loose 
teeth and 'amend other vices of the mouth', and to heal 
'the Cancer, Noli me tangere ['Touch me not' - often 
referring to cancer of the eyelids], Scurvy, Imposthume, 
Ulcers, Corrosion, etc.' . 
Figure 3. Gideon Harvey ( circa 1640-circa 1700). Line 
engraving by P. Philippe, 1663. WeUcorne Library, London. 
• With old Hog's grease, white turpentine, sulphur, a by the Spanish apothecary, Juan de Loeches (dates 
range of types of lead, Tutty, Pompholix and a range of unknown, but late 17th century) where a range of 
other ingredients to make Unguentum medicamentosum. supplementary ingredients ( e.g. absinthe, artemisia, 
This was then used to treat Scabs, running sores, tetters chicory, plantain and myrrh) are added to the usual 
(eruptive skin diseases such as Herpes or eczema), itch, alkalis.s William Salmon's Lapis medicamentalis has a 
elephantiasis, alopecia, sores on the head and for the composition which is quite similar to Lapis salutis : 
removal of scurf Hungarian vitriol, salt of nitre, cerusse, alum, bole, 
• With Ashes of Hermodactylus (Snake's Head, a sandiver and sal ammoniac mixed together in white wine 
member of the Iridaceae ), Asphodel root, Bean stalks, vinegar. 9 
wood of Elder, figs, vine cuttings, and dwarf elder, Gideon Harvey ( circa 1640-circa 1700; Fig. 3) was 
cummin seeds, Bay berries, cloves, brown bread, vinegar born in Holland and studied at Oxford, Leiden and in 
and white wine, and boiled gently to produce the France before settling as a physician in London. Widely 
Cataplasm of Ashes. Linen cloths soaked in this mixture published, his writings tend to be somewhat elf- <:rving, 
were then applied to 'Dropsical tumours and swellings' , and he claims responsibility for Lapis salutis with the 
working in a pathway downwards toward the feet. 6 following composition: 
By the late 1760s this recipe was being dropped from Roman and martial vitriols (sulphates of copper and iron 
~e official pharmacopoeia; the otherwise anonymous respectively), viride aeris (verdigris), cerusse, litharge of 
M.S.' remarked, in 1744, that 'This composition is a silver dissolved in vinegar and thickened with Annenian bole 
very odd one, very rarely prepared and much seldomer to produce the stone-like consistency. 
used '.? The stone powder could then be suspended in red wine 
Lapis salutis and applied with beneficial results to 'depascent and 
Lapis salutis or the Stone of Health was detailed in dysepulotic Ulcers' (i.e. those which were eating away at 
the tissues and intransigent to other treatments).10 
several recipes: a pound each of alum, Hungarian vitriol 
(?), half a pound each of white vitriol (zinc sulphate), Geoffroy's Stone . 
white lead, sandiver, and Armenian bole, four ounces of Etienne-Francois Geoffroy ( 1672- 173 l ; Fig. 4), Master 
frankincense and one and a half ounces of myrrh were Apothecary in Paris reported to the Ro~al Academ~ in 
ground together to form a powder. Alternatively, vitriol, 1713 concerning some spherical stone-like preparations 
sal nitri, cerusse, bole armeniac and sal ammoniac were made by French surgeons and used to treat battle 
blended together. The most enthusiastic recipe is given wounds. Iron filings, haematite and rerun of Tartar were 
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Figure 4. Etienne-Francois Geoffroy ( 1672- 1731 ), 
Line engraving by L. Surugue, 1737, after N. de 
Largilliere. Wellcome Library, London. 
ground and mixed together in white wine in order to form 
a paste. To this was added mastic and saffron, and then 
the whole confection was dissolved in wine, myrrh and 
aloes. After thorough mixing, the liquid was allowed to 
stand and the fluid allowed to evaporate. The precipitate 
was then moistened with brandy, shaped into balls, dried 
in the sun and stored in stoppered bottles. When the 
medicine was needed, a ball was soaked in wine or 
brandy (or in the absence of both, fresh urine) to form an 
infusion. Subsequent treatment depended on the severity 
and depth of the wound; simple cuts and scrapes were 
washed with the fluid, deeper cuts had the tincture 
injected directly into the wound, and arterial cuts 
warranted the spheres being pressed directly into the 
wound and compresses soaked in the tincture used to 
cover it. The tincture was also applied to intransigent 
ulcers, supposedly with beneficial results.'' 
Lapis divinus 
Lapis divinus is a term that has been applied to two 
stones, one naturally occurring, and the other artificial. 
Nephrite jade, sometimes also referred to as lapis 
nephriticus, occurs in some materia medica collections 
( e.g. John Burges Materia Medica Collection at the Royal 
Pharmaceutical Society Museum, specimen 1063), and 
was used amuletically to guard against and remove a 
wide variety of renal calculi, particularly bladder stones, 
and to ease the bites of insects. 12 
Directions for the manufacture of artificial Lapis 
divinus involved melting together alum, saltpetre and 
vitriol of Cyprus in a glazed earthenware vessel placed in 
a charcoal furnace. As soon as the mixture began to 
seethe, camphor was added and the whole unit sealed. 
After 24 hours, the pot was broken to extract the 'stone' 
inside, which was then stored in a stoppered glass bottle. 
When required, up to half a drachm of the stone was 
powdered into half a pint of water, to which was added 
sugar candy and a spoonful of brandy. 13 The identity of 
vitriol of Cyprus is not absolutely clear; both Dioscorides 
(first century AD) and Pliny the Elder (AD 23-79) 
referred to vitriol forming as white dripstones in caves, 
mine tunnels and pits in the vicinity of copper ore 
deposits on Cyprus, which suggests that blue vitriol or 
copper sulphate was meant. 14 
Helcoma, a corneal ulcer, was supposedly cured by 
irrigating with a solution of lapis divinus, which was also 
recommended in several varieties of ophthalmia (with 
pimples and abscesses on the cornea, or ulcers on the 
eyelid). It was also used in cases of gonorrhoeal 
ophthalmia, characterised by purulent conjunctivitis, and 
otorrhoea (discharge from the ear). 15 
The famous French ophthalmologist, Charles de Saint-
Yves, ( 1667- 1731) used solutions of lap is divinus 
extensively in his work. De Saint-Yves learned medicine 
and surgery in his position at the pharmacy of the Priory 
of St Lazarus, part of the Roman Catholic institution of 
priests and brothers known as the Congregation of the 
Mission. Leaving the Priory in 1711 , he set up his own 
practice in Paris, becoming well known, especially for 
his work with patients suffering from cataracts. His 
treatment of a French farmer's wife with long-tenn 
ophthalmic problems involved removing the greater part 
of the globe of the eye when her life was threatened by 
the high fever, extreme headaches and beginnings of 
gangrene in an eye which was bulging from the orbit; 
part of the post-operative treatment involved washing the 
wound with a solution of lapis divinus three times a day. 
He also used it in cases of what he referred to as 'Nail or 
Pterygion', a wedge-shaped fibrosis growing inward 
from the conjunctiva and distorting the cornea, as well as 
in the various types of ulcer listed above. 16 As an 
ophthalmic remedy, Lapis divinus was still being used 
well into the mid-nineteenth century. 
Lapis infernalis 
Lapis infernalis or the Infernal Stone (also referred to in 
various works as Lunar Caustic, Lapis septicus, Lapis 
coelestis and the Chirurgical Stone) is the subject of 
considerable variation in terms of its content. John 
Quincy gives three recipes for this highly caustic 
preparation: 17 
I. Evaporated 'strongest soap lees' (lye or sodium and 
potassium hydroxide). 
2. Calcined vitriol and tartar, quick lime (CaO) and sal 
ammoniac, boiled together in water, strained and evaporated. 
3. One part quick lime to two parts potash or calcined tartar, 
infused in hot water for five or six hours, boiled, strained 
through brown paper and evaporated. 
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LeClerc, however, suggests dissolving one part silver in 
three parts spirit of nitre (nitric acid) and boil, reducing it 
to one third of the original volume before pouring into a 
mould and allowing the residue to set. 18 One such mould 
is described and illustrated by Nicholas Lemery (1645-
1715) in his Cours de Chimie (1675). 19 
The corrosive ( escharotic) preparation was used as a 
cautery to remove dermal 'excrescences', warts, penile 
and preputial gonorrhoeal ulcers ('skankers') and 
'carunculae', cankers, gangrene, tumours, 'caries of the 
bone', fistulae, abscesses, carbuncles, ulcers in sufferers 
from the King's Evil, and excess post-operative tissue 
associated with removing lachrymal fistulas or 'fungous 
carnosities' associated with lithotomy.20 Mixed with 
distilled Oil of Tobacco and placed for a short time on the 
surface of the abdomen, it was used topically to provoke 
vomiting.21 The Cork physician Edward Barry used 
repeated applications of lapis irifernalis to remove 
testicular tumours; he used oil of vitriol to ameliorate the 
pain suffered by the patient during the treatrnent! 22 
Lapis seu Sal Prunellae 
Nicholas Culpeper (1616-1654) describes the production 
of this stone as heating pure saltpetre in a crucible and 
slowly adding yellow sulfur.23 It was supposedly 
therapeutic in cases of toothache, inflammation and 
bucco-pharyngeal sores, as well as being taken inwardly 
in cases of hot fevers (such as attended cases of plague), 
worms and kidney stones. Incorporated into a liniment 
with brimstone, Salt of Saturn (lead acetate) and 'Oyl of 
Rape', it was also used to treat 'Rebellious Herpes' . 
Lapis prunella was even used in cooking, as part of the 
lengthy process of preparing 'Dutch Beef'. 24 
.l.,· Pm· F,"Jtlti1,1ml ! t;{,,;,,1. 
Figure 5. Ferdinand Verbiest (1623-1628). Detail of an 
engraving by J. van Solingen, 1736. 
Wikimedia Commons. 
Lapis attrahens venenum 
In addition to the artificial stones detailed above, Johann 
Helfrich Jungken (1648-1726) lists Magnes arsenicalis 
based on Hungarian antimony, brimstone and arsenic, 
which was either worn amuletically or as a plaster; 
supposedly it worked magnetically, drawing poisons out 
of plague victims. 
Lapis attrahens venenum - the Poison Attracting Stone 
- also cited by Jungken, presumably worked in a similar 
fashion against the bites of venomous animals, and was 
based on poisonous secretions from toads, viper jelly and 
terra lemnia.25This appellation is also found in a treatise 
by Ferdinand Verbiest (1623-1688; Fig. 5), a Flemish 
Jesuit missionary to China, probably more famous as an 
astronomer and seemingly the designer of the first ever 
self-propelled vehicle. Verbiest's treatise is entitled Hsi-
tu-shih yuan-yu yungfa ('The origin and usage of the 
stone that attracts the venom') and is thought to have 
been composed circa 1686.26 His text advise that the 
Poison Attracting Stone should be prepared from flesh of 
the viper, earth (perhaps terra sigillata) and the tone 
taken from the head of a snake in India. 27 The latter is the 
snakestone or lapis serpentinus, which has, itself, been 
the subject of much debate, particularly over its origin 
and composition, as well as its supposed therapeutic 
effectiveness. Many, including Verbiest, credulously 
assert that it is a stone taken from the head of certain 
species of snake and consider this to be the 'natural' 
snakestone. German Jesuit scholar Athanasius Kircher 
(1601/2-1680), a possible source for Verbiest, also s~ms 
to credit the existence of a 'natural' snakestone, retneved 
from the head of a snake, as well as an 'artificial one 
which can be made of little crushed stone fragments from 
the snakes' heads, hearts, livers and teeth. These portions 
are mixed with some special kind of earth'. 28 However, 
one of the earliest seventeenth-century travellers' 
accounts which reference the snakestone describes it as 
being composed of the ash ofb~t ro_ots and the earth of 
a city in India - the country m which _the nake tone 
tradition may have originated - named D1u: 
In this Town ofDiu the so much famed tones of bra are 
made they are composed of the A hes of burnt roots, 
mingied with a kind of Earth they ~ave, and o~ce again burnt 
with that Earth, which afterwards 1s made up mto a Paste, of 
which these Stones are formed. 29 
Generally, snakestones were thought to ~ effective 
against the bite of venomous animals, especially snak_es, 
as they were believed to draw the venom from ~e ~1te; 
the stone's ability to adhere to a wound tnSpired 
confidence in this theory. More detailed discussion of the 
snakestone will be given elsewhere. 
Conclusion 
The 17th century and the first half of the 18th ce~tury, 
during which time Paracelsianism was progress~v~ly 
replacing the more traditional ten.ets and p~cnbmg 
practices of Galenism, mar~ed a ttme_ o~ con td~~ble 
innovation in the production of art1fic1al med1cmal 
'stones'. These dried, ball-like addition to the pan ply 
of apothecarial preparations had the advantage that, on e 
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manufactured, they were stable, easily transported and 
stored (usually in sealed or luted glass containers), had a 
relatively long shelflife, and could be administered easily 
with standardised dosage in powdered form suspended or 
dissolved in a suitable medium and, often, the solution 
itself also kept for several weeks. The nomenclature of 
these preparations provided a comfortable link with the 
popular geological and sometimes zoological simples 
th<!t were a feature of the more highly folkloristic medical 
traditions of the Middle Ages and enshrined in many 
materia medica and pharmacopoeias. 
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Jndies. London: Archibald, 1687; Part ill, Book I, Chapter XVIII). 
Based upon Verbiest's work, the Poison Attracting Stone (hi tu s1) 
was included in various eighteenth century Chinese works, 
including the Kuang-tung t'ung chich, The Gaz.etteer of 
Kuangtung (published by Hao Yu-Jin in 173 I) and the Pen ts-ao 
kang mu shi i (1760). 
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In Iranian traditional phannacy, not only were 
oil=bearing plants used to produce medicinal oils, but 
also every part of the plant could be used. Peganum oil is 
a good example of this kind which was prepared by 
processing the seeds of Peganum harmala L. with an oily 
vehicle. This paper introduces this oil and its medical 
uses as well as the preparation method from the 
phannaceutical traditional treatises called Qarabadins. 
Introduction 
O ils are ancient forms of medicine1 which were used 
traditionally in Chinese, Greek, Egyptian and Indian 
systems for example.2 This dosage form is also an 
important part of the Iranian traditional pharmacopoeia. 
Oils are still a popular remedy among the people and 
available in traditional herbal markets (Attan). Many 
different kinds of oils with various therapeutic properties 
are mentioned in traditional medical and phannaceutical 
treatises. A Qarabadin (Pharmacopoeia) is a kind of 
pharmaceutical treatise that includes details of modes of 
preparation, combination, preservation and administration 
of dosage forms. It may be a part of a larger treatise like the 
5th book of Avicenna's Canon of Medicine, or in most 
cases an independent work such as Qarabadin Salehi. It 
persisted as a pharmacological form well into the 
nineteenth century.3 Usually this kind of treatise has been 
written according to dosage forms in alphabetical order. 
The Qarabadin Salehi, Qarabadin Kabir, Qarabadin 
Shafayi and Qarabadin Azam are the most important 
Qarabadins in Iranian Traditional Pharmacy. 
One of the main parts of this type of treatise is Oils 
(Roghan in Persian or Dohn in Arabic). Traditional oils 
could be divided into mineral, animal and herbal oils, with 
herbal oils forming the major part. They could be used 
orally or topically. The interesting point about herbal oils is 
that they were not only produced from oil-bearing parts of 
the plant, but they could also be prepared from every part of 
every plant.4 Depending on the herb type and part, different 
ways of preparating oils were used, 4.5 of which some are 
comparable to modem ways.6 This paper introduces one of 
these oils, Peganum oil, as well as its traditional medical 
uses. Recently, the oil was prepared in the traditional way 
to evaluate its appearance. 
Figure 1. A traditional herbal market in Shiraz, Fars, 
Iran. (Photo by authors) 
Peganum Oil 
Traditional treatises mention Peganurn oil prepared from 
seeds of Peganum harmala L. This plant is a native herb of 
dry areas from the Zygophyllaceae farnily.7 The Persian 
name (Esfand or Espand) is derived from the ancient word 
Sepanta meaning pure and holy. It was first described by 
Dioscorides as 'Peganon agrion ', and later Greek authors 
mentioned it as 'Persaia botane'. The genus name is 
derived from the ancient Greek name of the plant. The 
specific harmala refers to the Syriac name of the plant 
(Hormal), which is still used as its Arabic name.8 In 
addition to various medicinal properties mentioned in 
Iranian medicinal treatises for P. harmala (Figure 2), the oil 
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Figure 2. Page of Arabic translation of Dioscorides 
Materia Medica, AI-Hashayesh1o which contains a 
monograph on Peganum harmala. 
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processed with its seeds also Table 1. Changes in acidity, peroxide value, iodine value and saponification value of oil 
had been shown to have 
therapeutic properties. 
Topical or oral use was 
considered aphrodisiac. It 
also was used in hearing 
problems, paralysis (Fakq), 
facial palsy (Laghve), tremor 
(Raashe), sciatic pain (Ergh-
ol-nasa), backache and other 
kinds of musculoskeletal 
Acid value 
Sample 
(% as oleic acid) 
Olive oil l.01±0.l 
Peganum oil 3.85± 0.24 
pain such as joint pain.4.5 This medicine was used by the 
rectal route as an enema for some kidney and uterus 
disorders caused by cold ternperament.9 
Preparation of Oil 
According to Qarabadins, there were two different ways 
for preparing Peganum oil (Figure 3). In the first method, 
which was the most common one, the seeds should be 
ground and macerated in water for one night, then boiled till 
the seeds soften and all the strength of the seed transfers to 
the water. Then it should be filtered. The aqueous extract is 
then mixed with an oily vehicle like almond, olive or 
sesame oil and boiled on a gentle fire to evaporate all the 
aqueous part The ratio between seeds, water and oil is 1 to 
6 to 1.5 by weight.4,5 Sometimes, before boiling with oil 
another herb was added to this formula, like the juice of 
Raphanus spp. (radish).s 
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Figure 3. Page of Qarabadin Kabir (18th century) on 
therapeutic uses and preparation of Peganum oil. 
In our attempt to prepare peganum oil, olive oil was 
used as the oily vehicle. The interesting point is that 
according to traditional treatises the last step of oil 
preparation (boiling the aqueous extraction with oil) 
should be necessarily done in a stone, copper or iron pot.4 
The use of a glass jar in our work resulted in a reddish 
two-phased turbid oil. But by using a copper or iron pot, 
a red clear odourless oil was obtained. 
The other method used for Peganum oil preparation 
was called Tankis ( ),s which is a method 
known as reversed distillation. 11 
Basic Analysis of the Oil 
Fo~ investigation of the changes in oil standard values, four 
typical tests, including acid value, peroxide value, iodine 
value and saponification value, were performed according 
to ~e pharmacopoeia standards for olive oil (the oily 
vehicle for the base) and prepared Peganum oil. Each test 
was performed 3 times for each sample (fable 1 ). 
Discussion and Conclusion 
Oils~ among the main topical dosage forms of traditional 
medicme and pharmacy in many countries.' The 
-
Peroxide value Iodine value Saponification 
value 
(meq/kg oil) (g of lz/100 g oil) (mg KOH/g oil) 
11.50± 1.12 90.21±2. 85 191.82± 5.63 
13.38± 1.46 91.83± 2.05 201.23± 6.78 
therapeutic impact of some of these dosage forms in folk 
medicine may be a reason to reestablish the preparation in 
current medical approaches. On the other hand oils, 
especially rubbing and massaging types, are still popular 
among traditional practitioners with cultural beliefs. Their 
ease of preparation and administration as well as rapid 
abs01ption via massaging on the area are some advantages 
which make the dosage form a convenient and highly 
applicable pharmaceutical form in traditional medicine. But 
pharmaceutical research and precise analytical methods of 
detennination for this dosage form are scarce. 6 
However, remaking a traditional preparation should be 
performed in correspondence with the cited procedure. 
Figure 4. Distillation method which is traditionally used 
in Iran. (Photo by authors) 
Otherwise, clinical evaluation may lead to W1certain or 
undesirable results. As a topical remedy in neurological and 
painful conditions, peganum oil is a traditional preparation 
from a traditional pharmaceutical manuscript. ln our work, 
the oil was prepared by the procedure employed in the 
manuscript and a red transparent oil formulation was 
obtained With reference to the boiling process, ome semi-
lipophilic constituents of Peganum may be trapped in the 
oil phase following aqueous phase evaporation. On the 
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other side, amounts of heat-sensitive ingredients extracted 
in the water phase may decompose via overheating. This 
fact may have resulted in the elevation in acid or peroxide 
value compared to the olive oil. 
Other than the historical clarifications, peganum oil 
presented and prepared in this research can be submitted 
for clinical evaluation. 
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Insomnia is a common sleep disorder and oral sedative 
drugs are the most commonly used in allopathic 
medicine for its treatment. In Iranian traditional medicine 
(ITM), different drugs are used for the treatment of 
insomnia, as well as in other schools. One of the most 
important characteristics of ITM is that it recommends 
the use of non-oral drugs to treat insomnia. In this 
method, not only are gastrointestinal adverse effects of 
drugs eliminated, but also in many cases speed of 
efficacy of the drug increases compared to oral the 
method. In ITM one of the best methods of giving drugs 
in neurological diseases such as insomnia is the nasal 
route. Nasal drugs are used in traditional medicine in 
various forms. The aim of this study is the investigation 
of some inhaled hypnotic herbs and description of their 
administration in ITM. This study is a review ofliterature 
based on credible ITM textbooks. The present study 
collects some of the inhaled hypnotic herbs which are 
used to treat insomnia in ITM and describes all non-oral 
methods of their administration. Since intranasal drug 
consumption is one of the principal treatment routes for 
insomnia, a description of the method and introducing 
current herbs for insomnia can be considered as sections 
of principal treatment in different clinical studies and 
even as complementary medicine alongside modem 
current treatment methods. 
Introduction 
Insomnia is the most common sleep disorder. Almost 30 
percent of people in each society suffer from insomnia in 
some period of their life, while 1 O percent of them exhibit 
chronic insomnia. Furthermore, insomnia is usually 
more prevalent among elders, females, divorced people, 
widows and those who suffer from other physical or 
psychological diseases. 1 Insomnia affects other aspects of 
life as well. To name a few, fatigue, day-time drowsiness, 
reduced memory and concentration, depression, anxiety, 
high sensitivity and irritability, work disturbance and 
reduced life quality, are among side effects of insomnia.2 
Benzodiazepines are frequently prescribed to treat 
insomnia but they increase the probability of adverse 
effects such as slowness, sleepiness, fatigue, 
nervousness, forgetfulness, headache, irritability, 
dizziness, aggressiveness, change in sexual drive and 
confusion.3 GABA is the main inhibitory 
neurotransmitter in the central nervous system and 
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benzodiazepines intensify GABA inhibitory effects in all 
nervous levels. But 5-HT, dopamine neurotransmitter and 
nicotinic and muscarinic acetylcholine receptors also 
affect the sleep mechanism.4 In ITM, non-oral treatment 
methods, specially inhalation, are used very often. Old 
Iranian traditional physicians believed that in neurological 
diseases inhaled drugs work faster than oral drugs due to 
the speed of reaching the brain.5 This study is a survey 
which investigates different credible textbooks of Iranian 
traditional medicine. It collects all the herbs that are used 
in the form of inhalation as a hypnotic for insomnia and 
expresses their hypnotic mechanism. The aim of this 
study is to find new and safe solutions to treat insomnia 
by recognition of some different inhaled hypnotic herbs 
which are used in ITM. 
Method and materials 
In this review, we studied printed versions of the most 
important ITM books, such as The Canon of Medicine by 
Avicenna (1 Oth-1 lth centuries), Exireazam by Cheshti 
(19th century), Tohfat Al-momenin by Tonkaboni(l?th 
century) and Makhzan-al-advie by Aqili (18th century), 
etc. These books are important clinical or pharmaceutical 
texts which have been widely taught in traditional 
medicine schools in Iran. 
In ITM insomnia is considered to be a neurological 
disease. We searched the term insomnia in the 
neurological diseases chapters of the clinical textbooks in 
ITM. Then, by using the pharmaceutical texts, we found 
all the herbs prescribed for the disease intranasaUy. In 
addition, some other books such as Matching the Old 
Medicinal Plant Names with Scientific Terminology and 
Popular Medicinal Plants of Iran were studied for 
nomenclature of medicinal plants. Additionally, for all 
herbal remedies, an extensive search of scientific data 
banks such as Medline was performed to find related 
works concerning the improvement of sleep using these 
plants and the results were sorted alphabetically in a table. 
The principles of insomnia treatment 
from the viewpoint of Iranian Traditional 
Medicine 
From the perspective of traditional medicine, the main 
principle of treatment is the elimination of the causes of 
disease. Improvement of the affected organ's tempe-
rament is recommended in the next stage. Since the main 
reason for insomnia was considered to be dryness or 
hotness along with dryness in the brain, ITM physicians 
suggested wetting the brain as the treatment. The wetting 
process can be done by eating moisturising foods, taking 
herbal drugs or physical activities such as massage. 6 
ITM physicians' views on insomnia treatments can be 
divided into two sections: 
1) Non-drug treatments or sleep hygiene, which are 
ess~ntial for health. Eating moisturising food, not eating 
~es1ccant food, relaxation, tempering bath, massage, 
listening to beautiful songs, avoiding bad thoughts, and 
lack of coitus are among these treatments.6 
2) Treatments by drugs which can be taken either oraUy 
or non-orally. 
Non-oral (local) treatments in ITM 
Inhalation: Putting very fluid liquid in the nose. 
Prostration (incense): Boiling drug in water and keeping 
the head in its vapour. 
Fumigation: putting medication on a fire and inhaling 
the smoke. 
Anointing: Unction. 
Olfaction: Smelling aromatics. 
Plaster: rubbing the paste on the member and dressing it. 
Liniment: rubbing a thin lotion on the member. 
Drops: dropping the drug as a liquid in the nose. 
Douche: pouring medicinal liquid on the affected organ 
by force. 
Snuff. pounding dry medication and insufllating in the 
nose.7•8 
Among the above methods, inhalation, pro tration 
(incense), fumigation, olfaction, drops, and nutf are 
inhaled forms of drugs and have an effect intranasally. 
This procedure is used to treat neurological di ease in 
ITM and accelerate the drug's efficacy; it has fewer 
gastrointestinal side effects compared to oral fonn-
ulations. Since insomnia is a neurological disorder, ITM 
physicians recommend these method for its treatment. 
Mechanism of hypnotic herbs in ITM 
Before investigating hypnotic herbs' mechanism of 
action in ITM, it is necessary to know the opinions of the 
ITM physicians about the spirit, psychic faculty and 
sleep physiology. ITM introduces the heart as a source of 
spirit. This spirit flows in the body through the blood in 
the arteries. When it - known as vital spirit - reaches an 
organ, its temperament will change to the organ's 
temperament. Spirits carry three faculties: natural, vital, 
and psychic9 that originate from the liver, heart, and 
brain respectively. 10 
Iranian traditional physicians believe that sleep occurs 
when heat moves towards the body interior, affects food 
moisture and evaporates it. When the generated vapour 
reaches the brain, it relaxes neural tracts or compre e 
them on each other and hampers the p ychic faculty to 
reach the brain. In this perspective, the main material that 
causes sleep is moisture. 10 Therefore, it i believed that 
bodies with more moisture need more leep and people 
with dry temperament need les sleep, and are more 
subject to insomnia. 11 
Therefore, according to the above explanation, brain 
dryness or warmness is the main reason for insomnia. o 
the principle of insomnia treatment is correction of brain 
temperament by wetting or cooling it. This work can be 
done by foods or drugs. 6 The drugs which are prescribed 
based on this viewpoint are those which prevent the 
psychic faculty from reaching ~e brain, and th~refore 
induce sleep. However, hypnotic herbs use different 
mechanisms to prevent penetration of the psychic faculty 
to the brain. 12 
The hypnotic herbs which are u ed as inhalations for 
insomnia are collected in Table 1.6-8•12•13 ome of the e 
herbs are studied in modem medicine as well, and their 
hypnotic effects are confirmed. For ome _of tl1~e herb_ , 
their pharmacological effects are explained rn detail. 
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Table 1. Hypnotic inhaled herbs in Iranian traditional medicine and comparison with modern medicine. 
Common Scientific Method of Pharmacological effect 
name name administration 
inITM 
Amomon Amomum Smelling13 Not found 
cardamomum 14 
Basil Ocimum Smelling13 Insomnia, depression 16 (eugenol binding of GABA to its receptor) 17 
basilicum 15 
Belladonna Atropa Smelling7•13 Consumption of powdered belladonna orally has sedative-hypnotic 
(deadly belladonna 14 effects, 18 sedative and antispasmodic19 
nie:htshade) 
Cabbage Brassica Intranasal drop7 Not found 
oleracea14 
Chamomile Matricaria Intranasal oily Essential oil aromatherapy has been used to treat insomnia. Inhalation of 
chamomi//a15 dropl3 the vapour of chamomile oil reduced a stress-induced increase in plasma 
adrenocorticotropic hormone (AC1B) levels.20 Electrophysiological 
studies performed on cultured cerebellar granule cells showed that 
apigenin reduced GABA-activated CJ- currents in a dose-dependent 
fashion.21 
Coriander Coriandrum Smelling13 An anxiolytic, sedative and relaxant. Its mechanism of action for 
sativum 15 anxiolytic activity may be similar to that of diazepam [that acts via 
the gamma-aminobutyric acid (GABA)A receptor complex] , as 
flavonoids and diazeoam are structurallv similar.22 
Cucumber Cucumis sativus15 Smelline:12 Not found 
Dill Anethum Inhalation of the Mental disorders and inducing sleep,23 sedative (carvone)24 
J?raveolens 15 oiJl3 
Feverfew Tanacetum Smelling7 Parthenium has high affinity for the GABAA-benzodiazepine site. Apigenin 
parthenium15 has high affinity for the GABAA-benzodiazepine site.25 The presence of 
melatonin in Feverfew plant tissues may provide some explanation for the 
anecdotal evidence oftheirohvsioloe:ical effects in humans.26 
Lemon Balm/ Melissa Smelling13 Anxiolytic effects and improvements of sleep disturbance in 
German officinalis15 humans.27 It inhibits nicotinic and muscarinic acetylcholine 
Madwort receotors. 28 
Harmel Peganum Smelling & The alkaloids exert an inhibitory action on central dopaminergic 
harmala15 plaster13 system inducing sedation and paradoxical sleep disturbances (~-
carboline alkaloids have affinity to benzodiazpines, 5-HT, dopamine 
receotors) . 29·30 
Henbane seed Hyoscyamus Intranasal oil It has sedative and antispasmodic effects (hyoscyamine, atropine, 
niJ?er15 droo7 scooolamine. atroscine ) .19 
Lemongrass Cymbopogon Smelling The essential oil of cymbopogon is effective in increasing the sleep duration 
o/ivieri15 blossom13 in comparison with pentobarbitaJ.31 The anxiolytic-like effect of essential oil 
of one species of Cymbopogon mediated by the GABAA receptor-
benzodiaz.enine comolex. 32 
Lettuce Lactuca sativa 14 Smelling leaves13 Seed oil is found to be a useful sleeping aid in geriatric patients 
suffering from mild-to-moderate forms of anxiety and sleeping 
difficulties.33 It has sedative and analgesic effects (non-selectiveµ 
ooioid receptor antae:onist) .34 
Melon Cucumis melo 14 Smelling13 Analgesic (triterpenoids) .35 
Myrrh Commiphora Smelling7·13 Not found 
mo/mo/14 
Nenuphar Nymphaea Intranasal oil An ethanolic extract of N alba may possess anxiolytic activity. It 
(European alba15 drop6 also produces calming and sedative effects upon the nervous system, 
white water and is useful in the treatment of insomnia36 
lily) ( Continued> 
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Table 1. Hypnotic inhaled herbs in Iranian traditional medicine and comparison with modem medicine. (continued) 
Common Scientific Method of Pharmacological effect 
name name administration in 
ITM 
Oakmoss Evernia Smelling13 Not found 
vrunastri 14 
Orris root Iris Intranasal oil drop13 Not found 
£ermanica 15 
Poppy Papaver Smelling13 Narcotic (opium alkaloids)19 
somniferum 15 
Pumpkin Cucurbita Intranasal oil drop7 Antidepressant (silymarin)37 
vevo 15 
Safflower Carthamus Smelling13 Not found 
tinctorius 15 
Saffron Crocus Smelling, 12 intra- Antidepressant effect38 
sativus 15 nasal oil droo 13 
Sweet violet Viola odorata15 Smelling fresh viola Used to treat chronic insomnia in humans.40 .The presence of 
and intranasal oil drop7 
From ITM physicians' point of view; there are three 
mechanisms for the effects of hypnotic plants: 12 
1. Moisturisers: The herbs have natural moisture or their 
moisturiser vapours induce moisture in the brain. 
Therefore, they relax neural tracts, compress them on 
each other and inhibit the psychic faculty from reaching 
the brain. Examples of these herbs are sweet violet, 
lettuce, pumpkin, nenuphar, cucumber, dill, melon, 
feverfew, cardamom. 
2. Warmers: These herbs have little heat and it causes 
moisture flow in the brain. Examples of these herbs are 
lemongrass, orris root, sweet almond, cabbage, myrrh. 
3. Narcotics: These herbs have much coldness and 
compact the psychic faculty and prevent its movement 
towards the brain. Examples of these herbs are poppy, 
henbane seed, coriander, belladonna. 
Discussion 
According to Table 1 we found that most herbs that are 
prescribed as inhalants in ITM to treat insomnia are shown 
to have hypnotic, sedative, anti-stress, anti-anxiety or 
antidepressant effects in modem medicine. Some herbs 
have a certain hypnotic mechanism and known 
pharmacologic effects but others use still unknown 
mechanisms. For example, there is evidence to suggest that 
lemongrass, feverfew, chamomile, basil, coriander would 
affect GABA receptors; sedative effects in harmel relates to 
?-HT and dopamine receptors; and madwort (lemon balm) 
Improves sleep disturbance by inhibiting nicotinic and 
muscarinic acetylcholine receptors. 
We found that there are three different mechanisms for 
hypnotic effects in medicinal herbs considered by ITM 
physicians: moisturisers; warmers and narcotics. Though 
we can not match the traditional mechanisms with modem 
pharmacological effects, it can be said that these plants can 
be used as adjunctive drugs in insomnia treatment. 
melatonin in Viola odorata plant tissues may provide some 
explanation for the anecdotal evidence of its physiological 
effects in humans.26 
Finally, we suggest more investigations on herbs 
which are recommended in ITM, but have missing 
information about their effects in treatment of insomnia 
in today's medicine. 
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Extemporaneous Preparations from 
the Past 
Angelique Camilleri, Anthony Serracino-
lnglott, Lilian M. Azzopardi 
Department of Pharmacy, Faculty of Medicine and 
Surgery, University of Malta 
Compounding involves the preparation, packaging and 
labelling of a drug specifically for a particular patient 
according to a medical prescription. 1 
Until the rnid-1900s, the compounding of such 'on-
demand' pharmaceutical preparations, also known as 
extemporaneous preparations, was the basis of pharmacy. 
1n Italy, in 1580, descriptive catalogues and standards for 
quality and uniformity of pharmacy formulas for 
pharmaceutical preparations were compiled. These 
became known as the 'pharmacopoeia' .1 In the 1930s and 
1940s, about 60% of all drugs were compounded. 
However, in the 1960s, manual preparation declined. 2 
The objectives of the study were to demonstrate 
different methods of preparations of various drug 
formulations irrespective of the active ingredients used 
and to compile a List of extemporaneous preparations that 
were compounded between the years 1955 to 1965. 
Methodology 
University of the Third Age (U3A). The re-enactment 
activities were further promoted through an advert on a 
health professionals portal Facebook page and eNews and 
published in one issue of the printed journal of the same 
entity. A leaflet and a questionnaire in English were 
formulated, validated and checked for grammatical 
mistakes. The aim of the questionnaire was to evaluate the 
quality of the re-enactment activities and the leaflet given 
to each participant. The test-retest method was used to test 
the questionnaire's reliability where 10 lay persons 
completed the questionnaire twice with a 2=week interval. 
Re-enactment activities, in which 220 participants 
attended, were organised at Au/a Magna Valletta during 
the Annual Pharmacy Symposium 2012 Campus, Santo 
Spirito Hospital in Rabat, and Department of Pharmacy 
at University of Malta. Participants came from secondary 
schools and the University of the Third Age. 
A list of extemporaneous prearations was compiled 
using Microsoft Excel. The 1955-1965 timefrarne was 
chosen and extemporaneous preparations were obtained 
from Pharmacy Drug registers found at the former Santo 
Spirito Hospital in Rabat, Malta. The Excel sheet formed 
consisted of 5 columns; 
A. Number - each extemporaneous preparation was 
noted with a number. 
B. Medicament - the extemporaneous preparation 
name. 
C. Ingredients - all the ingredients used, active 
ingredients followed by inert ingredients, to produce 
such an extemporaneous preparation. 
D. Use - the indication and/or the properties of the 
extemporaneous preparation where applicable. 
E. Dosage form - drug formulation of the extemp-
oraneous preparation. 
Results 
The 11 re-enactments activities were attended by 65 
males and 155 females, none of whom had a medical 
profession. 
A total of 192 complete questionnaires were collected, 
resulting in a response rate of87.3%. The presentation was 
graded from l to 5, with 1 being the least sati factory and 
5 being the most satisfactory; none was graded least 
Dosage forms, including Liniments, ointments, 
suppositories mixtures creams and sachets and their 
correspondin~ ingredi~nts were identified and the 
necessary active ingredients according to the British 
Pharmaceutical Codex J 9 3 4, 3 apparatus and materials 
were obtained. Preparatory sessions, were attended to, in 
which with the help of a pharmacy compounder with , 
experience in the preparation of the identified produc~, the ,........., otHt 
compounding of the selected dosage forms was practlsed. . _ 
The re-enactment activities were promoted at the Figure 1: Grade of pre entatlon (n- 192). 
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satisfactory and 68% graded the presentation as most 
satisfactory. 
Only 19 respondents thought that the activity was 
either short or long (Table 1 ). 
Table 1: Timing of the Presentation (n=192). 
Time Frequency Percentage 
Short 10 5.2 
Satisfactory 173 90.1 
Long 9 4.7 
Total 192 100 
16 of the 192 participants did not agree with the 
location chosen, the main reason being it was a small 
place. 
Three-quarters of the respondents thought there was no 
room and need for improvement. However 25% thought 
that the sound, leaflet provided and the demonstration 
display needed to be improved. 
Figure 2: Any Need for Improvement? (n=l92). 
Only 2 of the 192 respondents thought that the activity 
was not worth the time and effort of the student 
organising it. 
Positive comments regarding the demonstrations 
included 'Professionally presented by the student', 'Very 
interesting' and 'Well constructed'. 
The leaflet given to each respondent was informative 
according to all and 65% of the respondents graded the 
leaflet's overall layout as most satisfactory (Fig.3). 
On the other hand, 75% of the respondents graded the 
presentation of the leaflet as most satisfactory (Fig.4). 
Preparations 
133 extemporaneous preparations were compiled from 
the pharmacy drug registers at Santo Spirito Hospital in 
Rabat, with 31 different types of drug formulations: 22 
mixtures; 18 ointments; 19 syrups and 9 tablets. 
Capsule, ear drop, emulsion, infusion, linctus, liquor, 
paint and suspension were the dosage forms least 
encountered during the compilation of the 
extemporaneous preparations. 
Figure 3: Grade of Leaflet's General Layout (n=l92) 
Figure 4: Grade of Leaflet's Presentation (n= l92). 
Discussion 
It may be impossible to determine exactly when human 
beings first began to mix substances and compounded 
preparations that they perceived to exert a therapeutic 
effect on administration. However, the compounding of 
medicinal products of materia medica of plants and 
animals was practised since ancient times. 4 
Ancient Egyptians, Greeks, Romans, and Arabs all 
developed medical knowledge resulting in the integration 
of various aspects of pharmacy and compounding.4 
Medicines were concocted with a mixture of 
empiricism and prayer. Trial and error, inherited lore and 
mystical theories were the basis of pharmacopoeias. In 
the 1960s, the technology of making drugs was crude at 
best; medicaments were mainly of herbal origin. 5 They 
were generally made with water or alcohol-based 
extracts of freshly ground or dried herbs or animal 
products. 
The re-enactments, which were targeted to all age 
groups, were all well attended and proved to be fruitful, 
as tremendous interest shown by both the secondary 
students and the third age students was evident. Eager 
secondary students were allowed to participate in the 
compounding of the chosen extemporaneous 
preparations where they weighed the active ingredients 
using the the weighing balances, hence gaining first-hand 
experience, especially for those who had not yet attended 
42 Phann Hist (Lond) 2015; 45 (2): 
https://dx.doi.org/10.24355/dbbs.084-201801291213
Table 2: Section from the Compiled List of Extemporaneo p us ti ( 133) repara ons n 
Number Medicament lntredient$ 
l Canellae Cinnamon dismlate 
2 Acrifla:vine gJycerin Acriflavine 1dvcerin 
Compound Tincture of Rhei, Simple Syrup ( l part 
3 sugar and 2 parts water), Rhubarb Cardamom 
Mistura Potassium Pottuium citrate, citric acid, 
4 syrupus aurantis, Aqua Citrate Chlorofonn 
s Hamech Thyme, anise, ginger, absinthe, 
scammonv 
6 Diacatholicon Cassia, lamarind, rhubarb, 
violets. aniseed. su2ar. 
7 Jera 
Aloe, spikenard, honey, mastic, 
u:aric 
8 Senna Aromati~ Senna, jaJap1 rhubarb, 
aromatics 
9 Galbanum pi115 Asafetida, galbanum, myrrh 
10 f oetidae Pillulae Turpetb, sagapeuwnand, myrrll 
any chemistry practicals. This enhanced the need for 
appreciation of the way pharmacists had to compound 
drugs accurately and in a meticulous way. 
What was of much concern was the fact that the interest 
shown was not by pharmacists or by people with a medical 
profession but by Laypersons. Hence healthcare 
prof~~ionals do not show much interest in the way 
medic~es were compounded in the past and do not 
appreciate much how the pharmacy profession evolved 
through the years. This was evident from the number of 
demonstrations organised since the publication of the 
advert in the healthcare professionals journal. One may 
argue that healthcare professionals have a hectic Lifestyle 
an~ :"_ere not able to attend these activities although the 
actJ.VItJ.es were relatively short. Some Third Age students 
showed so much interest that they even asked whether they 
could attend the next re-enactment activites in order to 
r~U the older ways of compounding in their younger 
tJ.mes. 
Dosage forms chosen to be compounded during the 
re:enactment activities, including creams, sachets, 
nux~es and ointments, are still compounded nowadays in 
a clinical or community setting hence making the study 
ben.eficial by advancing the phannacist position in today's 
society. On the other hand, these demonstrations should 
also pave the way to indulge in the many obsolete or near 
obsolete extemporaneous preparations that were 
compounded long ago by pharmacists. 
After compilation of the List of extemporaneous 
preparations, it was evident that a vast range of drug 
fo~uJations existed in the past. However, apart from 
this, the need to discuss certain important ingredients 
Use DosattForm 
Antipvretic tonic Solution 
Disinfectant reduce swellin11 Solution 
Flatulent colic, dyspepsia, 
constipation. Mixture 
Cystitis - decreasing urine Mixture 
acidity 
Venettal di$ease Mixture 
Analgesic - pain relief Syrup 
Blood purifier Syrup 
Constipation Syrup 
Digestion problems, 
flatulen(e, poor appetite, Pill 
coufrlt snasms. 
Constipation, stomach ache, Pill 
cou2h 
considered to be essential for human health is of 
importance, since some ingredients tend to be found in 
more than one extemporaneous preparation. 
Some imparted more than one therapeutic property and 
hence were indicated for several conditions. Among 
others, the following ingredients were of utmost 
importance. 
Boric acid was administered in the form of cachets, 
pastilles and orange-flavoured rnixtures6 to sooth 
irritation and as hot applications for the treatment of 
boils, carbuncles, ulcers and whitlows, hence imparting 
its antiseptic property by being bacteriostatic.7 
Iodine was administered in the form of a liquor for tl1e 
treatment of chronic rheumatism, hypothyroidism and 
for preparation for surgery in hyperthyroidism.8 Iodine 
was also present in preparations applied externally as 
parasiticides and counter-irritants, such as Liquor Jodi 
Fortis7 which was used to kill tinea and other fungi. In the 
form of a colloid or an ointment such as the Non-staining 
Iodine Ointment. It was also used for chilblains, 
ringworm9 and swollen glands . 7 A few drops of iodine 
were sometimes added to hot water to form a weak 
solution for inhalation in phthisis and chronic 
bronchitis. 10 It was also applied topically as a weak 
solution for the cleansing of wounds 11 to prevent sepsis 
since it has excellent antiseptic properties. 
Rhubarb contains certain anthraquinone derivatives12 
as chief constituents with purgative properties, especially 
when used in large doses. A purgative effect was 
generally followed by an astringent effect from the tannin 
constituent. Hence, rhubarb preparation were employed 
as occasional aperients but not in chronic constipation. It 
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was also employed in diarrhoea7 and as a stomachic in 
dyspepsia and as a laxative. 13 
This study can pave way to further research to 
disseminate knowledge on traditional formulations used 
in pharmacy and also to identify most prominent 
ingredients preferred by prescribers at the time for the 
preparation of extemporaneous preparations. Trends in 
changes in the use of ingredients throughout the years 
could be identified. 
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The Anglo-American Pharmaceutical 
Company Limited 
Norma Cox BPharm, MSc, MRPharmS 
While researching British pharmacy for the period 
around World War I, I came across an advert in the 
Chemist and Druggist Diary for a pharmaceutical 
manufacturing company that I didn't know. The 
company was the Anglo-American Pharmaceutical 
Company Limited of Croydon; it offered a list of 
interesting products and had won gold medals at 
London, Bombay, Buenos Aires and Sao Paulo, Fig 1.1 
The founder of the company was Mr Hubert Huxley 
Mason, Fig 2.2 He came from a family of chemists going 
back to Aaron Huxley, his grandfather, 'a distinguished 
practitioner of the art and science of his day,' who 
pioneered bone phosphate manufacture at Newport 
(Shropshire) in 1850. Mr Hubert Huxley Mason passed 
his Minor examination in 18833 and soon after opened a 
pharmacy at Parsons Green, London. SW. 4 He formed a 
company in 1892 with his brother. In 1898 Mr Hubert 
Huxley Mason ventured into the wholesale manufacture 
of medical preparations, notably those of the glycerol-
phosphate type, and introduced Huxley's Syrup 
T.,,,,,,rw A"-1 
ANCLO.CROYVON,"' 
PftODUCT& o, THE C.i,u w..J 1 t 
A . 8 .C: 'itl, E<lfflffl. 
'i"' 
.. ~:i;,~f ·): _, )' i 
HUXLEY'S PREPARATIONS. 
Oenz..Klnone (9r,ifl'} 
Oen:w- K l"Onc a. H....a. 
llcnz.t,. Klnon• c. Plc:fttoxbt 
8 1tul,OI (LUI . l.Lw.t.ho. N IGb)'l. Balicylalt) 
Clubolysio (Tritur.a~ 
Cok.hl-S.I (C"!WMI 
Uq. &rntal. Flav, 
M.a.L A ntl- Rlleamatk: Cone. 
MIit. Tonic. tl~t. Con~. 
MIit, TUNI Rub. lnfanll 
Mlst. Tu•I Rl,.b. AdulU 
Elixir Bromldl Co. 
Ooldcn Kcauty Oll 
lodohdne 
Oro Nual Ph•pn-1011 T•b .. 15 
Ptl, Pho.tph , Co. !Oval Supr-C'l)at.nd) 
_ .5olu.ble_A t1ll!!!P!fc 511.r~al L11brl.;ant 
- Suppoa1tor1ie, of tiiiin1milll - -
Unrt. B,eud• Co. K11.(lohl!f (Caru1nlr11) 
1...-10 1·ormaU1t Plg:•cnt 
Lin . Sall~yllc. Co. 
Uquor AntJsopCiCUI 
Wlntoit:tt (Coll•p1ibl6 1'1.1\1.l 
X-Jodl D11muu, Pcrwdcr !Cur.) 
X-Jodl Dl.s.au.1th 'l 'abfe,.JI. (Carr.) 
FERMENLACTYL Aall-Dlphtherlc Dragees. PIPERAZINE-MIDY 
T.-t•ta. 
, Labo<ratorte.- Oal-.. W,....,, CIIOYDO•, LONOON , ...... 10-M ... kfflAn ............. ..-oM(. 
Re ct•tcnMI Office &I Ottl«w_.l ....., OltO'fDO"' 
Olb OWlc:.....Clllch ...... ~-..... N .... CllaftGClr')' .... " .. LONDON. 
Figure 1. Advertisement for Anglo-American 
Pharmaceutical Co. Ltd, 1911. 1 
44 Pharm Hist (Lond) 2015; 45 (2): 
https://dx.doi.org/10.24355/dbbs.084-201801291213
(glycerole) of the acid glycerol-phosphate. The product 
was 'a bright, clear, non-depositing, non-fennenting, 
Figure 2. Hubert Huxley Mason, 1931.2 
sugar-free glycerole'.2 From 1892 to 1901 Mr Hubert 
Huxley Mason lived in West Brighton, then West 
Norwood, London SE , then Purley, Surrey and at 45 
Kidderminster Road, West Croydon in 1902. 3 The 
Croydon Directory4 for 1904 and 19055 listed H Huxley 
Mason as wholesale chemist with premises at 3 & 5 Frith 
Road, Croydon. In the 1906 Croydon Directory, 6 the 
business at 3&5 Frith Road, Croydon was called the 
Anglo-American Pharmaceutical Company Lirnited,2 
incorporated as a limited company in 1906. The Chemist 
& Druggis 7 detailed the new company: 7 
'whose objects were to take over the business of chemists, 
druggists, perfumers, manufacturers of and dealers in toilet-
preparations etc canied on by H.H. Mason, in some respects 
under the name of the 'Anglo-American Phannaceutical Co' 
and in other respects under the name of the 'Huxley 
Pharmaceutical Co at 3 and 5 Frith Road, Croydon, Surrey, and 
in New York, Montreal, and other places including a portion of 
the assets thereof, but not the right to sell in France, Belgium, 
Spain, Portugal, Italy, Roumania, Switz.erland, Turkey, 
Columbia, Cuba, Venezuela, Brazil, Ecuador, Peru, Chill, 
Uruguay, Mexico, Guatemala, Honduras, Salvador, Costa Rica, 
Nicaragua, Argentina, Bolivia, Paraguay, and Panama, and the 
respective Colonies thereof, the preparations known as "Colchi-
Sal", ''Betul-01" and "Antipaludic".' 
The first subscribers were listed and HH Mason was 
the chainnan and managing director with remuneration 
of £300 per annum. The business progressed and 
exhibited two new products, 'Huxley's syrup of acid 
glycerol-phosphates with formates' and 'benzo-kinone 
with heroin' (a guaiacol derivative for cough), at the 
Royal Horticultural Society's Hall, Westminster for a 
week in October 1906. s 
In 1907 at another exhibition, at the Royal Horticultural 
Hall, the Anglo-American Pharmaceutical Co Ltd 
promoted a new lactic fennent made by the Pasteur Vaccine 
Co of Paris. This ferment was said to be antagonistic to the 
germ that caused auto-intoxication and was of peculiar 
value in infant feeding. The product was in tablet fonn and 
one tablet was added to milk at a certain temperature. It was 
specially recommended in cases of infantile diarrhoea.9 
Another product, a Menthol and Wmtergreen Cream 
known as 'Tubelette,' was advertised in the Chemist & 
Druggist 1908 trade notes. 10 The price was protected under 
the Proprietary Articles Trade Association (PATA) scheme. 
The scheme was championed by William Samuel Glyn 
Jones, a proprietor pharmacist, in 1896 against price-cutting 
on proprietary medicines. 11 
In March 1909 the company opened a city office and 
showroom on the ground floor of Chichester Chambers, 
Chichester Rents, Chancery Lane. London, where 'they 
would receive inquiries and execute small urgent 
orders'. 12 
In 1909 in Bombay, the company exhibited 'Huxley's 
Syrup Ner-Vigor', promoted for diabetes and neurasthenia, 
and other special pharmaceutical preparations including 
compressed tablets representing, in small bulk, the active 
constituents of Huxley's Syrup. In addition their Creme-
de-Luxe toothpaste received considerable attention. 13 In 
the same year the Chemist & Druggist reported: 
an outbreak of fire in the early morning of July 21st on the 
premises of the Anglo-American Pharmaceutical Co, Ltd at 3 
& 5 Frith Road, Croydon. A timber and conugated-iron 
building in the rear, which was stored with drugs and 
chemicals and contained valuable machinery, was totally 
destroyed, while the shop and warehouse fronting the road, 
was also gutted. The total damage was estimated to be 
£1,500.14 
Despite the fire the business continued and on October 
9th 1909 the company exhibited in the Royal 
Horticultural Hall at a medical exhibition organised by 
the British and Colonial Druggist on the theme 
'Aesculapius and the disciples of Galen '. 15 The Croydon 
Directory of I 910 showed that the Anglo-American 
Pharmaceutical Co, Ltd had moved to 59 Dingwall Road, 
Croydon.16 There was further very interesting coverage 
in the Chemist and Druggist Supplement of July 30th 
1910. 
An injunction in the Chemist and Druggist 
Supplement of July 30th 191017 informed the reader ~at 
in the Chancery Division on July 28th 1910, Mr Justice 
Swinfen-Eady heard a motion in an action brought by Mrs 
Eliza Jane Chapman against Mr Hubert Huxley Mason trading 
as the Anglo-American Phannaceutical Co and the Linilin_e ~ 
Ltd for an injunction to restrain the first defendant permitting 
certain premises at Croydon to be occupied by the Liniline Co 
or any other person or company carrying on the business of 
linen water-proofers or other dangerous business which 
rendered premises uninsurable against fii:e. An injunction was 
also asked against the Liniline Co to restram them from carrying 
on the business of linen waterproofers or other dangerous 
business. Mr Macnaghten KC and Mr G B Hamilton appeared 
for the plaintiff; Mr Paterson for Mr Mason and Mr H F F 
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Greenland for the Liniline Co. His Lordship granted the 
injW1ction W1til judgement in the action or further order.' 
The company continued to exhibit their products and 
in the Great Hall of London University, London on July 
30th 1910 the main exhibit was Huxley's Syrup of Glyc-
erophoshates in various combinations; also exhibited 
was Huxley's Protein Food, a 50% mixture of 
assimilated proteins from milk and egg made using an 
active lactic ferment called Fermenlacyl obtained from 
the Pasteur Vaccine Co. 18 
There was reduced information about the company 
and its products in the Chemist and Druggist in the years 
leading up to the First World War. A quotation from 
Veterinary News Jan 2nd 1915 promoted the 
'professionalism of the veterinary products and their 
packaging as made by the Anglo-American 
Pharmaceutical Co Ltd at that time.' This quote is found 
in a promotional price list produced in 1934. 19 The 
Chemist and Druggist trade news in 1915 reported that 
drug shortages meant 'the advance in the cost of raw 
wholesale price of Huxley's Syrup of acid 
glycerophosphates'. The new prices were given in the 
company's advertisements.20 
With war regulations relaxed in 1919, the Anglo-
American Pharmaceutical Co. Ltd advertised 'The 
Company now can supply proprietary articles held up 
due to the war'.21 In July of that year Huxley's 
glycerophosphate syrups, Sap-Lauand, Zita Baking 
Powder and Huxley's Vanishing Cream were exhibited 
at a Chemists Exhibition in London.22 They also 
exhibited Sal Antisepticus, a nasal douche product for 
cold symptoms, 23 and Tubelette at an exhibition in 1919 .24 
The Miscellaneous section of the Chemist and 
Druggist for August 16th 1919 reported 'A Mysterious 
Window Fracture in the factory of the Anglo-American 
Pharmaceutical Co Ltd, Dingwall Road, East Croydon.' 
A bullet was believed to be the cause of the broken 
window but as a number of packing cases were stored 
close to the window, a missile could not be found. 
Windows in this factory had been broken in a similar 
manner on five occasions a few years before. A reward 
was offered for information which would lead to a 
conviction for the damage.25 
At another medical exhibition in October 1919 in 
London the company had a large stand fitted with their 
products. A centre stand was given over to Huxley's 
glycerophospate syrups with formates, red bone-marrow 
etc. Elsewhere on the stand was Sal Antisepticus, Zita 
dusting powder and Tubelette of menthol and 
wintergreen cream.26 The Chemist and Druggist in 
March 1920 referred to the recent price changes in the 
price of menthol and wintergreen Tubelettes which had 
increased from 3s to 3s 6d.27 
Huxley's Witch Hazel Toilet Jelly was promoted in the 
Chemist and Druggist trade novelties in June 1925 as a 
jelly for midge bites, packed in collapsible tubes and 
yellow and brown cartons, figure 3.28 A neatly lettered 
show-card was available for advertising purposes and 
further promotion of this product in the Chemist and 
Figure 3. Carton for Huxley's Witch Hazel Toilet Jelly.28 
Druggist in July 1927 offered 'to send to fifty lady 
customers of a chemist, free packages of Huxley's Witch 
Hazel Jelly, with chemist's name and address and other 
literature in the package. '29 The Chemist and Druggist in 
1932 carried details of the sole agent for Scotland, Mr A 
Duncan Mason of 30 Marlborough Road, Cathcart, 
Glasgow30 and listed Mr Curtis Marshall, a son of Mr 
GM Marshall, as representative for the company in 
Northern Ireland.33 
In April 1932 the Chemist and Druggist new 
companies section listed 
The Anglo-American Pharmaceutical Co Ltd. (P.C) - capital 
£10,000. Objects: to acquire the business now carried on by 
the Anglo-American Pharmaceutical Co Ltd (in liquidation) 
and all or any of the assets and liabilities, and in particular the 
fonnulae and full infonnation as to the process of 
manufacturing and the right to manufacture and deal in 
certain medicinal preparations, and to carry on the business of 
manufacturers and sellers of medicines and preparations, 
chemists, druggists, drysalters etc. R.O. ; 59 Dingwall Road, 
Croydon, Surrey.31 
The Chemist and Druggist Trade notes in May 1932 
advertised a new product named Sprai.32. It was a liquid 
fly killer of British manufacture. The outfit comprised a 
tin of Sprai which screwed on to a pump which readi~d 
the apparatus for use. When the tin was empty a new tm 
was screwed on in place of the old. The preparation was 
stated to be stainless and pleasantly perfumed. Apart 
from advertising in the national press, use was to be made 
of the cinema (talkie) for publicity purposes and 
particulars of the special offers which were being ma~e 
to chemists were found in adverts in the same Chemist 
and Druggist. . 
The Chemist and Druggist for July 2nd 1932 c~ed 
the obituary of Mr Hubert Huxley Mason, who ~ed at 
Addiscombe, Croydon aged 71 years.34 The wording of 
the obituary was identical to the report of~ in _'Who's 
Who in the Drug and Allied Trades' published m 1931 
and given in reference 2. 
The company continued to display new produc~. At the 
London Medical Exhibition at the Royal Horllcultun_il 
Society in October 1932, an interesting novelty was C~-
Alpha. This tonic was devised by Professor P Casali . to 
postpone the onset of arteriosclerosis without increas~g 
blood pressure and thus represented a ~stinct ad~~ce 1Il 
the treatment of conditions associated with asthema · The 
Anglo-American Pharmaceutical Co Ltd had taken an 
agency for this product and Huxley branded products were 
also displayed.35 
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At the September 1933 Chemist Exhibition at New 
~all, Royal ,Horticultura~ Soci~ty, London, the company 
mtroduced Dermafoam an 01! soluble emulsion which 
fa~ilitated . the extraction of embedded dirty deposits in 
skin crevices. Also exhibited was Casali-Alpha the 
'elixir of life' according to the press of the day.36 ' 
In October 1933, the Chemist and Druggist Trade 
notes reported that Mr H Chase Mason, son of the late Mr 
Figure 4. Advertisement for Casali-Alpha.42 
~holesaler Sanger's. The Sanger's List for 1951-195246 
listed Huxley's Antiseptic Dusting Powder, Pil Rhamni 
Comp and Sal Antisepticus; this was a small range of 
H~ey'~ products compared to the Sanger s List for 191 O 
which displayed about thirty items.47 The List of 196248 
showed the range ofHuxley's Preparations had increased to 
five, with several product sizes, making a range of ten items. 
In th~ 1965 S~nger s List49 only one product, namely 
Huxley s Dusung Powder, was listed and the 
manufacturer of this Huxley's product was a company 
called Gale Baiss and Co Ltd. The company was based in 
Slough and advertised in the Chemist and Drnggist Year 
Book of 1963 as Pharmaceutical Manufacturers. so 
The Anglo-American Pharmaceutical Co Ltd of 
Dingwall Road, Croydon therefore was no longer 
manufacturing its own products after 1965 and Huxley's 
Dusting Powder was absent from the Sanger s List of 
1966. There were factors after the Second World War 
which may have influenced the company's future. 
The Anglo-American Pharmaceutical Co Ltd which 
had been a registered pharmaceutical premises from 
19~7-1947 ~t 59 Dingwall Road Croydon51 topped 
bemg. a registered pr~mises after 194 7. The Anglo-
Amencan Pharmaceutical Co Ltd was still listed in the 
Hubert Huxley Mason of 9 Greencourt Gardens, East Croydon Directory until 1956 though as chemist 
Croydon, was solely engaged in the marketing ofStomo- suppliers and manufacturers.
52 
Croydon and Dingwall 
Tab, an anti-dyspeptic tablet.37 Another exhibition was Road had suffered much damage due to bombing in the 
reported in the Chemist and Druggist in October.38 Second World War;
53 
although Number 59 was not 
The 24th London Medical Exhibition in October 1934 damaged most of the street was. Croydon then underwent 
promoted Sal-Antisepticus, Huxley's Syrup Glycero- a massive rebuilding program and today Dingwall Road 
phosphate Co, Pit Rhamni Co, a surgical powder, Casali- is a modem tower-block dominated road with no 
Alpha d D .:: d evidence of where no 59 was.54 
an erma1oam, recommen ed for use after 
handling the motor car.39 In December Mr Thomas H The Huxley brand was manufactured by the Anglo-
Da~idson had joined the company as a representative to American Pharmaceutical Co Ltd up until at least 1962. I 
assist Mr A Duncan Mason in Edinburgh and East of have not found a date when the Anglo-American 
Scotland.40 The Chemists Exhibition in September 1938 Pharmaceutical Co Ltd ceased to trade nor any 
featured the Anglo-American Pharmaceutical Co. Ltd information on the internet for the dissolution of the 
who promoted Huxley's Wintogeno, Sal Antisepticus, company. 
Dermofoam, Renula tablets and Menthol and The Anglo-American Pharmaceutical Co Ltd seemed 
Wintergreen Cream.41 to have gradually faded away. Market force , the effects 
D?Mg the Second World War (1939-1945), there was of the Second World War bombings or changes due to the 
no information in the Chemist and Druggist on the newly formed NHS in 1948, may all have played a role 
Anglo-American Pharmaceutical Co Ltd. After the war, in the decline of this pharmaceutical company. 
ad~erts for Huxley's products Ner-Vigor and Huxley's Endnotes and References 
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Pharmacy student Laura Ghiggino giving the 
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BSHP president Briony Hudson presenting a Lesley 
Matthews Medal to secretary Peter Homan. 
A Medal was also awarded to Dr John K Crellin, 
who was the first secretary of BSHP. 
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Chemicals, Herbs and Liquors: 
Medicines in 1914 
Laura Ghiggino 
3rd Year MPharm Student, University of East 
Anglia , Norwich 
One hundred years ago the landscape of medicine and 
hospitals was almost unrecognisable compared with 
today. The NHS did not exist, nor did antibiotics or many 
synthetically made medicines. The research is based on 
'The London' Hospital in Whitechapel which was one of 
the most advanced hospitals of the time and offered free 
healthcare to the poor who were abundant in the area. Its 
complete and extensive records from the pharmacy and 
hospital have been used to understand what drugs were 
available, what were the most common conditions and 
how they treated them and to a lesser extent how did they 
compare with modem medicine. 
Overview and issues with the research 
The records used were the The London Hospital 
Pharmacopeia 1914 and an update insert, the index of 
admitted patients, the pharmacy log book and a number 
of patient files (all male). There were some errors in the 
records, especially the index: it was noticed when 
looking up patient files that the condition on the in~ex did 
not always match the condition on the file. This_ 0?1y 
occurred once; however, it would affect the statistics. 
Some conditions were not docwnented and a nwnber of 
patients had no notes or their illnesses were not recorded. 
This only affects the prevalence of conditions at the time. 
The London did have patients of different levels of 
wealth but the majority were poor; this skews the types 
of co;ditions at the time and comparison study with 
hospitals from rural and/or wealthy areas would be 
favourable. The medicines themselves would not have 
been affected by the location of the hospital, however; 
other resources would most likely have been used 
alongside the resources accessed. 
The London Hospital Pharmacopeia~ 
Whilst the pharmacopeia looked extremely small, 1t took 
a long time to copy out and research, partly because the~e 
were many remedies but also because they ~ere all m 
Latin. The majority of drugs listed were ch~trucal (such 
as ether silver nitrate or prussic acid), drugs isolated from 
plants (~orphine, codeine or quinine) or ""'.hole herbs or 
plants (digitalis leaf, belladonna extract, 1pecacuanha). 
Pharm Hist (Lond) 2015; 45 (3) 53 
https://dx.doi.org/10.24355/dbbs.084-201801291213
There was a wide range of formulations, such as 
powders, elixirs, suppositories, subcutaneous and 
intravenous injections, inhalation powders, syrups, 
treated plasters, liquors, extracts, oils, liniments, lotions, 
enemas, infusions, ointments, creams, poultices, liquid 
mixtures called mistura and tablets (tabellae). Most 
medicines came in multiple formulations such as 
atropine injection, atropine lamellae ( eye disks) and 
belladonna tincture. Some of the medicines are no longer 
used2 due to the fact that they are highly poisonous such 
as mercury ( for diarrhoea), strychnine ( for the emergency 
stage of pneumonia)3 and hemlock (sedative). 
Figure 1. An example of a Pharmacopeia used in 1914: 
Martindale and Westcott. The Extra Pharmacopoeia, 
16th edn, vols 1 and 2. (Not the London Hospital 1914 
Pharmacopeia) Used with permission from the 
University of East Anglia. 
Infection without antibiotics 
In 1914 there were no antibiotics available. Penicillin 
was of course not discovered until 1928 and the 
sulphanilarnides in 1935,4 and there were not many 
vaccines available, only smallpox, rabies, tetanus, 
cholera and typhoid. Infection was controlled mainly by 
cleaning with antiseptic liquids such as carbolic acid 
(phenols), potassium permanganate and hydrogen 
peroxide, which are all still used today.5 Perchloride of 
mercury was often used to disinfect homes where 
someone had suffered from an infectious illness. 6 
Childhood illnesses killed many children, most of which 
are rare now or easy to cure. Measles, mumps, rubella, 
whooping cough, diphtheria and scarlet fever were 
common and with the exception of diphtheria not 
hospitalised by the London as there were fever isolation 
hospitals which had special ambulance services to try to 
prevent spread in the population. In 1914 scarlet fever 
cases increased as did deaths from 1913;7 there were 16 
cases and 1 death at the London hospital. 8 Simple 
gastroenteritis, known as D and V [ diarrhoea and 
vomiting], was one of the biggest killers; it especially 
killed in the summer months and often in clusters of 
admissions. It wasn't until the 1920s that simple saline 
and sugar infusions that kept children alive was 
administered. One attempt at curing D & V in 1914 was 
shown in the case of a 4-month-old baby admitted 26th 
September 1914. He was given milk, barley water and 
lime water in an attempt to keep up fluids and minerals, 
an enema, and mercury with chalk. He survived and was 
discharged on the 22nd October 1914.9 According to the 
1914 index of admissions there was a total of 224 cases 
of enteritis, with a 50% death rate. There were 297 
enteritis deaths in 1914 in the district of Stepney where 
the London hospital was situated.7 
In terms of other deaths due to infection, 
pneumonia, TB and TB-related infection such as TB 
meningitis were in the majority. Cases and deaths can 
be seen in Figure 2 (p. 55). Pneumonia and other 
respiratory infections killed 929 people in the Stepney 
district,7 including approximately 184 deaths at the 
London hospital.8 In such cases, brandy was often 
used as a stimulant and magnesium sulphate as a 
laxative. Prussic acid, present in cherry water, was 
mentioned in the pharmacopoeia and was discovered 
to have been used for TB and pneumonia; 10 there was 
no mention of prussic acid being used in the case files 
but the prescribing of this medicine was in decline by 
1914. Syrup of squill was also regularly used in 
respiratory cases due to its expectorant qualities.2 
Morphine was used in a number of different 
formulations including, injection, liquor and linctus. 
Morphine, like its predecessor opium (which was also 
used at the time), was administered for pain relief and 
sometimes coughs. 
The Heart 
Digitalis was used to correct heart arrhythmias, similarly 
to digoxin use today.2 Interestingly, emphasis on heart 
medication has been a more modem development. 
Aspirin had only just been introduced in 1914, in fact it 
is mentioned on an insert of new drugs halfway through 
the year. According to one worrying case, aspirin was 
used to treat a haemophiliac with internal bleeding, but 
fortunately the patient survived11 • It seems a fuller 
understanding of the effects of aspirin had yet to take 
hold. Adrenaline was used in heart failure and caffeine 
used as a stimulant as well as many types of alcohol. In 
2013 the most prescribed NHS drug was simvastatin12 
and others in the top 1 O included prophylactic 
medications for heart conditions. Heart medication in 
1914 was reasonably basic with a poor success rate. 
There has been a shift in the last 100 years from solely 
treating maladies to trying to prevent them from 
happening in the first place. 
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Cancer - a losing battle 
There were fewer cases of the majority of cancers in 
comparison to today but unusually high levels of brain 
cancer with 48 cases mentioned - 29% of the cancer 
cases, compared with around 2-3% UK wide today, (see 
Figures 3 and 4, p. 56).. It is possible some were 
misdiagnosed but when looking at patient notes, two 
cases mentioned brain cancer, one included a post-
mortem which concluded a gliosarcoma was present in 
the brain. 13 The reasoning for this anomaly should be 
researched further. After some discussion it could be 
reasoned that rates were high due to the severity of brain 
cancer symptoms. This would force a patient in a society 
that normally wouldn't go to hospital for symptoms such 
as abdominal pain (which could be a symptom of certain 
cancers). This meant more cases of brain cancer would 
have been brought into the hospital than other types of 
cancer. As shown by the post-mortem case above the age 
of onset could be younger than other cancers such as lung 
or colon. The age of the population in Whitechapel was 
younger than today with many children dying before 
they were five and only a small number of people 
reaching seventy. 
Medications used in cancers generally centred 
around palliative care with pain killers such as 
morphine; in the other case of cerebral tumour a 
mixture of iron and strychnine was used, possibly as 
an attempt to kill the tumour. 14 Surgery was the most 
common treatment of cancer but many tumours were 
inoperable due to the fact symptoms had been ignored 
and the cancer had spread. 
Asthma 
Cases of asthma were low, with 19 patients and one 
death.8 In one case a five-year-old boy was admitted to 
The London with asthma and was given a laxative (mag-
!I. Fomales ea 
250 -
nesium sulphate mixture), a mixture of lobeline 
(which contained tincture of lobeline, potassium 
iodide, tincture of stramonium containing atropine to 
cause paralysis of the airways and therefore prevent 
spasms, and camphor water). Also he was given 
oxygen, pulverised lobeline for inhalation and liquor 
of adrenaline. 16 It's interesting to see the use of 
inhalation as a delivery method. Lobeline is no 
longer used as it has unpredictable effects on the 
body due to its agonistic effects on nicotine 
receptors. The number of asthma patients has soared 
in recent time and salbutamol is one of the most 
prescribed drugs. 12 
Endocrine 
Hormonal conditions such as hypothyroidism and 
diabetes were seen in the 1914 records as well as their 
treatment in the pharmacopoeia. Injection of 
pancreatic extract, isolated from pigs was used for 
diabetic patients and thyroid extract was used for 
hypothyroidism. 1 Like today thyroid conditions 
affected many more women than men, 43 to 6 at the 
London Hospital in 1914. There were 50 cases of 
diabetes in 1914 with a 22% mortality rate.8 There 
were mentions of complications of diabetes including 
amputations in a few case notes. 
War 
1914 was of course the start of World War I. Whilst 
looking at the records it was noted that suddenly an 
unusual range of conditions was coming into the 
hospital records in September 1914. For example 
exhaustion was deemed strange as no one would 
have gone to hospital for such a thing in 1914; then it 
was realised that these were soldiers already coming 
back from the front line. There were many young 
unemployed men from the East End of London who 
would have been some of the first to sign up to fight 
for the country. It was also thought that the war 
would be over by Christmas. 
Conclusions 
---------- 11 Feinolesi"llelllrlr---------
It is fascinating to see the types of 
medicines that were used in 1914 
as well as the conditions and 
formulations and just to get a 
glimpse of the lives of the people 
that were treated at the London 
Hospital all those years ago. The 
changes and advances in pharmacy 
and treatment over 100 years are 
incredible. One of the main focuses 
is the shift from just treating 
ailments and preventing them 
happening in the first place. Just 
imagine what pha1:11ac~ and 
medicine will look !tke m I 00 
years from now. 
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which insights from modern research into esoteric 
religion are combined. 
1. Pharmacy in Ancient India (circa 
1500 BC to the 5th century AD) and 
Ayurveda 
Herbal knowledge has been the foundation of medication 
since antiquity. Ancient Indian medicine can trace its 
origin to a myriad of deities celebrated in the Vedas. 
Believed to have been composed around 1200 BC, the 
[fg-Veda is the oldest of the scriptures passed down from 
the Aryaris who migrated to the northwestern reaches of 
the Indian subcontinent around 1500 BC. This scripture 
records how the people of this period prayed to deities for 
blessings such as longevity, good fortune and victory in 
battle. It also contains hymns with magical properties such 
as the soma-sukta and 0$adhi-sukta, in which soma is 
described as a climbing vine that produces a milky liquid. 
Moreover, soma as described in the f!-g-Veda is identified 
with the moon God, and is referred to as the 'king of the 
medicinal herbs'. 1 A variety of medicinal plants such as 
soma are likewise used in the pu,ja (rituals) found in the 
Vedas. Some other descriptions related to medicinal and 
pharmaceutical plants in the Vedas and other Indic 
scriptures are cited below and discussed to provide an 
overview of the genealogy of medicine as it appears in 
Indian mythology. 
In the Sg-Veda, the soma plant is described as a vine. 
The soma also refers to a sacred drink, which is in essence 
a stimulant beverage made by pounding the stalks of the 
soma plant with stones to squeeze out liquid which is 
filtered through a wool sieve and mixed with a moderate 
amount of water and other liquids such as cow's milk. In 
Vedic rituals, soma was offered to deities as libation 
poured into sacred fires, with the remainder consumed by 
priests and other ritual participants, while its efficacy and 
preparation process were deified and sung by poets. The 
processes of collecting and preparing soma and other 
medicinal plants were considered sacred. Thus the 
knowledge and techniques of extracting and purifying 
natural drugs with instruments and equipment can be 
regarded as an important heritage of ancient Indian 
pharmacy.2 
The Atharva-Veda, believed to have been compiled 
arourid 1 OOO BC, is a compendium of curative procedures 
for exorc1smg demons, popularly believed to cause 
illness, and magical incantations for granting the various 
wishes of the people.3 The Atharva-Veda describes two 
kinds of magic. The first of them 'imprecates', or 
enchants, an opponent. The objective of this kind of magic 
is to cause illness and misfortune on the part of the enemy. 
In contrast, the second kind of magic, called Bh~jani, is 
of a medical nature, related to therapies and potent 
medicinal herbs. For example, a medicinal plant with an 
attached talisman inscribed with magical incantation was 
supposed to have curative efficacy. Water was also 
believed to have significant power as a medicinal drug. 
Medicine in this period was closely associated with 
magical and religious practices. 
The introductory section of the ancient Indian epic 
Mahabhiirata describes the beginning of the universe 
with a detailed account of the creation of all the deities and 
living things in the world. Regarding plants, the forest is 
portrayed as a symbol of abundance and the prosperity of 
the maternal womb, as an entity that nourishes the myriad 
animals with its trees and plants. Typical depictions of 
medicinal plants include how the plants that thrive on the 
slopes of Mount Meru emanate divine light, and how 
amrta, an elixir of immortality, is created by churning the 
'ocean of milk' to extract the essence of trees that then 
mingles with the seawater. The origins of plants associated 
with deities are described in the Purii,:za, an Indian 
collection of epic poetry, ancient tales and legends.4 The 
ancient Indian study of medicine is known as Ayurveda, 
which is an auxiliary Veda belonging to the Atharva-Veda. 
Ayurveda, a combination of the Sanskrit words for 'life' 
(iiyur I iiyus) and 'learning, knowledge' (veda), is 
traditionally held to have been conceived by Brahma, 
creator of all of the entities of the universe. Legend holds 
that this knowledge was revealed to Dalcyt Prajapati by 
Brahma in the early Vedic period, thought to be around 
800 BC. Then, in the late Vedic period, Indra learned 
medicine from the twin Asvin deities and transmitted this 
knowledge to the sage Bharadvaja, from whom the 
knowledge later passed on to Atreya according to the 
legend. From the time of Atreya, the legendary accounts 
begin to assume some credibility. Tradition holds that 
Atreya had six disciples. One of these was the sage 
Agnivesa, whose teachings are said to_h~ve influenced the 
medical tradition founded by the phys1c1an Caraka, author 
of the Caraka-sarrihitii, a medical treatise that came to 
form the basis of the internal medicine component of 
Ayurveda. There is also a separate line of tradition ?eld to 
have been inherited from Indra by Dhanvantan, then 
passed down to the legendary ph~sician S~ruta.5 This 
tradition became established as surgical medicme through 
later revisions and annotations to the Susruta-sarrihitii by 
Nagarjuna. Between the 6th and 5th . cen~es ~C, . a 
medical school is believed to have eXIsted m Taxila_ m 
northwestern India, where the physician JTvaka studied 
the theory and practice of Ayurveda.. . 
Ayurveda holds that all the matenals m the world ru:e 
composed of five basic elements of earth, water, fire, arr 
and ether, and that the human body is an aggregate 
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transformation of these five elements. Pairs of these 
elements in the body form three humours (do!fa) , called 
pitta, viiyu and kapha. According to the trido!fa theory, 
illness results from disturbances to the balance among 
these three humours. In this way, Ayurveda explains the 
basic principles of the functioning of the human body by 
identifying correspondences between the human bodily 
functions and the observed phenomena in the natural 
world. 
Regarding Basic Literature on Ayurveda 
The Caraka-sa1?1hitii (CS),6 Susrnta-sa1?1hitii (SS)7 and 
A$fiinga-sa1?1graha (AS)8 are famous as the three great 
medical texts of ancient India. Since AS is a compendium 
based on the former two, CS and SS are commonly known 
as the two great works of Ayurvedic literature. The CS is 
based on Agnivesa-tantra, in which Agnivesa first 
summarised the teachings of Atreya. It acquired its 
present form as the result of repeated revisions and 
reorganisations. A different legendary account holds that 
the text was completed by Drc;lhabala, a physician who 
lived in Kashmir in the 8th and 9th centuries AD and is 
believed to be responsible for the addition of Chapter 17 
at the end of Text Six, as well as the addition of Texts 
Seven and Eight. The current edition of the CS comprises 
eight books and one hundred and twenty chapters. 
Substantively, Ayurveda is premised on a tradition of 
eight disciplines. As for the basic principles of treatment, 
it defines the 'four pillars of treatment (physicians, drugs, 
nurses and patients)' and recommends dietary and drug-
based treatment regimens. In addition, Caraka classifies 
drugs into fifty separate groups according to their medical 
effects. The CS is understood to have been influenced not 
just by medical knowledge, but also by the somatic 
theories of the Sii1?1khya school, the theoretical logic of the 
Niyaya school, and the natural philosophical categories of 
the Vaiseshika school. The name 'Caraka' is believed to 
refer to itinerant physicians who travelled around the 
country to tend and treat the ill. Conversely, passages in 
the Chinese Fu-fazang-yinyuan-zhua 
(tN!Jitlzsl~{f )['History of the Transmission of the 
Dharma Storehouse'] and the Chinese translation of the 
Tripi/aka also suggest a link between the CS and a 
physician in the 2nd century AD at the court of King 
Kaniska. The CS was translated into Arabic and Latin in 
the 8th century, Persian in the 9th century and into English 
from 1890. On the other hand, SS deals primarily with 
surgical medicine. The fact that Susruta discusses 
differences between his own way of thinking and that of 
the Atreya school as to the number of bones in the human 
body suggests that Susruta came after Atreya. Yet, there is 
little evidence available to determine the period when 
Susruta was active. The SS is based on the Salya-tantra, 
believed to have been compiled in the 2nd century BC. It 
is believed that Susruta supplemented this text with the 
Uttara-tantra to complete the SS sometime before the 2nd 
century AD. Palhat;ta, the author of a commentary on the 
SS active in the 12th century, argued that revisions to the 
text were made by Nagarjuna. However, scholarly 
opinion generally makes a distinction between the 
physician Nagarjuna and the Buddhist scholar of the same 
name. SS comprises five books and one hundred and 
twenty chapters. Drugs are therein classified into thirty-
seven different groups according to their nature and 
medical efficacy. Over one hundred types of medical 
equipment and over twenty types of steel surgical 
instruments are listed, including knives, scalpels, lancets, 
saws and scissors. Book Three, alongside a systematic 
observation of functional , developmental, and structural 
aspects of internal organs, explains the importance of 
surgical procedures and discusses a primitive stethoscope 
with a tubular instrument, plastic surgery to create 
artificial earlobes, incisions using cucumbers or gourds 
and phlebotomy techniques making use of a lotus stem. 
For these reasons, Susruta is regarded as a pioneer in the 
field of surgery. 
The Bower Manuscript 
These two great works mentioned above are thought to be 
related to the Bower Manuscript, which is a birch bark 
manuscript of fifty-four leaves purchased in 1890 by a 
British Lieutenant Hamilton Bower in Kucha in East 
Turkestan. This is an example of a treatise describing 
ancient Indian pharmacy.9 Written in the Gupta script in a 
format used in Buddhist scriptures, the manuscript 
contains formularies included in the Ayurveda, 
divinations and incantations, and contents associated with 
Buddhism. The Bower Manuscript was deciphered by AF 
Hoernle and an annotated English translation was 
published in the years between 1897 and 1912. Named the 
Bower Manuscript in honour of the man who discovered 
it, it was initially determined by philological research to 
have been written sometime between 350 and 375 AD. 
There are, however, palaeographical reasons to place the 
date between the 4th and 6th centuries AD10 and current 
research reports that it was written between the beginning 
and the middle of the 6th century. 11 In particular, the 
second part of the Bower Manuscript, which is called the 
Niivan"itaka, is intended to provide a standard manual of 
the foremost medical formulae as 'approved items'. The 
composition and contents of the 11 th chapter of the 
Niivan"itaka, which is a monograph on har"itaki (Har"itaki-
kalpa) that supposedly corresponds to the pl~t 
Terminalia chebula Retz., are also listed in the Ayurvedic 
Pharmacopoeia of India. According to the Har"itaki-ka/pa, 
herbs can also be applied to various symptoms caused ~y 
the disorder of three humours as a depurative or as a tome 
for perpetual youth and longevity. The discovery of the 
manuscript later triggered a flow of expeditions along the 
Silk Road and in the Western Region of China. The 
manuscript is presently preserved in the Bodleian Library 
at the University of Oxford. (Figures 1, 2) 
2. Pharmacy in medieval India (from 
the 6th to 17th centuries) 
The pharmacological history of medieval India ?ad 
large scale interconnections with religious medtc~l 
practices in Asia, the Middle East and Europe. ~his 
section draws on major medical books at the ttt?e 
to outline the history of pharmacology with 
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Figure 1. Title page of the Bower Manuscript, 1912.9 
particular focus on the relationship between religion 
and pharmacy. 
Early in the 7th century, there was a growing 
trend toward tantrism, a common concept among 
Indian religions. This trend subsisted ti ll the 13th 
century with the 9th century celebrated as the golden 
age of tantrism. 13 1.antra means 'warp of a loom' in 
Sanskrit, but its significance is not clearly explained 
in the scriptures. 1.antra deals with natural sciences 
such as astronomy, mathematics and medicine, as 
well as the legal field of everyday life. In the 6th 
century, Wiriihamihira wrote in the Brhat-samhitii 
about the use of mercury or iron in ·combin.ation 
with medicinal plants to prepare an aphrodisiac or a 
tonic. 14 The Sanskrit dictionary called Amarakosa, 
compiled during the same period, lays out medical 
formulae that make use of red lead, lead, gold, 
~ercury and silver. These major works in medical 
literature are typical of the early medieval Indian 
pharmacology. They are based on the Caraka 
medical system and are impacted by tantrism. 
A!?tanga-hrdaya-samhita 
During the 7th century, Viigbha/a IT treated the same 
field in the A$/iinga-hrdaya-saf!1hitii (AHS) as 
Viigbha/a I's A. 15 It is a formulary that comprises CS 
and ~S. It ~as tra~slated into Arabic in the 8th century 
and mto Tibetan m the 11 th century. (Figure 3, p.60.) 
Madhavakara Nidana 
The Miidhavakara Nidiina 16 is famous because it 
contains the writings of Miidhava, who was active 
between the 7th and 8th centuries. It is a commentary 
on the causes of diseases and is based on three major 
medical textbooks in ancient India. It was translated 
into Arabic in the 8th century and into English in the 
20th century. While it describes drugs that cause 
diseases, the amount of pharmaceutical content i 
smaller than that found in the three major medical 
textbooks in ancient India. 
Siddhayoga 
Vrinda authored the Siddhayoga in the I 0th century. It 
cites formulations from the works of Caraka, Susrnta 
and Viigbha/a and was used for preparing variou 
compounds for eye drops. 
Cakradattadipika 
According to Cakrapanidatta (active circa 1060), 
the Cakradattadipik:a comprises notes on CS. It 
refers to the Siddhayoga of Caraka, Su 'ruta, 
Vagbhata and Vrinda and is related to the rituals of 
tantra. It uses iron powder, copper powder and 
talcum powder as therapeutic agents. 
Early Uses of Metals in Medicine 
In the time of the Veda, soma and its juice represented 
early Indian alchemy and were used for worshipping the 
gods. The word rasayana, which means 'the juice of, 
originates from somarasa, which is known as a drink that 
makes men and gods incredibly cheerful. Rasa implies 
'mercury'; thus, rasayana means mercury medicine, i.e. 
mixture of mercury with medicinal plants, or the Elixir of 
Life. Thus, alchemical processes u ing various medicinal 
plants gradually came to take the form of fonnulation 
containing mercury. For example, in the Atharva-J.eda, 
gold, having a noble nature, is described as being present 
in the elixir of longevity whereas curses and magic are 
recommended as ways of treatment. In later generations, 
men sought pleasure rather than relief from disasters, 
pains and diseases, in opposition to the actions of the 
•--==,.......---------------:-----------i shaman Atharvan. 1n tho e day , 
;.'.;<'Lt'\'\' ~ ~\. o \\ n -:. t:i. V' . authorities saw Atharvanic healing as 
an evil occupation, and alchemy was 
a mysterious art and science of 
converting one substance to another; 
it was a magical art taught only to 
disciples in esoteric religious 
organisations. Thus, Indian alchemy 
originated in the Veda and had a deep 
connection to tantric prayer therapi 
and longevity concoction for 
'----------------------------- rejuvenation and rebirth. 
Figure 2. Bower Manuscript, 1912, Plate X.9 
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Figure 3. A~tiing-hrdaya-sarrzhitii (around 15th century). Image courtesy of DAY College Library, Chandigarh. 
During the 11 th to 13th centuries, pharmacology 
was under the influence of tantrism, and thus, tantric 
rituals began to be favoured. In alchemy, however, we 
find a precursor to medicinal chemistry. Here, I 
would like to discuss the three main tantric works in 
the literature that are related to alchemy. 
Rasaratnakara (Treasure Trove of 
Mercury and Gemstones) 
The Rasaratniikara is a work from the 7th and 8th 
centuries, before Muslims entered the northern parts 
of India. It is a tantra from Mahayana Buddhism 
related to alchemy. It contains the chemical knowledge 
revealed to the author Niigarjuna by prajiia-paramita 
(complete wisdom) that appeared in his dream. In 
addition to mercury/mercury sulphide formulae, 
methods for metal purification, metal and gemstone 
polishing and mercury solidification as well as the 
apparatus used for these processes, the elixir of 
longevity is discussed here. 
Rasar,:,avakalpa (The Unlimited Power of 
Mercury) 
This is an Indian metallmgy classic of unknown authorship 
supposedly written during the 11 th century. kalpa refers to 
something that can be operated by its own potential and it 
can more specifically refer to the power of various metals 
for transforming base metals such as copper and lead into 
silver and gold. It classifies substances on the basis of their 
potential to transform metals. Ka/pa, written in the form of 
a dialogue between Siva and his companion Parvafi, 
provides a mythical description of the process of alchemy 
and the origin of plants, minerals and mineralised water. It 
emphasises the tantric ritual performed before using the 
material and represents a phase of alchemy that 
emphasises the immortal quality and metamorphic 
processes of a substance. 17 
Rasaratnasamuccaya (Collection of 
Mercurial Treasure) 
The Rasaratnasamuccaya, authored by Vagbha/a, is a 
literary work from the 13th century on metallurgy, 
Ayurvedic therapy and pharmaceuticals. The first 
chapter lists the names of 27 scholars of mercurial 
study (rasa-siistra), among which appear the names of 
Nagarjuna and Nagabodhi. It preaches the auspicious 
importance of rasa (mercury). Siva is the god who 
governs rasa, which is regarded as his essence or 
semen. Thus, the text reasons that rasa has the power 
to absorb all metals and the ability to heal and prevent 
ageing, pain and death. 
Medical Chemistry and Tantrism as Late 
Esoteric Buddhism 
Esoteric Buddhism is a part of tantrism founded by 
Nagiirjuna in the 7th century. In the 7th century it was 
influenced by Mahayana Buddhism and became Tantric 
Buddhism, which was practised in India between the 8th 
and 12th centuries. It was at the same time absorbed into 
Brahmanism and Shaivism tantra between the 7th and 
8th centuries with the decline of Buddhism. Between the 
10th and 13th centuries, Tantric Buddhism integrated 
with a Hindu sect to form ha/hayoga. In this sect, the use 
of chemicals such as mercury, sulphur and mica is 
believed to be essential for longevity. Some of the 
chemicals are used by Atharvan for medical treatments. 
From the 11th to 12th centuries, before the Muslim 
invasions, Vtkramasila University was one of the two 
most important centres of Buddhist learning in India, the 
most important being the Nalanda University. Chemistry 
and medicine, as well as Buddhist philosophy, were part 
the curriculum of study there. Buddhism in medieval 
India had a significant impact on medicine. The ties 
between medicine and Buddhism in India date back to 
ancient times. During the ancient times, medicine 
(vyiidhi-cikitsa-vidya) had taken on a broad meaning as 
one of the five sciences (paiica- vidya-sthaniini) defined 
as auxiliary sciences by the Centre to Preserve the Study 
of Buddhist Doctrine. Magic was included here 
alongside pharmacology. Medical care was preached 
even in Buddhist scriptures as a metaphor of the 
doctrines. These descriptions contain the same conte~ts 
as Ayurveda and discuss treatments to prevent pam, 
sickness and old age. Among them, Vzkramasfla 
Mahiivihiira was destroyed by Muslims during the 13th 
century. Learned priests were killed, but, some of them, 
who excelled in learning, fled to Nepal, Tibet and South 
India. As a result, Buddhism and scholarship found 
asylum in the areas where they sought refuge, thereby 
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propagating medicine and Buddhism in various regions. 
In this way, Buddhist scriptures also found their way to 
China because of the Chinese translations and began to be 
integrated into Chinese medicine. 
Pharmacology after the Muslim Invasion 
Kruacakra tantra was compiled in the 11 th century from 
the words of Buddha in his later years. It is well known as 
the late Esoteric Buddhism's most holy scripture. It is a 
representative scripture of Anuttarayoga Tantra, the most 
esoteric form of Tibetan Esoteric Buddhism, and deals 
with the signs of death that is outside the medical causal 
theory that Caraka and Susrnta and preach. Then, during 
the 12th century, pulse diagnosis was introduced from 
Tibetan medicine. Also, between the 11 th and 12th 
centuries, an encyclopaedia of medicinal plants 
(nigha,:itu) was compiled that intended to identify 
medicinal plants found in ancient medical literature. 
During this same period, use of mineral drugs became 
popular. South India established a system of medicine 
called siddha that used mineral drugs, primarily mercUI)'. 
After the 13th century, it was influenced by the Islamic 
medicine, unani. This medicine was created in the 11 th 
century on the basis of the Greek medicine by the Persian 
(currently Iranian) physician-philosopher lbn-Sina 
[ Avicenna). 18 Then, in the middle of the 15 th century, 
foreign medicinal plants, such as opium poppy and kino, 
were introduced for drug treatments. Also, Chinese 
merchants brought syphilis from Portugal to Goa in West 
India. This was treated using mineral acids, such as 
phosphoric acid or arsenic acid, as therapeutic agents, 
which had the property of dissolving metals. Insoluble 
mercUI}' was also prepared for mercUl)''S sterilising and 
insecticidal applications. In the 16th century, Indian 
medical literature described the validity of exotic drugs. 
Thus, practising alchemists as well as people who 
pharmaceutically use mineral drugs greatly contributed to 
the development of pharmacology in medieval India. 
3. Pharmacy in Modern India (From 
the 17th century to the present) 
Since Dutch, English, and French expansion into India in 
the 17th century, Ayurveda has been in contact with 
Western medicine. As a result, in practical aspects, Western 
medicine was gradually incorporated into Indian medicine. 
In the early 19th century, Indian medicine was further 
westernised, but movements to revive traditional Indian 
medicine occurred throughout India, notably Bengal, .with 
the rise of independence movements. What was reVIved, 
however, was an eclectic one with significant deviations 
from the classic. Traditional medicine, while embracing 
~estern medicine, attributed the decline of Ayurveda to the 
mtroduction of Western medicine.19 
Formal pharmacy education in India began with a 
course taught at a medical school in Madras ( currently 
Chennai) under British rule in 1860, focusing mainly on 
practical prescriptions and principal compo~ds o~ ~e 
British Pharmacopoeia, which was enforced m _India Ill 
1885. This school was designated as a 'college' m 1860, 
and the institution came to be known as the Madras 
Medical College. 
In Britain, apothecaries had separated from grocers 
during the 17th century. By the early 18th century, 
apothecaries achieved some recognition as medico-
pharmaceutical practitioners. Two groups of apothecaries 
arose: one group was mainly interested in the practice of 
medicine and the other in pharmacy. From the latter 
emerged chemists and druggists, who were expected to 
have practical knowledge of pharmacy. 
In India, a 'chemist' or 'druggist' course had been taught 
since the 1870s. In colonial India, this was the only course 
of its kind and standing, geared to providing qualified 
manpower for pharmacy practice and governed in line 
with the instructions imparted by the Pharmaceutical 
Society of Great Britain. In l 9th-centlll}' India, those who 
specialised in pharmacology were given the English title 
of chemist or druggist. Similarly, in 1894 the Madras 
Medical College began to grant certificates of chemist and 
druggists to those who attended all course in pharmacy 
and chemistry including practical subjects. Thus, the 
pharmaceutical profession under British rule transformed 
from 'those who dispensed' into 'tho e who are 
scientifically educated.' 
The Institutionalisation of pharmacy in 
modern India 
Right after independence, the Indian government enacted 
the Pharmacy Act in 1948, which established the 
standards for education and qualifications for pharmacy 
practice.20 Thus, graduates of a diploma course, which 
consisted of two years of classroom education and three 
months of practical training, were recognised as 
pharmacists who were licensed to dispense and sell 
pharmaceuticals. The Pharmacy Act required each state to 
establish a pharmacy council to which regulation and 
registration of pharmacists were mandated. To implement 
the act, the Pharmacy Council of India was established in 
1949.21 The framework of pharmacy education in India 
was formed this way. As new dynamics in pharmacy in 
India between 1930 to 1931 , the Indian government 
established the Drug Enquiry Committee. This committee 
made recommendations for legislation to regulate the 
pharmaceutical industry, drugs, and the government. 
The foundation was thus laid for the development of 
the pharmaceutical profession and the chemical 
manufacturing industry, which created the greatest 
challenge for developing a competent human resource 
pool for pharmacy education. 
Madan Mohan Malaviya, president of the Banaras 
Hindu University, recognised the importance of the 
aforementioned recommendation and Mahadeva Lal 
Schroff was tasked with the mission to promote 
pharmaceutical education in the university.22 Along with 
this task, Schroff, who was entirely aware of the need. for 
high quality, affordable texts in pharmacy ed~cat:Jon, 
wrote textbooks with his former student GP Snvastava 
and other people which contained principles of 
pharmaceutical chemistry, commentary on pharma-
ceutical arithmetic, and general pharmacy.24 chroff wrote 
six textbooks, including some that were ~-authored. 
Overall, 23 works related to pharmacy are attnbutable to 
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him. Currently, this is a record number for lifetime 
publications in Indian pharmacy. (Figure 4). 
Schroff also carried out studies on the history of 
pharmacy in their mother country. From 1950 to 1953, he 
repeatedly contributed papers on his research results to the 
American Institute of the History of Pharmacy. These 
works were gathered and reprinted as History of Indian 
Pharmacy by Srivastava in 1953.23 These works explain 
the processes of drug formulation in ancient times in their 
every aspect and comments on what relevance they have 
to the origin of Indian pharmacy (Figure 5). 
Now let us turn our attention to the potential in all 
aspects of drug discovery and development in India. The 
concept of a pharmaceutical central research institute that 
was proposed by Schroff to the government of India in 
1954 was taken over by Harkishan Singh. At that time, 
Singh was a professor at Punjab University. In respect of 
pharmacy education, it is worth briefly mentioning the 
National Institute of Pharmaceutical Education and 
Research (NIPER).25 In 1991, the first NIPER was 
founded in SAS Nagar, Mohali, Punjab, 250 km north of 
Figure 4. Title page of General Pharmacy, Part III, Vol. II, 
referred to in Indian Pharmacopoeia (1966), British 
Pharmacopoeia ( 1968), the British Pharmaceutical Codex 
(1968), and United States Pharmacopeia, XVII, (1965). 
Delhi. It is a state-of-the-art pharmacy education institution 
that symbolises contemporary India. This NIPER, the first 
national level institute in Indian pharmaceutical sciences, is 
to become a centre of excellence for advanced studies and 
research in pharmaceutical sciences. Since then, six 
NIPERs have been established - at Ahmedabad, Hajipur, 
Hyderabad, Kolkata, Rae Bareli, and Guwahati. Now 
Singh is a Professor Emeritus of Punjab University and 
recognised as the leading authority in the modem 
pharmaceutical history of India. 
As for hospital pharmacy, in 1963 the Indian Hospital 
Pharmacists Association, inaugurated by Bhagwan Dass 
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Figure 5. Title page of Volume I of History of Indian 
Pharmacy. 
Miglani, assumed the central role26 in arts and sciences of 
hospital pharmacists and disseminated opinions on 
medical reforms and pharmacy to the public. The Indian 
Pharmaceutical Congress began publishing a bimonthly 
journal The Indian Journal of Hospital Pharmacy in 
1964. This journal is still published today. 
Conclusion 
In this paper, major works in Indian pharmacy from 
ancient times to the present were listed and outlined. 
Indian pharmacy has its origins in mythology. In the 
Middle Ages, gold and rasiiy:ma for longevity 
respectively corresponded to alchemy and perennial 
youth or long life. The fusion of these two coincided 
with a new tide of tantrism in India. Since before 
independence, Indian traditional medicine had been 
incorporating \\estem medicine. Currently, Ayurveda, 
modem Western medicine, Unani, Tibetan medicine, 
and Siddha are performed concurrently and 
characterise pharmaceutical practices and drug 
discovery in India. Vcirious works in Indian pharmacy 
have been handed down in pharmaceutical education.27 
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The Islamic Middle Era is an important historical period 
due to the separation of pharmacology from medicine 
and its development as a specified branch of medical 
sciences. Pharmaceutics, toxicology, production of 
narcotic drugs, publication of herbal books and 
pharmacopoeias developed in this era. The Abbasid 
Caliph (King) ordered legislation on pharmacology and 
these laws played an effective role in promotion of this 
science. The aim of this study was to show the process of 
development and specification of pharmacology in the 
Islamic Middle Era and discuss some influential factors 
in this promotion. 
Medicine and pharmacy 
The scientific movement in Islamic civilisation did not 
occur due to Abbasid and Omavian politics; it was the 
direct result of Muslims' relationships with civilised 
nations like Iranians, Greeks, Syrians, Hebrews and 
Indians which were accompanied with Islamic teachings 
about seeking knowledge. In this regard prophet 
Mohammad (PBUH) said, "Seek knowledge even ifit is 
in China". 1 This encouraged Muslims to search and learn 
knowledge even if it was in China and had risks for their 
life. So, Abbasid Caliphs supported scientific devel-
opment for their political goals and used its results for 
their governmental plans. 
The Abbasid dynasty was the second dynasty of 
Islamic Caliphs which ruled after the Omavian 
[Umayyads] from 132 to 656 A.H. [750-1258 AD] 
Their great ancestor was an uncle of Prophet 
Mohammad, Abbas ibn Abdolmotalleb, so they called 
their dynasty Abbasid or Ale-Abbas. Shiite's of 
Khorasan released Abo/ Abbas Abdallah and his 
brother, Jafar (Mansour Caliph) from Kufa's prison 
for allegiance to the Abo/ Abbas (who was known as 
'Saffah' [killer]) in Kufa mosque in 132 A.H. After 
that, all the Islamic lands were captured by Abbasids 
(from Send in the east to the west). 
The Abbasid dynasty started with the reign of Abol 
Abbas, but the main founder of the Abbasids was his 
brother, Mansour, who was Caliph for 21 years and 
the other 35 Caliphs after him were his descendants. 
He built Baghdad city as his Caliphate's centre. 2 In the 
Harun al-Rashid period, Baghdad gained its higher 
position as capital of Abbasids because of Iranian, 
Indian and Syrian's scientists and healers. 
Non-Muslim scientists encouraged Muslims to 
acquire the science and knowledge of earlier 
scientists. At first, Muslims thought all other sciences, 
except medicine, were against Islam. But when 
physicians went to the Caliphate, they tried to teach 
philosophical and logical knowledge to the Caliphs. 
Therefore, Caliphs no longer burned the books of 
conquered cities and countries. They wanted their 
soldiers to gather and transfer them to Baghdad for 
translation into Arabic. As some books from 
conquered cities like Ankara and Arnorium were 
transferred to Baghdad, they were translated into 
Arabic by 'Yuhanna ibn Masawaih ', Physician of 
Harun al-Rashid. 3 
Mamoun (one of the Abbasid Caliphs) also sent a 
letter to the Roman king and wanted him to send any 
books of old sciences. He sent to Rome some 
scientists like Hajjaj ibn Matar, Ibn Betarigh, and 
Sa/ma, the supervisor of 'Beyt Al-Hekmah' (House ?f 
Wisdom, a great and famous library established m 
Harun al-Rashid period), for gathering and translating 
books.4 Unfortunately, all these great activities were 
not continuous and after Mamoun the Caliphate's 
system and scientific situation changed.2 The last 
Caliph of the Abbasids was Al-Mu 'tasim who started 
his Caliphate in 640 A.H. [1252] In 656 A.H., 
Holakookhan was sent to Baghdad to open Esmailian 
gates and conquer Baghdad. By killing the Caliph and 
his children, he ended the Abbasid dynasty. 2 
Medical and pharmacological sciences enter~d 
Islamic civilisation from the translation movement m 
the Islamic middle periods. Medical sciences, 
especially pharmacology, developed and because of 
cohesion and unity with medicine, they couldn't be 
differentiated from each other. 
Some pharmacological books translated from 
Greek to Arabic in the Islamic middle era included 
Tarkib-Al-Advieh ( drugs mixture), Al-Advieh Al-
Mofradeh (single drugs), Ghova-Al-Aghzieh (foods 
potency), Al-Advieh Ao Al-dava (drugs or drug), Al-
Oram (the swellings), and Al-Teriagh (The Book of 
Theriac). 
Also some Indian books like the book of Indian 
b. 5 drugs names were translated from Hindu to Ara 1c. 
At that time, medical discussions and subjects were 
deeply related to phytology. So, pharmacies had a~ 
important role and position in hospitals for the1r 
medicinal plants. . 
A pantry (or syrup providing centre) was_a roo~ m 
which drugs were prepared. Before this penod, 
Arabic pharmacological books included simple drugs 
with animal, plant or mineral source~ and 
compounding drugs ( aqrabadins ), most of which are 
forgotten today. 6 In fact, Muslims paid much more 
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attention to the . therapeutic effects of plants, so 
pharmacology switched to practical herbal medicine.7 
Islamic scientists were then the best in the 
pharmacological field. At first, they learned about all 
kinds of drugs from Greek books like the Materia 
Medica of Dioscorides. This book was translated into 
Arabic by Estefan ibn Basil and edited by Hunayn ibn 
Ishaq (Johannitus).8 In fact, Muslims resurrected the 
phytology which was being forgotten in Greece after 
Theophrastus. Muslims of the Islamic Middle Age were 
more advanced in phannacology and the natural and 
chemical history of simple drugs than the Greek and 
Latin nations of the time. Latin and Greek herbalists were 
then directly and indirectly influenced by Arabic books 
of the 9th and 10th centuries AD, because Islamic lands 
had spread from China toAndalusia.3,9 
It is known that Iranians in the Sassanid era were 
expert at pharmacology and many Iranian names of 
medicines from that time are still used, especially for 
compound medicines. For example, in the Sassanid 
period, a group of physicians named Oroor Pezeshk 
(plant physician) tried to cure and heal their patients 
with extracts of herbs and medicines. The ability and 
status of these physicians of the Sassanid dynasty in 
Iranian society is comparable with phannacists and 
pharmacologists of the Islamic Middle Age. There are 
no instructions about the preparation of medicines 
and extracts of plants in Avestan [an Old Iranian 
language] texts, but Greek and Islamic historians and 
even medical books commented on Iranian's ability 
to prepare different and effective medicines which 
amazed Greeks and Muslims. 10 
During the Islamic Era Iranian continued the way 
in which pharmacology was developed and surpassed 
the knowledge ofTheophrastus and Dioscorides. This 
tradition culminated in the Safavid period which was 
named the Golden Age of pharmacology. Muslims 
divided medicines into two groups: simple and 
compound, and called them Aghaghir. There were 
different kinds of pharmacological books: on poisons, 
lists of compounding drugs, summarised essays (that 
were something like today's handbooks) and 
aqrabadins (taken from the Greek word Craphidion, 
pharmacopoeia of compounding drugs). 11 Each 
aqrabadin is arranged alphabetically and is a lexicon 
and dictionary.9,3 Botanists supposed that if you name 
!he plant, you should recognise and identify it, but it 
1s only the first step ofrecognition. If you recognise it 
better, you can give it many names. They didn't try to 
match names with objects and find its similarities. 12 
. Pharmacology was a precise and advanced science 
m the Caliph's territory. Mirhouf clarified that 
Baghdadi pharmacists could weigh their medicinal 
herbs with a Grain scale ( each Grain is 65 mg). 
Baghdad medicine dealers limited themselves in their 
main profession. They had a high position in society 
but most of them treated patients informally. There 
were no limits for dealers of medicine and for 
physicians. Usage of medicine developed in the 
A?basi~ dynasty and many books were published in 
this penod. The first great writer in this field wa 
S?apour ibn 
4 
Sahl who wrote Agharabazin-fi-Al-
bzmarestanat. Rhazes was one of the scholars who 
recognised pharmacology as an independent field but 
related to medicine. He was one of the first scientists 
who made drugs in chemical laboratories. He 
~entioned 800 medicines (most of them herbal) and 
discussed the theoretical and practical basics of 
pharmacology. In addition, Abu Rayhan al-Biruni 
was known as the founder of indigenous phytology in 
pharmacy.3 
Drugs were apparently expensive at that time. 
Compounding drugs and medicines that were made 
from scarce sources were more expensive than imple 
ones because people thought they were more 
effective. However, exact information about the 
prices is rare. Physicians also were worried about the 
prices of medicines.7 Medicine and spice were 
important objects of business, but patients usually 
couldn't buy them. Dealers in medicine worked a 
second-class physicians and were from the lower 
level of society. Medicine retailers were at the level of 
tricksters and illiterate physicians. ome of them 
cheated in the sale and making of medicines. 
In the book Tabaghat-Al-Atebba (Order of 
Physicians), it was explained that there were some 
physicians who couldn't choose the correct medicine 
for treating patients; so Mamoun ordered the dealers 
of medicine to be evaluated. Also, Moatasam 
commanded that a charter be given to dealers of 
medicine who had enough knowledge. He assigned 
inspectors (called Muhtaseb) to supervise dealer of 
medicine. Of course, the main duty of inspectors was 
forbidding what was not right according to religion, 
but protecting artisans and their work was also their 
duty.13 
Moghtader, another Abbasid Caliph at the 
beginning of the third century A.H, ordered his men 
to check pharmacists' competence. Ba ed on thi 
command, As lbn Ghafti said that people who could 
prove their competence to Sanan ibn abet were 
allowed to treat patient and pre cribe medicine. They 
gave unreal (te t) prescription to group of 
pharmacists and required them to prepare tho e 
medicines. Pharmacists who gathered and prepared 
the wrong medicines were rejected by the Caliph and 
others, who knew the meaning of pre cription , kept 
their positions. 8 
Rhazes and the science of pharmacology 
Rhazes is important in the science of pharmacology 
because of his Mojarrabat (Drugs which were 
experienced practically). This collection of clinical 
experiences include 650 reports on ~i pa?e.nts. At ~e 
time of Rhazes, patients used to explam the1r 1llne es m 
different ways: they either saw the phy ician directly, or 
wrote their history for the doctor or even asked another 
one to explain about their problem for ~em. Mo t 
probably, the most interesting case , e pec1ally th e 
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who benefitted from prescribed medicines, were recorded 
in his books and essays. 3 
One of the innovations of Rhazes in phannacy was 
using chemistry and alchemy together. Up to the time of 
Rhazes, alchemy was a supernatural and virtual science 
and it was not related to experience. 14 He produced 
ammonia by dry distillation of animal excrements. He 
also categorised mineral ores and explained some 
chemical tools. Rhazes tried to use his chemical 
knowledge in medical treatments and brought many 
materials into chemistry and phannacy. In addition, his 
discovery of alcohol and sulfuric acid were other 
achievements. Rhazes made alcohol from distillation of 
fermented sugar and starchy material and extracted 
sulfuric acid from the breakdown of sulfate of green alum 
and introduced it as a disinfectant. 15 Also, he examined the 
effect of mercury on monkeys and prescribed it as a 
diarrhoea-inducing agent. '6 
When he tried to find 'The Philosopher's Stone', 
which was supposed to change worthless metal to 
gold and silver, and 'The Great Elixir' to make an old 
person young, he discovered many chemical 
materials. 17 Kampe! said in his book, regarding 
Arabic medicine and its influence in the middle era: 
'Rhazes is the first person who entered chemical 
extractions in medicine. He could be considered as 
the ancestor and scout of chemical teachers of The 
Age of Doom' or 16th century. In addition to being a 
chemist, Rhazes was also a physicist; he used the 
balance ofliquids for testing density.12 
Avicenna and the science of 
pharmacology 
Ibn Sina (Avicenna) has had a great impact on 
phannacology because of his important book Canon of 
Medicine. He explained each medicine, its usage and 
ingredients. In addition to his knowledge about drugs 
presented in other books, he discussed the characteristics 
of herbs based on his own experiences. He skilfully 
categorised medicines like antiseptics, narcotics and 
analgesics. The fifth book of Canon is a course of 
phannacy and phannacology. He explained all medicines 
types, such as tablets, balms, pills, powders, syrups etc. 18 
800 simple medicines are explained in the Canon and 
introduced by text. Avicenna described each medicine, its 
nature, the best and the worst ofit and its origins (mineral, 
herbal or animal). Also, he believed that patients shouldn't 
only keep to medicine; they should use diet regimens as 
well as warm baths and sun baths for some illnesses. He 
thought watery food was better for a patient's treatment 
(generally liquids). Then, functional foods, nutraceuticals 
and simple medicines should be used. At the end, if the 
treatment was not effective enough, compound medicines 
should be prescribed. Compound drugs are produced 
from two or more simple medicines and have different 
forms of elixir, pill, decoction, etc. 18 
Pharmacy or drugstore 
The phannacy or drugstore was an important place in the 
hospital in which documents and deeds of a hospital's 
Figure 1: Islamic pharmacy image: From Golshani, 
SAR. Medical History In Bani Abbas Era (A.D 750-
1258). Supervised by: Dr SA. Foroozani. MA Thesis in 
Islamic History. Shiraz University. February 2012. 
buildings and its endowments were kept.6 The phannacy 
of a hospital, which was called Sharbat Khaneh, was like 
a treasury because it was generally adorned with artistic 
objects, porcelain and clay jars. Some phannacies rivalled 
royal palaces because of these treasuries. The chief of the 
drugstore was named Sheykh-e-Seydalani or drugstore 
manager. This title was given to all alchemists of that time. 
Common employees were called major and other service 
workers like dishwashers or porters called Sharbat dar. '9.2° 
Phannacists in drugstores charged the prices of 
medicines but one of them, named Jbn-Al-Hazar, 
condemned this job. He employed a slave in front of his 
house named Ras high and made him give out medicine to 
patients and take the cash. 13 (Figure 1) 
The tradition of writing herbal 
pharmacopoeias and aqrabadins 
Writing herbal pharmacopoeia is a branch of 
pharmacology that started from the beginning of the 
translation movement. Hunayn ibn Ishaq (Johannitius) 
translated a book of plants from Greek to Arabic and after 
him many scientists and translators oflslamic civilisation 
started to compile their own books. Ali ibn Rabban 
Tabari compiled Ferdos-al-Hekmah and described 
applications of medicinal plants and herbs. 16 
Yuhanna ibn Masawaih was one of the first writers 
of aqrabadin. He was known as the Gospel writer of 
aqrabadin in Europe. Another more famous aqrabadin 
belongs to Shapour ibn Sahl in Jondishapour. The 
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philosopher Alkandi wrote some essays about 
medicine and perfumes, and also wrote an aqrabadin 
book. Furthermore, Rhazes, the famous philosopher 
and physician, composed a famous aqrabadin which 
was translated into Arabic and Latin. In addition, 
Avicenna's Canon had a complete and comprehensive 
chapter about medicines which are still used in some 
regions of the east. 21 Ali ibn Abbas Majusi Ahvazi 
also described the effects of medicines on the human 
body.22 He explained the application and importance 
of medicine and its nature (cold or hot) .23 In fact, 
writing herbal pharmacopoeias was an Arabic-Islamic 
tradition. 
The first Christian Arab scientist who wrote a 
herbal pharmacopoeia was Ibn Sarabiyoon Asghar. 
Today, only one part of his Arabic essay exists but its 
translations into Hebrew and Latin still exist. 
Moreover, Ibn Telmiz wrote the most important 
Arabic herbal pharmacopoeia of his time ( after Ibn 
Sarabiyoon). He was a Christian and manager of 
Baghdad physicians. 12 Ibn Bitar (646A.H./l l 75AD) 
compiled the most masterly Arabic herbal 
pharmacopoeia which was the most important work 
from Dioscorides until the 16th century. He traveled 
to Greece, Asia Minor, Egypt and other cities to find 
medicinal herbs. He compiled a book with 1400 
medicinal herbs and influenced many Iranian writers 
who followed him. Ibn Bitar prepared a long list of 
simple medicines and their applications. Accordingly, 
he could be considered as the founder of writing 
Persian aqrabadin books. 24 In fact, Ibn Bitar's book 
was a botanic encyclopedia which included Greek 
and Arabic scientists' experiences like Dioscorides, 
Galen, Rhazes, Avicenna, Edrisi and others. 12 
Ibn Moskooyeh, a philosopher and historian 
contemporaneous with Avicenna, also had a book 
named Al-mofradat (simple medicines). But, Abu 
Mansour Movaffagh ibn Ali Al-Heravi wrote the most 
important Persian herbal pharmacopoeia, which is 
known as Al-Abniyah An Haghayegh Al-Adwiyah. It 
is the first prose text in the Persian language (357-
366A.H./968-977 AD). He described 585 medicines 
from Greek, Syrian, Iranian, Arabic, and Indian 
sources. This book also has a scientifically interesting 
chapter about advanced medicines. 11 
One of the important pharmacological books of that 
time was AI-Saydaleh (Pharmacology) of Birooni. ~e 
used Babylonian, Greek, Syrian, Indian and Arabic 
sources in his masterpiece. Birooni also used some 
ancient Iranian books which no longer survive. Al-
Saydaleh is not only a valuable masterpiece of ~e 
period, but also an old masterpiece of Iraruan 
pharmacology.'' 
Toxicology science 
Toxicology is another part of pharmacology and many 
books and essays are compiled about it. Poison and 
toxicology science have a long background. Indians ?ave 
precise texts about poisons and Iranians, like Indians, 
were eager to find different ways for making poisons. As 
we see in stories like The Thousand and One Nights, 
powerful men like physicians tried to learn about 
different toxins and poisons. 11 Aristotle warned 
Alexander about gifts from Indian Rajahs because there 
was a girl who had grown up with poison and had a 
snake's nature. 15 In fact toxicology, like some other 
branches of pharmacology, is deeply rooted in Indian 
sources. Indian medicine generally includes essays and 
texts about poisonous herbs, toxins and antidotes. Most 
physicians and people of India were knowledgeable 
about toxicology. 
In old medicine, we have a word 'Mithridatism' 
which means that people try to use poison; they 
increase the dose step by step to make it harmless for 
their body. So, after that no poison can affect them. 
This word comes from Mehrdad, king of Pentus land, 
who reigned from 123 to 63 BC. He tried to use 
poison and increase its dose step by step, bccau c he 
was afraid of Roman foes .15 After that, no poison 
affected him. He was always searching for science 
and perfection and was familiar with mo t of the 
languages of his time. He hated Romans; however, he 
lost the war with them. Then he tried to commit 
suicide with poisons, but they no longer affected him, 
so he asked one of his soldiers to kill him by dagger. 
He was the world's first immunologist. Thereafter, 
Galen made a theriac and named it 'Theriakos 
Mithridatus' .15 
Poison and its remedial effects were used in Indian 
Roman and Iranian courts. Therefore, scientists tried 
to find anti-poison and anti-toxic remedies. Galen, 
Dioscorides and Ibn Vahshieh have books on toxins. 
Two valuable books in this field were Toxins by Jabir 
ibn Rayyan (Geber) and Toxins by Avicenna. We can 
understand the close relationship between pharma-
cology and the concealed character of reme.dies7 because famous writers had essays on the subject. 
Manke the Indian physician, also translated Kitab 
Al-Sor:zum va Al-Teriagh Shanagh into Pahlavi in 
Yahya ibn Khaled Barmaki ' period and then Abba 
ibn Saeed Johari translated it into Arabic for Mamoun 
the Abbasid Caliph.25 
The science of sedative and analgesic 
drugs . 
The use of analgesics and sedatives dates back to ancient 
times. Shahdanj (Cannabis saliva) was used before and 
after the emergence of lslam.26 Bang ~Hyoscy~mus 
niger) is also known as a narcotic drug and 1s a_ forbidden 
substance for abortion. In some books, Bang I wrong)~ 
called Showkaran (Conium maculatum) or BazrolbanJ 
(Hyoscyamus spp. )26 Another rival ot:Bang i Ko~enar or 
Opium (Papaver so:'1nif~rum). ~pnu~ ?r thenac has 
been used since ancient tirnes. It 1s ongmally a G~k 
word meaning antidote. Profes or Pourdavood m 
Hormoznameh mentioned opium as the ~rsecutory 
agent of the devil. Thi drug came to Iran m the first 
century AH. reached India in the econd century A.H. 
' hin 26 and two centuries later it was transferred to a. 
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The important point is that Greek physicians used 
theriac or opium as a medicine and knew of its harm 
in the third century BC. Although opium has been 
used as an analgesic everywhere, it has destroyed the 
life of thousands of people. According to ancient 
sources, theriac was not smoked but eaten; indeed, 
after the discovery of America and production of 
tobacco, theriac and bang were smoked.26 
Another historic drug is Hashish (Cannabis sativa). 
Nowadays, hashish is used in all Islamic countries 
from Morocco to India. We understand that it reached 
Iran in the 13th century AD according to some poets 
like Hafez and Mawlawi (Rumi) that mentioned it in 
their poetry.27 However, the stigma of hashish at that 
period was because of its use by a group of Muslims 
(Hassan Sabbah and his followers) who were familiar 
with hashish's features. Leaders of Nizari Ismailis 
used hashish to kill and threaten their enemies. They 
also gave it to their own 'devotee' soldiers to maintain 
their ignorance. 27 So, followers of Nazaryeh were 
called 'Hashishieh' or 'Hashshashin' from 6th 
century A.H in Syria. This is the name that was 
brought to Europe by Crusaders as the general name 
of Ismailis. 26 
At the time of Hassan Sabbah (1050-1124 AD), 
Alamut was one of the main centres for pharmacology 
and growing medicinal plants. His agents in this city 
were busy in growing medicinal plants, making 
traditional drugs and selling them, so they were called 
Hashshashin (pharmacists). He was selling drugs in 
Alamut at the lowest price and always aimed to help 
indigent patients. 28 
In addition to Hashish, Ban} was named as a toxin 
in Muslims' medical books after the 4th century A.H. 
Geber in his book Al-Somum (toxins) also mentioned 
Banj as a sedative drug. Moreover, Abu Mansour 
Movaffagh ibn Ali Al-Heravi, the ancient writer of 
pharmacological and medical books mentioned 
Shahdanj (Cannabis sativa) as an analgesic for 
headache and earache in his book Al-Abniyah An 
Haghayegh Al-Adwiyah. Other Islamic writers 
mentioned Shahdanj or its Arabic name Ghonab as an 
analgesic substance.26 
Conclusion 
Medicine and pharmacy developed more than other 
sciences in the Abbasid period. Other branches related to 
pharmacology, such as pharmaceutics, toxicology, 
production of sedative and narcotic drugs, and 
publication of herbal books and pharmacopeias, were 
important. 
The experiences of other civilisations helped 
Muslims to progress in this field. Iranian, Egyptian, 
Greek and Indian civilisations transferred their 
ancient experiences to Islamic civilisation. 
Medical sciences had such a significant importance 
that the Caliph ordered the knowledge of dealers of 
medicine to be examined to make this as scientific as 
possible. Development of science at that period was 
the beginning of research. After the Renaissance, 
chemical medicine was replaced with active 
ingredients from natural medicines. But nowadays 
there is a great tendency to use alternative medicine to 
treat resistant diseases. We hope traditional medicine 
has the potential to improve alternative medications 
and suggest new approaches to medicine. 
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1815 and the Pharmaceutical 
Apothecaries 
Nicholas L Wood, BPharm, FRPharmS, 
FIPharmM 
Curator, Worshipful Society of Apothecaries of 
London 
2015 marks the 200th Anniversary of the passing of the 
Apothecaries Act, an Act which changed the landscape of 
medical education and in many ways led to the formation 
of what is now the Royal Pharmaceutical Society. Using 
a number of secondary sources along with some new 
primary source material, this paper i intended to give 
some insight into the influence of the 1815 Apothecarie 
Act, and into the contribution that some members of the 
Society of Apothecaries made to the development of the 
Pharmaceutical Society. 
SWF Holloway in his 199 I Political and Social 
History of the Royal Pharmaceutical Society of Great 
Britain' describes in some detail the medical and 
pharmaceutical landscape of late 18th and early 19th 
century Britain. At the start of the 18th century, 
apothecaries had their place as the purveyors of 
,INc'lO ()lllliQUAGE>'IMO QUJ!iTO 
GEORGII III. REGIS. 
.......... . h• ,t) ,, • t ~ ....... . .. , ........ . .. .,,., , i,, .t 4-. •• • •••••• , , .. 
Figure l. The Apothecarie Act I 81 ~. ~ Act for better 
regulating the Practice of Apothecane m England and 
Wales. 
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medicines and were one of the three pillars of the 
medical profession along with the physicians and the 
surgeons. However, the 1704 Rose case somewhat 
changed the landscape by allowing apothecaries to 
prescribe, if not to charge for advice, a move that had 
long term unforeseen and unintended consequences. 
Penelope Hunting's 1998 History of the Society of 
Apothecaries2 describes how the rising social status 
of those apprenticed to apothecaries, and the support 
by apothecaries of such bodies as the Friendly 
Medical Society and the Medical Society of London, 
consolidated the ascendance of medically practising 
apothecaries to the extent that pharmaceutically 
practising apothecaries were to a degree excluded 
from the Livery (that is the higher grades) of the 
Society of Apothecaries after 17743. With many 
apothecaries therefore abandoning compounding and 
dispensing for medical practice, the need for a class 
of practitioner who could take on that role began to be 
filled by the rising numbers of chemists and druggists, 
not only in London, where, despite not having their 
own guild, they were legally tolerated from 1712, but 
also throughout the country. 
Chemists and Druggists 
The increasing competition from the chemists and 
druggists was irksome to many apothecaries who saw 
them as quacks and charlatans. Despite the fact that the 
apothecaries were increasingly medical men and 
expensive, they resented the loss of their retail trade to the 
chemists and druggists, and started to campaign against 
their encroachments and to call for regulation. Various 
pressure groups emerged and amid some dissension, an 
Apothecaries Act to regulate the emerging medical 
profession was passed in Parliament by one vote in 1815. 
Crucially however, while setting a mechanism to 
examine new entrants to the profession of apothecary 
and award them a licence from the Society of 
Apothecaries, in a final concession, the scope of the Act 
specifically excluded the chemists and druggists from its 
provisions, allowing them to continue and to prosper 
unregulated.4 
The 1815 Apothecaries Act hence consolidated the 
position and education of the apothecary as a medical 
man with a role in diagnosis and prescribing, and who 
might also, by the addition of a qualification from the 
College of Surgeons, be truly seen as a General 
Practitioner. The gap in the market for retailers of 
medicines thus inevitably created was filled by 
prominent chemists such as William Allen and Jacob 
Bell, Bell in particular being a noted opponent of the 
Society of Apothecaries. It is often considered that 
with rising numbers, the chemists and druggists came 
to dominate the professional and political agenda. 
However, in an early article in Pharmaceutical 
Transactions, perhaps authored by Bell himself, on 
the definition of a Chemist and Druggist, it states 
there are a considerable number of chemists and druggists 
possessed themselves of the Licence of the Society of 
Apothecaries as a precaution.5 
This raises the question of how much did those qualified 
as apothecaries really contribute to the rise of the 
pharmaceutical chemist and of the Pharmaceutical 
Society? 
Founding members of the Pharma-
ceutical Society 
If a 'considerable number' of chemists and druggists held 
the Licence of the Society of Apothecaries (the LSA), 
one starting point to identify them is the list of chemists 
and druggists who attended the public meeting held at the 
Crown and Anchor Tavern in 1841 , where the resolution 
to found the Pharmaceutical Society was passed. A 
further reference source is the list of those Founder 
members of the Pharmaceutical Society who were 
London based.6 Such lists can be cross-referenced with 
the lists of those persons who gained the LSA between 
1815 and 1840 and compared with general membership 
lists at the Society of Apothecaries. Such comparison 
identifies a number of Pharmaceutical Society members 
who were also members or Licentiates of the Society of 
Apothecaries. 
Figure 2. Charles James Payne 
Perhaps one of the best known of pharma~ist 
apothecaries is Charles James Payne, first Vice 
President and second President of the then 
Pharmaceutical Society of Great Britain. A previous!Y 
published article7 has outlined his career. Born m 
1794 in the house of his grandfather, also an 
apothecary, he was apprenticed to an apothecary b_y 
the name of Burkitt in Fleet Street. On completing his 
indentures, he took up his Freedom of the Society of 
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JOHN SAVORY, 1844-48. 
Figure 3. John Savory. 
Apothecaries in 1815, and so just avoided having to 
take the LSA. After becoming free he worked for a Mr 
Winstanly in Poultry, but in May 1817 he was able to 
open his own shop, a pharmacy, in St Martin's Lane 
where he remained for the rest of his life. In political 
terms, Payne's importance grew in the 1820s and 30s, 
and he became prominent is the movement to close 
shops on Sundays. However it was in the uproar over 
medical reform that culminated in the famous Crown 
and Anchor meeting of 1841 that saw Payne's 
eloquence lead him to be elected Vice President of the 
nascent Pharmaceutical Society of Great Britain to 
Willam Allen's President. On Allen's death in 1843, 
Payne became the second President of the Society. As 
a clear advocate for pharmacy practice, at least one 
report stated that he 
could not be said to practice as an apothecary, having a 
decided dislike to the profession.8 
However, his route to pharmacy practice had been via 
membership of the Society of Apothecaries, showing that 
at least some of those at the very top of the new 
profession had also arrived there as refugees from the 
rapidly medicalising Apothecaries' Hall. 
Payne, like Allen before him, was soon struck down 
with an illness from which he subsequently died, and 
stepping down as the Pharmaceutical Society's 
President in 1844, he was succeeded by the third 
President, another apothecary, John Savory. 
Savory had been apprenticed in the family bu iness 
of Savory and Moore to Thomas Moore, an 
apothecfil1'. who had been admitted to the Society of 
Apothecanes as a Yeoman in 1794. Since he was 
already practising, Moore himself would not have 
needed to take the LSA but Savory trained under his 
supervision at the family business in Bond Street, and 
took the LSA examination in 1825. The same year 
Savory also became a yeoman of the Society of 
Apothecaries as Moore had before him. It is worth 
noting here the distinction that the Society of 
Apothecaries was now an examining and award 
granting body and that most new holder of the L A 
did not become yeoman or liveryman member . 
Savory however did become so and soon after went to 
Paris to study at the School of Pharmacy there, 
returning to the Bond Street bu iness after a three-
year stay. He remained a member of the Society of 
Apothecaries until at least the late 1850 having been 
advanced to the Livery in 1854, de pite not practising 
medicine. 
~·H . ... l 1. 
Figure 4. Thomas NR Morson. 
President of the Pharmaceutical ociety until 1 4 , 
Savory in his turn was ucceeded by Thoma Mor on 
who thus became the fourth President. Mor on wa 
apprenticed in 1814 to Charle Dunn, a surgeon-
apothecary at 65 Fleet Market. Dunn died while 
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Morson was still apprenticed, and Dunn's practice and 
his apprentice were taken over by Henry Morley. 
Morley was very young himself and had only just 
qualified MR.CS. Morson, however, on completing 
his apprenticeship and deciding he preferred 
chemistry, like Savory, went to Paris to continue his 
studies. On returning in 1821, he went back to 
Morley's old business at 65 Fleet Market where, 
presumably practising as a chemist and druggist, he 
succeeded his mentor who continued to practise 
medicine.9 Morson moved rapidly into manu-
facturing, particularly in that of vegetable drugs, later 
expanding into a vast range of chemical entities and 
developing the firm of Thomas Morson and Son, now 
incorporated into MSD. Morson's career therefore 
also started off as an apprentice to an apothecary, 
although there is no record at Apothecaries' Hall of 
Morson actually taking the LSA. Morson served a 
second term as President of the Pharmaceutical 
Society in 1859-61 while by an unusual juxtaposition, 
his former apprentice master, Morley, as a medical 
practitioner, went on to be Master of the Society of 
Apothecaries in 1870. 
In Payne, Savory and Morson therefore we have 
three examples of influential early members of the 
newly created Pharmaceutical Society having 
educational backgrounds, apprenticeships or exam-
inations involving the Society of Apothecaries. 
Taking this theme further and comparing the lists of 
Founder members of the Pharmaceutical Society 
against the lists of those who held the LSA, we find 
several more Licentiates or members of the Society of 
Apothecaries amongst the early members of the 
Pharmaceutical Society, although perhaps fewer than 
might have been suggested by the statements in 
Transactions. A comparison of just those Founder 
Members of the Pharmaceutical Society who were 
based in London, against the LSA pass lists at the 
Society of Apothecaries shows that those who also 
held the LSA included John Freeman of Blackfriars 
Road and John Stirling of Whitechapel. 10 
Furthermore some apothecaries who joined the new 
Pharmaceutical Society in 1841 had qualified like 
Payne as apothecaries under the old apprenticeship 
system prior to the passing of the Apothecaries Act in 
1815. Those included Edward Newnham Winstanley 
of Poultry, who is recorded in the Livery in 1848, as 
well as Thomas Moore of Bond Street, previously 
mentioned as the apprentice master of John Savory. 
Furthermore Winstanley, Payne, Savory and Morson 
had all been listed as on the original committee of the 
Pharmaceutical Society formed at the Crown and 
Anchor Tavern meeting on 15th April 1841. 
It can therefore be shown that in London there were a 
number of pharmacists and particularly some influential 
ones, who came from a background with the Society of 
Apothecaries. If the statement in Trancactions is to be 
believed it is likely there were also a number in the 
provincial lists who were connected with the Society of 
Apothecaries in some way. 
Haselar papers 
At the Society of Apothecaries some new primary 
sources, a set of family documents, have recently come 
into our possession and which serve as further 
illustration. Through the generous gift of Miss Elizabeth 
Turner we recently acquired at Apothecaries' Hall the 
indentures of two of her ancestors, Albert and Alexander 
Haselar. The indentures are in e:ff ect the contract of 
employment of these two young men, and in both 
instances record their apprenticeships to their uncle, 
Charles Churchill Haselar. 
Charles Haselar was probably born in Westminster 
in 1782, 11 and is recorded as himself having gained 
his basic qualification, the Freedom of the Society of 
Apothecaries, by servitude, that is apprenticeship, on 
December 3rd 1805. 12 The records unfortunately do 
not record the name of his apprentice master, but he 
would have been articled around the beginning of the 
19th century. The documents show that in 1814 
Charles Churchill Haselar, who at that time was an 
apothecary in Lenham near Cranbook in Kent, took as 
his apprentice Albert Edward Haselar, his brother's 
son, the indentures being signed on 2nd August. 13 
Three years later, in 1817, Charles also took on 
Alexander Haselar, younger brother to Albert, who 
was likewise indentured, this time on 2nd September 
1817. In due course Albert Edward Haselar took the 
then new LSA examination upon finishing his 
apprenticeship, and became a member of the Society 
of Apothecaries, as did his brother. 
Amongst the new documents acquired however, is 
evidence that a member of the family made a number 
of genealogical enquiries around 1895 to The Society 
of Apothecaries, The Royal College of Physicians, the 
Pharmaceutical Society and to a Haselars Pharmacy 
in Kent. In a reply, the letterhead of Haselar's 
pharmacy purports to show it to have been founded in 
1785. Further enquiries of the Pharmaceutical Society 
confirm that an Albert Haselar of Cranbrook was 
listed as a member of the Pharmaceutical Society as 
early as 1842, again in 1851 and between 1856 and 
1868. After the passing of the 1868 Pharmacy Ac~, 
Albert Haselar appears in the registers from 1869 unttl 
his death two years later in 1871 . 14 This latter date 
seems to be confirmed by the surviving corres-
pondence as well as from other sources. 15 Last revised 
in 1935, the family documents appear to show th~t 
this Albert was Charles Haselar's own son, born m 
1808, ( and not to be confused with Albert Edward one 
of the two nephews who were apprenticed) and who 
it seems became a pharmaceutical chemist rather th~n 
being apprenticed to his father as an apothecary as his 
cousins had done. Family and other enquiries reveal 
that Albert ran a pharmacy in Stone Street, Cranbrook 
in Kent up until his death in 1871. 16,17 
Of interest is the early date for Albert Haselar's 
pharmacy. Was this pharmacy previously the 
apothecary's shop run by his father Charles and 
perhaps founded by a forbear in 1785? The Society of 
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Figure 5. Haselar pharmacy stamp. 
Apothecary records show Charles Haselar as being in 
practice in Cranbrook in 1829 but there are no earlier 
members of the Haselar family in the Society of 
Apothecaries archives. Since Charles was a Livery-
man of the Society of Apothecaries, it must be 
assumed he would have been practising as a 
medically inclined apothecary and that he trained both 
his nephews, Albert Edward and Alexander, in order 
for them to gain the then new Licence of the Society 
of Apothecaries as created by the passage of the 1815 
Act. However, since his own son Albert trained as a 
chemist and druggist and then also practised in 
Cranbrook, this may be an example of an 
apothecaries' business subsequently metamorphosing 
into a chemist and druggist, with its owner in 
allegiance to the Pharmaceutical Society rather than 
the Society of Apothecaries. If this conclusion is 
correct, it is a provincial example of the fluidity of the 
practice of medicine and pharmacy at that time and of 
the closeness of the calling of apothecary to that of 
chemist and druggist. 
Similar provincial examples are reported by 
Holloway and so the Haselars were undoubtedly not 
alone. Indeed many provincial apothecaries may have 
taken the LSA after 1815 but found it more profitable, 
or, like Morson and Payne, simply more congenial, to 
practise pharmacy. Perhaps however, it is hardly 
surprising that this group of better educated chemists 
and druggists, who held the LSA or had connections 
with the Apothecaries, were a significant part of the 
driving force behind the formation of the 
Pharmaceutical Society. After the 1815 Act, the 
Society of Apothecaries, although it examined in 
pharmacy, had the wider interest in training for 
General Practice. By contrast, the new Pharma-
ceutical Society had education for chemists and 
druggists as its top priority. Therefore those who 
wished to restrict their practice to pharmacy found 
that now, the Society of Apothecaries neith~r 
promoted suitable education nor represented therr 
interests, nor indeed was interested in them unless it 
was to restrict their activities. Hence, although the 
new men making up the chemists and druggists II?-ay 
well have been driving the numbers in the formation 
of the Pharmaceutical Society, we perhaps need to 
recognise that there was a significant input at the 
highest levels from a noteworthy cohort of well 
educated pharmaceutical chemists and apothecaries 
with a background or qualification from the Society 
of Apothecaries, who nevertheless sought a new body 
to provide them with education and to represent their 
interests. The new Pharmaceutical Society was 
designed to do just that. It may well have been 
therefore that without the impetus of the Apothecaries 
Act of 1815, the Pharmaceutical Society of 1841 
might never have come into being. 
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The new RPS Headquarters and Museum 
On 27 July the BSHP held a joint meeting with the 
Friends of the Archives of the Society of Apothecaries at 
the new building of the Royal Pharmaceutical Society at 
66-72 East Smithfield, London ElW lAW. Members 
were able to see the new displays and given a guided tour 
of the new building, accessible from Tower Hill and 
Tower Gateway stations. 
John Betts, Keeper of Collections at the RPS 
Museum gave a short introduction to the current 
displays. The new RPS Museum displays will cover 
the development of British Pharmacy from the 1500s 
to the present day: 
•Pharmacy in the 1500s and 1600s, including Apothecaries 
•Georgian Pharmacy 
•The History of the Royal Pharmaceutical Society 
•Victorian Pharmacy, including equipment pharmacists used 
to make medicines. 
•The development of treatments for pain and infection. 
•Poisons as medicines 
•20th century pharmacy 
•Landmark Drugs and how they work in the body 
All of the displays are located together on the ground 
floor, including display cases devoted the Society's 
English Delftware and foreign drug jars and English and 
foreign bell metal mortars. The museum will be open 
Monday to Friday, 9am-5pm. Admission is free and there 
is disabled access. 
Photos: Michael Shaw 
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Welshman Sir William Vaughan 
(1575-1641) and his Popular Health 
Books: Observations, theory and 
therapeutic effectiveness 
John K. Crellin 
Honorary Research Professor, Memorial 
University, Canada and Totnes, Devon 
Sir William Vaughan of Carmarthenshire (1575-1641), 
Master of Arts and Doctor of Civil Laws from Oxford 
University, poet in Latin and English, colonial promoter, 
and author of many books including on health care, is not 
mentioned in Alun Withey's recent book on health and 
medicine in Wales from 1600 to 17 50. 1 There are perhaps 
good reasons to omit this 'worthy of Wales' .2 English-
language writings such as Vaughan's could have had little 
direct impact in Wales given the high illiteracy and about 
90 per cent of the population speaking only Welsh;3 on the 
other hand, as with all vernacular medical books at the 
time, one can assume the upper classes diffused some of 
the advice to friends, neighbours and others.4 
Vaughan himself acknowledged this confusing scene, 
maybe adding to the acrimony that characterised much of 
it. While he respected ' honest' physicians - after all, two 
editions of hi Directions for Health were marketed as 
'Approved ' remedies from the best physicians - he had 
harsh words about many practitioners in an age he saw as 
'full of deceit' .9 For instance, he told of ' rich people, 
chiefely ladies, [who] looke somewhat paler than they 
were wont, but their physitians, which commonly are 
cheating Mountebanckes, doe make them beleeve, that 
they are sicke of a consumption. 10 There were, too, 
'butchering Surgeons and bloud-sucking Empiricks'; 11 
'Druggists [who] sinne . . . against heavon and earth, by 
selling glozing blanchments of Italian and Jewish 
tromperies '. 12 And, in 1630, Vaughan alluded to greed 
when writing that, if he suggested more medicines, 
physicians would ' indite [him] for intrusion into their 
profession ' although he felt they would be more 
'offended [with] this Dietary Cure'. 13 
Vaughan's Authority 
Vaughan offered hints, some commonplace among lay 
authors, as to why he forayed into ' this kinde of studie' on 
' how every man should keepe his body and rninde in 
health: and sicke, how he may safely restore it himself e. ' 14 
For instance, aside from his obvious love of authorship 
reflected in his lifetime of publishing, Vaughan noticed his 
own poor health as a youth, once writing that his health 
was 'of more consequence' to him than his 'clientes case'. 
Evident, too, was his sense of public service Linked to 
concerns for those in remote places where 'honest 
physicians are scarce'; for the poor in Wales and 
elsewhere; and for the health of sailors on long voyages. 
Further, he took special interest in the effects of different 
climes on health. is But, more importantly, Vaughan 
needed to reassure readers of his authority in health 
matters. Relevant - even if implicit rather than explicit -
Figure 1. St Cyndeym's Anglican Church, was his positive writing style that hinted at extensive 
Llangendeirne, Carrnarthenshire where Vaughan is knowledge, personal experiences, and appreciation of 
buried (grave unmarked). s traditional/local information, along with his acceptance of 
The nature of Vaughan's advice in his Directions for such recognised medical authorities as Hippocrates and 
Health, The New/anders Cure, and other books (no Galen. All these factors, considered below, lead to my 
relevant manuscript material has been located) is the suggestions about Vaughan's guiding principles behind 
focus of this article. What types of evidence shaped his his choice of remedies. 
choice of treatment regimens that straddled both 'official' Personal experiences 
and home medicine?6 It is a question to be asked of other Assessing, at any time, the nature of evidence employed in 
authors when considering the scope of therapeutic everyday health care is never easy due to different levels of 
evidence during the late sixteenth to early seventeenth experience among practitioners or members of a family: In 
centuries. Vaughan 's time, observations were key 'evidence' behind 
Non-physicians, like Vaughan, defended their lack of generalisations about the value of a therapy. Early on, 
formal medical training. After all, they faced criticism Vaughan wrote that he did not need to explain a particular 
from physicians with university MDs who stressed the regimen, since ' that which is openly seene with eyes, need 
superiority of their scholarly knowledge over the no proofes'. 16 Yet he was silent on bow many 
oral/family traditions within home medicine.7 One observations/experiences were considered necessary to 
physician, who told a patient that Vaughan's prognostic generalise despite recognising the value of repetition. F?r 
was 'vain and frivolous, ' likely felt all lay authors added example: 'our late criticks collect by experience, that ID 
another negative feature to the medical market at the time [every] seaventh year more unnaturall ill humours are 
with its blurred boundaries between MD physicians, engendred' than can be handled by the body.17 
surg~~ns, ap?thecaries (i.e., ~g~sts who also practised Vaughan also occasionally used the . term 
medicme), 1tmerant quacks, nudwwes and lay bealers.8 'experimented' to justify a treatment, referring either to 
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putting to the test (often trial and error), or comparing e.g., 'Pease eaten greene, with Butter and Pepper, doe 
patients who had either received or not received a cure the jaundise and dropsie';26 and (iii) herbs that 
medicine. For instance, he advocated turnips ('a singular Vaughan saw as God's provision of simple remedies for 
remedy') for scurvy after the efforts of 'Mr. John Guy of the 'good huswife or gentlewoman to have alwaies in the 
[Bristol], a judicious Gentleman, and a worthy friend of gardens;' among many were 'piony and mugwort' for 
mine, [who] experimented in the Newfound-land' and 'difficulty in childe-bearing, and ... provoking of the 
showed that those who had eaten the vegetable fared better menstrues' . 2s In support of his confidence in herbs, he 
than a 'control' group.18 But Vaughan's apparent cited the longevity of man's biblical parents due to their 
commitment to empiricism was muddied when he knowledge of the 'hidden vertues of hearbs and stones 
inextricably intertwined observation and theory, for [without today's] delicate inventions and multiplied 
instance, 'Because [tobacco] according to the nature [polypharmaceutical] compounds'.28 
thereof, hot and dry, doth draw unto it such watrish Also resonating with some readers were proverbs, 
humours as otherwhiles offend the body,[it relieves] 'the well-known sayings, and biblical quotations laced into 
megrim [a type of headache and], the tooth-ache.' 19 Thus Vaughan's writings. Even if viewed as displays of 
the post hoe ergo propter hoe fallacy cannot be Vaughan's erudition, they offered notions of common 
discounted, a central issue in long-standing, confusing sense or collective knowledge accepted over time. This 
debates over empiricism/experience and rationalism in served as an added element of proof as when he responded, 
therapy. in English plus a Latin saying, to the question, 'What shall 
Unfortunately, the actual level of Vaughan's medical a man doe, if the Ayre be eyther too hot, too cold, or too 
experience is difficult to determine, despite the well corrupt?' He wrote: 'To depart thence into another place 
synthesised detail in his confident writing, and the were not arnisse: For oftentimes it is seene that sicke folkes 
reasonable assumption that, at times, he practised doe recover their former health onely by change of ayre; to 
medicine charitably because of his medical knowledge, which agrees that verse: Mox, procul, et tarrie, cede, 
his social position in Welsh society, and his concerns with recede, redi [Go soon far away, return slowly. ']29 
Welsh economic plight ('thousands yearly doe perish for Vaughan's medical books: theory 
want of reliefe. ')20 Aside from an occasional 'I By failing to clarify the extent of his own practice, 
commend' or 'I advise', only a few clear hints of actual medical books were seemingly the core of Vaughan's 
practice are evident. (i) 'I have found by experience [that authority. The announcement 'derived from the best 
Paracelsus his stiptick playster] heale any wound, physitians as well moderne as auncient' , on the title page 
whether it be olde or greene, sooner in one weeke then of Directions for Health, dove-tailed with Vaughan's 
any other in a moneth.' (ii) 'I have tryed that three parts 'chiefest pleasure ever since my childhood,' namely to 
of Sugar-Candy and the fourth part of Enula Campans 'reade more bookes of Phisicke than of any other'. 30 He 
and Licoras, being made to powder is an excell~nt appreciated doctors for their book learning, perhaps for 
remedy [to cure the cough]'. (iii) 'For the richer sort [with the same reason physician Juan Huarte noted that the 
one type of collicke], I prescribe this singular receipt; importance of physicians l~g ~om books ~tt~n_by 
take Venice Treacle or Mithridate with a few beaten 'reasonable experienced phys1c1ans was to av01d killing 
cloves dissolved or mulled in cup of wine'. And (iv) 'an infinitnumberofpersons before [a practitioner] could 
once, a reference to 'my patients', although, as part of attain to the knowledge of [medicines'] qualities' .31 
rhyming advice, maybe poetic licence.21 . Not surprisingly, Vaughan found_ . inconsi_stent 
Added to these are a few more indirect hints, though still information though hardly his reason for c1tmg, albeit not 
not pointing to widespread experience: (i) managing his consistently, authori~es.32 Classi~ auth~rs inclu,ded _(a) 
own early ill-health (he once noted that it might have Hippocrates: the basis of Vaugh~ s warmng that to give 
become 'more distempered and crazed, if [he] had trusted wine or milke to them that be s1cke of agues or head-
others more than [his] owne in-sight'22; (ii) a keen eye aches is to give them poyson' was a Hippocratic 
suggested by recollections from his impressionable aphorism.33 (b) Galen: for example, 'You must use after 
European travels (for instance, in Hungary a fiery fever the example of Galen, to carry about you a sweet 
was 'cured onely by salt niter prepared with_ s~ph~');23 Pomander and to have alwayes in your chamber some 
and (iii) the relatively small number of medic10es listed, good perfumes'. 34 And ( c) Celsus: 'The ancient Ph)'.sitian 
compared with the greater numbers found in many other Celsus approves: It is better ... to w_alke abroad 10 ~e 
books, perhaps a sign that he recommended those he knew Sunne if your head will permit, than 10 the shade, and 10 
' . th h ' 35 best.24 the shade rather than 10 e ouse .-
'Mode:Oe' writers included: 'Marsilius Ficinus, that local knowledge/tradition , fh h 
Given the uncertainty over the extent of Vaughan ~ great physician' who proclaimed the value o oney, w en 
personal experiences, his reference~ to 'local ~owledge used in diet, as a 'safegard oflong life and a trusty buckler 
at least added a 'pedigree' of expenence considered to be against all diseases'; Jean Ferne!, who ~ed 'that 
captured in oral traditions. Examples, mostly ~bout fasting worketh the like effect as bloud-lettmg, but more 
maintaining health, are: (i) the healthiness o_r otherwtse ~f naturally and with no danger;' ai:1d, Felix ~l~tter, ' that great 
Wi Professor of Physicke at Basill descnbmg a case of 
cheeses whereby 'the cunning of the Dairy- oman is . 36 la an eclectic Elizabethan was a 
most to be regarded)' ;i25 (ii) references to local vegetables, hypochondria. Hugh P t, ' 
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popular non-physician author quoted by Vaughan in 
advising on preserving meat and fattening capons.37 
Vaughan's commitment, supported by much of his 
reading, to the Galeruc theory of disease and treatment, 
which was generally familiar to the public as the need to 
rebalance humours to restore health. One thread of 
Galeruc medicine, namely Nature's healing power -
often referred to as vis medicatrix naturae - attracted 
Vaughan. This is evident in the importance he attached to 
the ' non-naturals ' as ways to maintain health around 
which he orgarused much of his Directions for Health. 
Thus he covered: the environment (air, fire, water); food 
and drink; evacuations (from blood-letting to sexual 
activities); habits (sleep, early rising, and exercise); and, 
motions of the mind (e.g., mirth and jealousy.) When 
ignored, Vaughan, as did others, preached that ill-health 
followed: 'He that conceme a good diet [here meaning all 
the non-naturals], neede no artificial Physicke'.38 
Moderation in food, drink and lifestyle was Vaughan's 
constant message throughout the editions of Directions 
for Health. For instance, a 'sparing diet' and fasting (even 
if this was limited), assisted Nature: 'In Ireland they cure 
their Agues onely with fasting foure or five dayes, from 
all kindes of meates, leaving Nature alone to spend out 
those superfluous humours. ,39 
Moderation was even more evident in Vaughan's The 
New/anders Cure, a book that, today, attracts much 
Newfoundland-Welsh interest because of Vaughan's 
promotion of colorual settlement in Newfoundland. Views 
exist that the book was a health manual for settlers, but it 
was hardly practical for the pioneering conditions. In fact, 
the book was a vehicle to extend two main themes - the 
roles of diet (food and drink) and of the mind in health and 
disease - covered in Directions for Health, a work he had 
likely offered to settlers. And, while Newfoundland was to 
the front of his mind when writing the new book, other 
factors were seemingly relevant such as his advancing 
years (preoccupation existed at the time with prolonging 
life) and his wish to continue serving the 'Publicke 
Good'.40 
Given Vaughan's previous attention to diet, it is 
noteworthy that The New/anders Cure announced two 
new authorities on diet, namely Luigi Comaro and 
Leonard Lessius.41 Despite both being Catholics -
Vaughan had a strong aversion to Catholicism - their 
works were a revelation to him. (His alliteration of New-
found land and Newfound Dyet on the title-page was 
telling.) In consequence, he promoted an 'admirable 
Dyet' for which he found further authority in the Bible: 
'When I had compared Lessius his observations with 
Daruels and his three Comparuons Dyet, and how by 
reason of their slender fare being but Pulse, they were in 
better state than those that fed on dainties, I concluded 
this new found dyet to be acceptable to Gods spirit' _42 
Indeed, for Vaughan, attention to diet added to necessary 
spiritual purification 'before a man can assume a glorified 
immortall body in Heaven' .43 
To soften his fear-mongering statement that 'all our 
sicknesses proceed from repletion,' Vaughan's salvation 
was, as expressed by other authors, to follow the 'Golden 
Meane,' defined as 'Temperance in our Dyet, that is, eating 
and drinking no more, than the stomacke can well 
digest' .44 Among many benefits, as rationalised by Galenic 
physiology, ' the gout, the dropsie, the asthmaticke 
passions, the cough, and catarrhs' could, for example, be 
cured by keeping 'backe all the Humours and watrish 
spirit, which arise from the stomach to the head' _45 
Although Vaughan recogrused a treatment for one person's 
constitution might not suit another (e.g., the elderly, or 
labourers who had stomachs like ostriches 'which can 
digest iron'), he still offered general advice with, for 
example, suggestions about the amounts of meat and 
drink.46 
Equally important for Vaughan was that, besides 
bodily benefits from his 'new' diet, 'the functions of the 
Minde' would not be 'hindered nor made obscure by [ an] 
excessive Quantity' of food. This was but one further 
statement in his long-time concerns with close body-
mind relationships that he summarised as: ' the Body is 
oftentimes turned Nolens volens, to serve and obey the 
mind, as the minde likewise to follow the inclination of 
the body' .47 
Comments on Choices of Treatment 
Like all practitioners and medical authors, Vaughan faced 
a vast range of medicines and many complex 
formulations in an age when polypharmacy remained 
widespread. What choices did he make and why? What 
was his evidence? While general recogrution existed that 
a wide range of medicines was necessary to accom-
modate the diversity of individuals and their ailments, 
Vaughan 's choices drew, as would be expected, upon the 
characteristics just noted that became his guiding 
principles.48 With regard to moderation, when attention to 
food and drink failed or needed supplementation, he 
encouraged simple regimens/ remedies to assist nature 
restore balance. When these failed, maybe due to the 
severity of the condition, 'artificial physicke' was 
necessary at times due not only to human foibles, but also 
because diet as treatment was slow such that a 'diseased 
party may in the meane time suffocate and perish, like the 
horse, that starved, while the grasse grew' .49 Vaughan 
then often selected 'official' medicines. 
Simple medicines. Vaughan's confidence in 
simple remedies is reflected in his antipathy toward 
many polypharmaceutical preparations, sometimes 
because of their doubtful quality. Gluttony, he said, 
might lead to regimens of 'nauseative and bitter 
potions ' for purging humours from the gut, the liver 
and the veins that, in turn, would 'weary the strongest 
Nature' .50 Elsewhere he wrote: 'It [would be] a work 
of charitie in our physitians, if herein they would 
admonish their patients to insist and to imitate the 
ancient prescriptions of Nature and not to surcharge 
them with so many monsters of Indian or Arabian 
mixtures.' Such 'monsters,' instead of rooting out the 
venomous seeds of sickness, left a ' cankred 
constitution ... ready to harbour new and unheard of 
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infirmities, occasioned by the poisonous relickes of readers, even those with experience in looking after 
their medicines '. 51 families, who merely read Vaughan to compare with or 
Favouring simple remedies drew on Vaughan's respect supplement their existing knowhow. As Vaughan made 
for local knowledge and herbs. For gout, as an example, clear, the individuality of patients and their situations had to 
Vaughan proposed applications of 'divers locall be negotiated; for instance, 'eight things' when admin-
medicines, as oyles of Roses, ofMirtilles, of Cammomill, istering purgatives, namely qualities of the drug, time of 
or wild mall owes, of turpentine or such like'. 52 However, year, climate of the country, age of patient, their customs, 
just as God heaped diseases on 'man for sinne,' treatinent the disease, patient's strength and position of the moon.61 
regimens also needed God's helping hand such that Polyphannaceutical preparations. In recognising that 
Vaughan wrote about preserving a man in a temperate not everyone would have even simple herbs to hand, 
state: 'first by Gods permission, and then by useing Vaughan indicated they could be obtained from 
weekely either the weight of one scruple of the spirite of apothecaries, as could the occasional polypharrnaceuticaJ 
the herbe called Rosa solis [ sundew] or the essence of preparation he recommended.62 Even some of the latter 
Celandine'. 53 An alternative to these two herbal prep- were relatively simple such as 'those which the Arabians 
arations was 'the quintessence of potable gold, wherein call the Blessed Pils of Aloes ... compounded of Aloes, 
pearles are dissolved,' another simple preparation if Mirrh, and Saffron', which, generally known as Pil Rufi, 
challenging to prepare, which Vaughan associated with had a long history as a physician's medicine. 63 
Paracelsus. Later, however, he dismissed the preparation, The really complex polypharmaceuticals recommended 
describing it as the 'vanitie of vanities' or 'our by Vaughan covered, with some exceptions, well-known 
Paracelsians ... beleeve,'strange miracles of their Elixir products such as 'Treacle' (Venice treacle) and 
and Potable Gold' for preserving the body.54 Mithridatium.64 While omitting these might have been 
Vaughan continued to accept other remedies of the viewed as negligence given the overwhelming authority 
Paracelsian school though he seemingly ignored the behind them, Vaughan was positive over their value as 
theory behind their use. Paracelsus' 'Stiptick Playster' preventatives. For instance, (i) to maintain good health 
has already been noted. Two others, alternatives to a 'first by Gods permission, by observing a good diet, & 
compound vegetable purgative, were antimonials: (i) sometimes by using of some treacle, mithridate or such like 
'Pils called Pantemagogon,' and (ii) 'three grains of in the spring time, & Autumne'; (ii) 'I advise all of them 
Stibium [prepared antimony] in a cup of beere steeped [who] make long voyages at sea, not to be unprovided of 
and beaten to powder,[taken] every second day for a Treacle'; and (iii) to prevent the infection: 'You must use 
weeke together'. 55 Stibium was evidently a favourite such Antidotes as resist poyson, to fortifie your fort, which 
with Vaughan as an emetic or purge: 'I see none indeed is Treacle, if it be truely made'.65 
comparable to Stibium ... which I dare boldly commend Vaughan's comments on another polypharmaceuticaJ 
as a most soveraine and cheape remedy for agues, deserve a note for leaving readers to make a judgment 
dropsies, fluxes and distillations unto the poorer sort'. 56 whether a better alternative existed to Doctor Stevens 
Indeed, this was but one inexpensive, hence relatively Water. This, a distilled aromatic water prepared from 
simple, medicine Vaughan recommended for the poor. twenty or so aromatic ingredients, already had a solid 
Vaughan's preference for simple treatinents is further reputation by 1600, one that survived into the eighteenth 
illustrated in his overall approach to purgatives that merit century and patchily beyond Vaughan described it as an 
notice if only as a key feature in Galenic regimens for all excellent preservative to prolong life. 'Hot in operation,' he 
manner of diseases. Perhaps as a result of this, Vaughan recommended a spoonful once in seven days and added 
was concerned that their frequent usage could be 'most oft-repeated evidence that Doctor Stevens used his water 
dangerous' through diminishing the vital powers of and lived 'one hundred years wanting two.' However, 
nature.57 Further, those taking 'exquisite purgations, and Vaughan informed readers that the Sublimated Wine o~ 
especially Electuraries soluble, shall quickly waxe old Andre Galli, physician to Emperor Charles V, helped Galli 
and gray-headed'.58 On the other hand, gentle purges 'to live six score and nine yeares without any disease: 
could replace vigorous medicines as 'little and little which I thinke to be better than Doctor Stevens Water',66 
[they] consume away the cause'.59 Vaughan's remedies and effectiveness 
When a relatively vigorous purgative was required, Unfortunately we do not know whether Vaughan, despite 
Vaughan still noted relatively simple preparations of, for his generic use of 'Approved,' had the same confidence 
example, senna, rhubarb or mechoacan [ a kind of jalap]. in all his suggestions. Unlike many authors of vernacular 
Vaughan described the latter as a 'sovereign' remedy medical books, he only appended to one treatinent the 
along with hints of first-hand experience: 'I could wish phrase probatum est. Its meaning, 'it has been proved' 
them that dwell farre from physitians to provide ( occasionally shortened to 'proven '), s~ggested 
themselves [with] the roote Mechoacan, which comes confidence in effectiveness either from expenence or 
from the West Indies; the best is white and heavy'· ro It was from authority. 67 Nevertheless, like other authors, 
just one of a number of New World drugs that entered gh ..;~ add d such descn'po·ons as Yau an somewues e 
'official' medicine during the 1500s and spread into 'sovereign,' 'singular remedy,' 'wholes_ome,' an? 
popular advice books. 'excellent preservative,' though, :frustratingly, therr 
Whatever the advice on purgatives (and _other classes of 1 ti weighting is presently unclear. 
medicines) uncertainties must have persisted for many re a ve 
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Given the uncertain effectiveness of therapies in 
Vaughan's time, this account closes on a speculative note, 
one pertinent to ask of other medical advice books 
contemporary with Vaughan. During his lifetime a slow 
shift took place toward more critical appraisal of 
observations over treatments in line with a growing 
questioning of Galenism. Leaving aside major attacks 
such as from the Paracelsian school, hindsight reveals 
isolated, but cumulative, stepping stones. For instance: (i) 
reminders of the Empirical school of physicians in 
classical Greece and Rome that highlighted the value of 
treatment outcomes on individual patients, rather than 
theoretical justification;68 (ii) statements as by Philip 
Barrough, who, in 1596, indicated that he laced the 
observations of others with 'experiments of mine own, 
which by long use & practice I have observed to be 
true' ;69 (iii) the dangers of early, over-enthusiastic 
observations as when John Cotta indicated that tobacco 
had initially acquired on its arrival in England, 'high 
fame and great renowne ... as an incomparable jewell of 
health;' however, Cotta noted that later experience 
showed this to be unjustified;70 and (iv) even the attacks 
by physicians on the errors of mountebanks, empirics, 
and so on, justifiably emphasised the importance of 
experiences over time.71 
From the available evidence, Vaughan was not part of 
the slow shift toward new appraisals of treatments. He 
gave no consideration to the quality of, or 'defects of 
observations' due to inadequate experiences or taking 
recipes from others on trust. 72 On the other hand, 
noteworthy are his concerns over polypharmacy as is his 
emphasis on simple treatments, even while accepting 
authorities 'auncient and modeme'. 
Vaughan tantalises modem readers. He offered a wide 
assortment of treatments, although more limited than in 
other advice ·books. Purgatives, syrup of poppy (a mild 
sedative), and herbs for stomach complaints, among 
many others, remained in practice until relatively modem 
times; some are still accepted today for their therapeutic 
actions, often symptom relief Moreover, Vaughan's 
attention to environmental factors and temperate living 
has stood the test of time despite changing details and 
theories. At the same time, many treatment recom-
mendations cannot be justified by today's standards of 
evidence, or even those that had emerged by the 
eighteenth century when practices were nearer those 
current in Vaughan's time. 
Placebo actions. Critics, nowadays, commonly 
dismiss, with exceptions, treatments from early times as 
mere placebos. Undoubtedly, placebo actions took place 
just as they are significant in therapy today. While it is 
sheer speculation to suggest that Vaughan consciously 
recognised imagination as a factor in the actions of his 
medicine - a placebo response - rather than God's hand, 
he believed in the power of the mind and imagination in 
illness. Once he noted that, in treating 'bodies griefes' 
and 'spirituall sicknesses,' the physician must change the 
imaginative faculty by endeavouring to 'deceive, and 
imprint another conceit. ' 73 
Yet aside from a possible role for imagination, 
Vaughan 's advice and treatments fitted with 
cultural/medical beliefs of his time, for instance, the 
power of God, public appreciation of the need to balance 
humours, acceptance of medical authority, recognition of 
astrological influences, individual diversity and the need 
to try different remedies. In drawing on these in one way 
or another, individuals might well add specific placebo 
responses to a simple or polypharmaceutcal treatment. 
Responses that, even today, may be considered to aid the 
healing power ofNature.74 
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36. Citations: D for H. 1617: 82-3 for Marsilio Ficino (1433-
1499). Vaughan called him a physician though the extent of formal 
medical education remains unclear. Jean Ferne! (D for H. 1617: 
109); Felix Plater (D for H. 1617: 151 and 198 respectfully, 
also NC. 1630: 88.) 
37. For Hugh Plat, D for H. 1600: 14, 18. For the 
influences of Plat, including medicine, Thick M. Sir Hugh 
Plat. The Search for useful Knowledge in Early Modern 
London. Totnes: Prospect Books, 20 I 0. 
38. E.g. D for H. 1626: I. 
39. D for H. 1617: 16, for 'sparing;' 108-1 2 for fasting and 
abstinence; D for H, 1617: 16 for quote about lreland. ee also 
regimen for 'sweating-sickness,' D for H. 161 7:15. 
40. For the place of The New/anders Cure in the literature of 
Canada, see Early Canadiana online http://eco.canadianaca/; 
Also Cell G. William Vaughan. Dictionary of Canadian 
Biography, online. 
For one view as a health manual for Newfoundlanders: 'William 
Vaughan' (swvvp/sw.emn.pdf) noting that the book: 
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New-found Isle' (NC. 1630: Blv). This followed many 
previous references to Newfoundland in Directions for Health 
and other non-medical books. It is easy to assume that Vaughan 
sent copies of his 1612 or 1617 Directions with settlers to 
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44. For respective quotes NC. 1630: 22 and 11. 
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Tomes, 1605: book 2: 48v. 
69. Barrough P. The Method of Physick. London: Richard 
Field, 1596: A 7r. Surgery clearly demanded experience, 
cf. Lowe P. The Whole Course of Surgery. London: 
Purfoot, 1597: B3r-v. 
70. Cotta J. A Short Discoverie of the Unobserved 
Dangers of Several/ Sorts of Ignorant and Unconsiderate 
Practisers of Physicke in England. London: Jones & 
Boyle, 1612: 4. 
71. For example, cf. Obemdorf J. The Anatomyes of the 
True Physition. London: Johnson, 1602. Vaughan himself 
had noted eight considerations in administering a purgative. 
72. For comments on 'defects' such that 'most learned 
Practitioners, fall often short in performing the cures they 
promise ': Hall J. Select Observations on English Bodies: 
or, Cures both Empericall and Historical/, Put into English 
by James Cooke. London: Sherley, 1657: A6r. Admittedly, 
considering ' defects of observations' as a way of thinking 
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73. DforH.1617:230-1. 
74. In this context, a preliminary survey of Vaughan's materia 
medica by the late Professor David Cowen (personal 
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Personal reflections on 
investigations of medical crises in 
the 1970s: contaminated glucose 
drips and a smallpox case 
HV Wyatt PhD, FSocBiol. 
Honorary Lecturer in Philosophy, Department of 
Philosophy, University of Leeds, En~land . 
(previously Honorary Research Fellow 1n Public 
Health Medicine) 
Infections acquired in hospitals are common, but it was 
only after two incidents in the UK and US that 
governments took a hand. The UK Clothier Report 
focussed on deaths without probing deeply into the 
manufacturing of the contaminated fluid. There had been 
serious breaches of accepted practices even after a 
previous incident. Although there had been five deaths, the 
Committee did not examine the clinical notes of patients, 
made few recommendations and only listed the 
qualifications of medical doctors. 
In the USA bacteria entered the fluids after 
autoclaving, with at least 500 patient deaths. A F~eral 
laboratory published many scientific papers and reviews 
and checked laboratory procedures. . 
A smallpox case in London in 1973 was the subJect of 
the 1974 Cox Report of 156 pages with maps ~d 
illustrations. Unlike the Clothier Report, there were six 
pages of recommendations, not only for the London 
School, but for other bodies. 
Introduction 
When things go wrong, governments investigate. 
Sometimes they appoint an enquiry, sometimes a 
government department investigates. In the early 1970s 
contaminated glucose infusions caused infections in both 
England and the United States. In England, a committee 
made a quick and unsatisfactory enquiry, whereas in the 
USA, the Federal Center for Disease Control (CDC) 
began a research programme to understand the problem. 
At the same time in London, a laboratory accident was 
the background for a committee to recommend a major 
review of laboratory safety. 
Sterilisation of a liquid is simple in theory, but difficult 
to achieve consistently when millions are needed. Many 
patients receive infusions of fluids and if the fluid i n t 
sterile, the patient's life may be at ri k. ln 1970 ix million 
litres of intravenous fluids were used every year in Briti h 
hospitals. As about eight million patients received one or 
more infusions every year in the USA, even a very mall 
level of contamination may result in many cases. In the 
USA nearly two million infusions were made every week 
and there had been a silent epidemic of illness and deaths 
among those receiving bottles of fluid - 8,000 hospitals 
had used bottles from Abbotts. In 1971 it was thought that 
perhaps 5,000 patients had been infected and 500 had died. 
Two major incidents involving glucose drips, in the US in 
1970-1971 and England in 1972, were investigated with 
far-reaching results. The investigations provided a contrast 
in style and show how government bodies deal with 
commercial firms in cases where patients' lives are at risk. 
In both countries, hospital personnel noticed a temporal 
relationship between the giving of infusion liquids and 
unexpected fever in patients. Tests showed that the 
infusion fluids were contaminated with bacteria The 
fluids were withdrawn until the cause of the 
contamination could be rectified. In England, due to faulty 
production, the infusion fluid had not been properly 
sterilised. In the USA, contamination had occurred after 
sterilisation: a new plastic liner replaced a previ us one 
and this allowed entry of bacteria via the screw cap 
closures. 
In England, a small outbreak of septicaerni~ in one 
hospital, with five cases, of whon:i four cli~ was 
investigated by a government comrruttee of a Judge, a 
pharmacist and the Director of the . ~blic Health 
Laboratory Service (PHLS). 1 They were Lm:uted to ~e one 
hospital and the manufacture of the con~ted drip and 
they reported in three months (The Clothter Reporl).2 
Eighteen months later a ~ort paper w~ pu~lished in 
4
The 
Lancet 3 and a critical arbcle appeared m Private Eye. 
In the US there was no official inquiry, but the Federal 
Center for Disease Control (CDC) investigated 25 
hospitals which had reported suspected ~ti~emia in 
patients receiving a gluco _e [dextro e] infusion. The 
scientists publi bed details of many laboratory 
experiments in medical journal from 1972 to 1976 and 
Pharm Hist (Lond) 2015; 45 (4) 3 
https://dx.doi.org/10.24355/dbbs.084-201801291213
the CDC National Nosocomial Infections group also 
made a survey of many hospitals. 
These inquiries resulted in far reaching changes in 
manufacture and hospital practice in the two countries and 
resulted in specialist societies, journals, books and 
symposia. I compare the Clothier Report with another 
enquiry in England in 1973 and the responses in the two 
countries. 
The outbreak in Devonport and the 
Clothier Report 
After some hospital patients had severe reactions while 
having treatment with a glucose drip, it was suspected 
that the glucose solution, manufactured by Evans 
Medical of Liverpool, was contaminated. A local 
investigation was made, but a full government inquiry 
was made by the Clothier Committee, whose report was 
made to the British Parliament. 
The Clothier Committee investigating Evans Medical 
chose to interpret its brief very narrowly: for instance 'it 
was not concerned with the cause of death of any 
particular person or persons' (para 4). The only other 
mentions of any consequence of the use of the 
contaminated infusion fluid are in paras 6 (10) and 55 
where 'there was a succession of untoward reactions in 
patients' - the number was not given. The nature of the 
unt?ward_reactions was given in the Lancet paper:3 four 
pa~ents di~d ( one of them died 20 minutes after collapse 
w~le ha"1:°g a glucose infusion); one other collapsed 
while . havmg glucose infusion, but was successfully 
resuscitated; and two others died in circumstances 
suggesting that they had been infused with contaminated 
fluid. Six deaths in Plymouth due to contaminated fluids 
were reported in Private Eye as early as 24 March 1972.4 
Infusion solutions are made sterile by one of two 
methods: by autoclaving, for example 30 min at 240°F 
( l 22°C) in a sealed glass or more rarely plastic container 
or by irradiating fluids in a sealed plastic container. 
Auto_claving was supposedly the method used by Evans 
Medical and was described in detail (paras 7-9). There 
had been a number of incidents in the UK and the USA 
when bacteria had survived the process or had entered the 
fluid either from non-sterile water used to cool the 
containers or later (para 32).s 
Th~ Committee investigated only the single sub-batch 
of flwds used at Devonport. This originally comprised 
612 bottles and sterility tests had been done only on 
bottles from the top of three vertical layers. The 
committ~e consid~red that bottles in the two upper layers 
were stenle, those m the lowest not. Of the remaining 600 
bottles only 155 were recovered and of these 54 were 
considered to be contaminated. What had become of the 
other 445 bottles? Single bottles only were recovered 
from the two other hospitals, Plymouth General Hospital 
and Greenbank and Freedom Fields (Appendix 5). 
Should someone have looked at the records of those 
hospitals for 'any untoward reactions' in those and 
perhaps other hospitals in the area? Nowhere in the main 
body of the report is there any indication that bottles from 
this sub-batch were recovered from other than the 
Devonport Hospital (para 59: 'only 155 bottles had been 
recovered ... all of these came from Devonport Hospital 
... no returns from any unexpected quarter'). The Lancet 
paper was sub-titled 'The Devonport incident' and no 
other hospital was mentioned.6 
Moreover, the Committee recorded that 'on some 70 
occasions ... between May 1970 and September 1971 
sub-batches of products had been produced for which the 
temperature rec?rder chart showed an inadequate cycle, 
generally no nse in temperature ... ' (para 18). The 
Committee's terms of reference apparently prevented it 
from investigating this further. The Committee had the 
batch numbers of these products and could have seen the 
quality tests on them. The Committee could have tried to 
trace where and when these sub-batches had been used 
and inquired about 'untoward reactions' in patients. 
The report made clear that sample bottles for chemical 
testing were taken by laboratory staff, but bottles for 
sterility and pyrogen testing were taken by production 
staff (para 38). Both samples were taken from the top 
layer of each cage (para 40). This was faulty procedure: 
all sampling should have been made by laboratory staff 
and samples should have come from different layers. 
~s. was a serious breach of an understanding with 
Ministry of Health inspectors following an incident in 
1966 when infusion fluids at Evans Medical were found 
to be contaminated (paras 32-35) and a breach of the 
Orange Guide (HMSO 1971).7 The release for sale was 
signed by the manager of the production unit - another 
serious breach of the Orange Guide. 
However, the Committee only said that information 
indicating that the test results were satisfactory was sent to 
the production manager (para 38). This was not the same 
as saying what the results of the test were. Did the 
Committee examine the records sent to the production 
manager and also the laboratory records of the tests? I 
think not, for if they had, one of two possible results might 
have been reported. It is implied that sampling by the 
laboratory staff was satisfactory, as no criticism was made 
of it. Yet the laboratory samples were tested for the 
pres~nce of hydroxymethyl:furfural 'produced during the 
heatmg of dextrose solutions and is rarely therefore 
completely absent after autoclaving. Its complete absence 
from samples might indicate inadequate heating' (para 73). 
Strangely, the results of this test were not included in the 
batch records, instead being separately recorded (para 73). 
Why? When tests to simulate the operating cycle on the 
autoclave were made by a ministry inspector, the 
temperature in the lowest of the three layers did not exceed 
a temperature of 118°F ( 48<>C)during the cycle (para 26). 
Unfortunately, the time of the cycle was not given and 
elsewhere there is evidence that the cycle for the 
co_n~ated glucose bottles might not have been the 
mmunum of 30 minutes (para 31 ). If the temperature only 
reached 118°F or even 'up to 176°F' (80<>C) as the report 
assumed elsewhere (para 27), it seems most unlikely that 
there would have been any hydroxymethylfurfura.I in any 
sample bottles from the bottom layer. This means that 
either the sampling by the laboratory staff was as negligent 
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as by the production staff or that hydroxymethylfurfural 
was not found in properly sampled bottles, yet the sub-
batch was still passed. Whichever reason it was 
convenient that the rec?rds never left the chemi~ testing 
laboratory. The Comnnttee should have investigated this. 
How many bottles were contaminated? 
It was assumed by the Committee that 'as two-thirds of 
the bottles of the sub-batch recovered were shown by 
laboratory examination to be sterile, . . . a satisfactory 
cycle must have been achieved for the two upper layers' 
(para 31 and also para 28) and this is emphasised as 'the 
remainder were sterile' (i.e. 2/3) (para 24). This was 
based on the report by Dr Meers that of 155 bottles 
inspected, 54 were estimated to be contaminated 
(Appendix 5). 
However, earlier in Appendix 5 and in the Lancet 
paper,8 details were given of the distribution in the two 
samples: 120 found sealed in 10 unopened boxes at 
Devonport Hospital and 35 other bottles, 2 opened and 
used, together with 31 unopened from Devonport and 
one each from Greenbank and Freedom Fields Hospitals. 
The results of the tests were shown in Table l: a statistical 
analysis strongly suggests that the two samples were 
from different sources. 
Thus the premise of the Report is unfounded. Dr Meers 
stated that the distribution of cloudy bottles, i.e. 
contaminated, in the unopened boxes 'is not Poissonian' 
(Appendix 5), i.e. that it was not random. This was 
changed by the Committee to 'Dr Meers found no 
significance in the distribution of contaminated bottles 
amongst the unopened cartons' (para 78) - not the same 
thing at all. The Committee and Meers et al made the 
assumption that the non-Poissonian distribution of 
contaminated bottles in each opened case of twelve 
bottles, two cases having no contaminated bottles, 
showed that all the contaminated bottles remained 
together.9 However, the chance of one case containing 
twelve uncontaminated bottles if one third of the sample 
is contaminated, is (213)' 2 or one in 130. The chance of 
two cases is one in 130 squared or almost one in 17,000. 
However, as Table 1 shows, the true level of 
contamination was 28% in these cases. Assuming 25% 
contamination, the chance is one in 32 of them being in 
one case, or one in l 024 of there being two cases without 
any contaminated bottles. There is therefore very little 
chance that these ten cases of bottles all came from the 
lowest level of the autoclave. 
At least one and probably two of the cases must have 
come from another layer. But which other layer? Tests of 
the autoclave were made by a Department of Health and 
Social Security (DHSS) inspector who stated that 'bottles 
in the lowest layer did not exceed a temperature of 
l l 8°F', but stated that 'bottles in the upper part on the 
autoclave reached 240°F' (para 26). No indication was 
given on how these measurements were made. The 
importance of autoclaving is 'to maintain the fluid at 
240°F for 30 mins' (para 7). The wording of the 
inspector's report suggests that it was ~eached, but T?ay 
not have been maintained for the full tune. The urv1val 
of bacteria in an autoclave is represented by a logarithrni 
decay curve over time (i.e. a traight Jin on a semi-I 
plot). Thus the probability of there being any urvivo 
dependent on the temperature, the duration the I pe of 
the decay curve (a constant) and the initial number of 
bacteria in the bottle. 
It was assumed in the report that all the bot:tl 
contained living bacteria before autoclaving. Thi would 
seem reasonable as six of thirteen tested bottl contained 
bacteria of two different specie (Appendix 5). Howe er, 
tests for the bacteriological content of the bottl befo 
autoclaving were carried out weekly (para 71 ). Th 
Committee could have inspected th rds and 
discovered the customary level of u h ntarnin ti n. lt 
could have compared thi with th pecifi ti ru fi r 
intermediate produc (if u h pccifi ti n i led) t 
see whether a contributory u uld ha n I 
than u ua1 number f b tcria in th Ouid! fi 
autoclaving: thi would in vitably hav led t 
probability of contaminati n aft r faulty aut 
The Committee did n t enquire if th p u ti n 
had control of the rejection of the intennediat p u if 
it failed the specifications. Thi houJd be th duty f th 
Quality Controller.10 Presumably the records of th 
weekly specification monitoring houJd have been 
attached to the records of each batch. Were they? 
The conclusion must be that the 35 loose bottl 
recovered were probably from the bottom and middle 
layers, that eight of the unopened cases probably came 
from the middle layer and that two unopened cases may 
have come from the top layer. Thi can be tested The 
chance that the 35 loose bottles and the eight 
containing contaminated bottles came from the sam I t 
was >0.005 and <0.002 (Yates' test), i.e. the contam-
ination in the eight cases was significantly lower. lf th" 
reasoning is correct, there were 200 contaminated ttl 
from the bottom layer and an thcr venty two m th 
middle layers, a total of 272. 
The Committee n ludcd that 2/ fth 
bottl were terile, 'a ti fi ry cy I mlll)t h 
achieved for the two upper layers I). Th· w uld 
imply that they accepted 2 ntamin ted ttl 
which only fifty four had been recovered (para 77 . 
Owen. MP for Devonport, asked the Health M1111 
about these other bottles: the Mini ter repued that 'th 
evidence is that the other bottles were p bably used with 
no ill effects'. 11 There i no evidence for thi in th 
Inquiry. It is odd that eight bottl~ used at Dev n rt 
resulted in four deaths, two po 1ble deaths and on 
collapse whereas the untraced 140 bottles were used with 
no ill effects: Meers et al concluded that the contaminated 
bottles began their life (!) together, were packed and 
tayed together. They further con luded that there w a 
maximum of 62 contaminated, f which 4 were 
recovered, 'plus at m t eight used n patien and l 
subsequently traced'.12 
I uggest that th tati tical e aminati n of lh 
ugges that 270 ttl may ha been ntarnma 
and that 200 were n t traced b k f h pita! 
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in the South West could have been made to trace any 
'untoward reactions' during or following glucose drip 
infusions. 
Personnel and Criticisms 
The qualifications of the Committee were given 
(Appendix 1 ), but not those of any other person except 
those prefaced by 'Dr', where no distinction was made 
between :MD, PhD or the courtesy title (Appendix 2 and 
para 55). This makes it difficult to know which persons 
at Evans Medical were professionally qualified - and 
thus with a double responsibility. The Committee 
exonerated Dr Smith, the Managing Director, and Mr 
Emery, the Production Director: it said that Mr 
McDonald, the Chief Analyst ( = chief of quality control) 
shared 'some responsibility because of his failure to put 
in hand inquiries designed to reveal shortcomings in 
company practice' (para 46). The shortcomings were not 
listed, but one was mentioned earlier, 'the major defect in 
release procedure in the Transfusion Unit' (para 46). Yet 
the Orange Guide13 shows many sections to be relevant 
(see Appendix 2 below). 
No reader of the Clothier Report would suspect the 
extent of the responsibilities of the Quality Controller as 
defined in the Orange Guide, which consists of a 
collection of known and accepted good practices (para 
36). There was no aspect of the operations at Evans 
Medical which conformed to the Orange Guide. 
The Committee did not ask for the tests, the records or 
anything. Were there no unopened representative 
samples which could have been examined? The 
management had a draft of the Guide in 1970 (para 37), 
many of the staff were professional persons who must 
have read articles about the Orange Guide in their 
professional journals; if they had not, the Committee 
should have admonished them. There is no evidence that 
any start had been made on the implementation of any 
part of the relevant sections. Dr Smith and Mr Emery, 'do 
not bear responsibility in any real sense' as 'they were 
entitled to rely on Mr Smart, the Pharmaceutical 
Production Manager (para 45). This is extraordinary: 
they were professional men in positions of authority who 
must bear responsibility for their omissions and their 
failure to see that their responsibilities were carried out -
unless their subordinates hid or misled them. 
However, the management was responsible for 
carrying out the 'understanding .. . between the 
management ... and Inspectors of the Ministry of Health 
as to the role of quality control in the management of the 
production of infusion fluids' following their contam-
ination in 1966 (para 32). The Report does not clearly 
state what this understanding was, but apparently six 
years was not long enough to make it effective. Yet there 
was no censure of the management, the Quality 
Controller or the Pharmaceutical Production Manager, all 
of whom should have known what the understanding was. 
It is curious that while the Committee made no 
recommendations relating to Evans Medical (paras 81, 
82), it considered that the 'absence from the Orange 
Guide of guidance on sampling procedures ... ' should be 
a matter to be considered by the Medicines Commission 
[para 81 (8)]. One would have assumed, as the framers of 
the Orange Guide assumed, that the principles were well 
known. There were other matters not considered by the 
Committee. 
Who was responsible for maintenance? 
Itr is not clear why there were virtually no entries made 
on the maintenance records after 1969 (para 18) or why 
the maintenance was faulty or non-existent for several 
years (para 18). The lack of maintenance 'allowed the 
equipment to deteriorate to an extent which would 
preclude its use for' testing the sterilising procedure: one 
of the recommendations of the Ministry Inspectors in 
1966 (para 33). 
Who drew up the Operating Instructions for Auto-
claves (Appendix 4) 'which were faulty'; was it the 
Quality Controller? Who had the authority to check that 
they were carried out and when were they drawn up? 
Were they the instructions drawn up with the Ministry 
Inspectors in 1966? (para 32). 
About December 1970, a late manuscript addition to 
the capital estimates was made by Mr Devonport, 
[manager of the transfusion unit], after discussion with 
the instrument technician, asking for replacement of all 
six temperature recorders (para 15). This must surely 
have been seen by management who must have realised 
that one doesn't replace all six temperature recorders if 
they are working properly. The Report merely says that 
' for one reason or another this request was not followed 
up' (para 15). I have previously mentioned a number of 
questions about the quality control which should have 
been asked. 
Individuals and the Inquiry 
The first person to notice anything wrong was Staff 
Nurse Picton who, on the night of 1st March, rejected a 
bottle of glucose drip because it was cloudy. 'Owing to 
the urgency of other matters subsequently demanding her 
attention' this bottle was lost (para 54). One might think 
that her action deserved praise, instead 'the Committee 
considers no blame whatever attaches to the actions of 
Staff Nurse Picton' (para 54). In the three days 1-3 
March 'there was a succession of untoward reactions in 
patients of Mr Gall and Mr Reilly'. [Surgeons in the UK 
were addressed as 'Mr'. Other medics assumed the title 
of 'Dr' whether or not they possessed a :MD or PhD.] It 
took three days in which five patients died and two others 
collapsed before Mr. Gall took the 'inspired decision' to 
stop the glucose drips (para 55). 'In the Committee's 
opinion the prompt and correct actions of Mr Gall and his 
colleagues deserve the highest commendation' (Para 55). 
'Prompt' - three days after five patients had died ? The 
action of Nurse Picton probably saved the life of her 
patient, but she received no thanks. 
Fifty seven other people were listed in Appendix 2 as 
having given oral or written evidence. No qualifications 
were given for any of these people although many are 
given the title of Dr. Mr Devonport was a 'qualified 
pharmacist' (para 43). The two consultant surgeons were 
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referred to as Mr in the body of the report, but were 
given the title of Dr in Appendix 2. It is unclear whether 
the Managing Director of Evans Medical was a chemist, 
biologist or pharmacist with a PhD or was a medical 
doctor. Various nurses would have had appropriate 
qualifications, but the report does not show if the staff at 
Evans Medical had adequate professional qualifications 
or experience for their jobs and responsibilities. 
Events at Evans Medical after the 
Incident 
Evans Medical were informed on 4 March, a Saturday, of 
the contaminated fluids and other distributors in the 
country were also warned (para 57). How Evans Medical 
reacted to the information is not recorded in the Report. 
The urgent investigation was begun by the Department's 
Inspectors (para 59) and it was an inspector who tested 
the autoclave (para 26). The Report infers that only the 
Transfusion Unit was investigated (para 26). It is clear 
that the investigation should have included the Quality 
Control Unit. Indeed, there is no mention in the Report of 
any internal investigation by Evans Medical, although 
this had taken place previously after the 1966 inspection 
(para 32). 
It was not until 8 March that the Department, in 
agreement with Dr Smith, placed an embargo on all 
Evans Medical infusions. The faulty operation of the 
autoclaves and the failure of the sterilisation process was 
presumably discovered on 7 or 8 March: what had Evans 
Medical been doing on the Sunday and the Monday and 
possibly even the Tuesday? The Clothier Committee was 
appointed on 17 March, the Private Eye article appeared 
on 24 March and the preliminary hearings began on 27 
March, yet at the end of the inquiry on 16 June the Report 
contained no information of any changes at Evans 
Medical, no record of any new understanding with the 
Ministry, not even that six new recorders had been 
ordered or installed. On 12 July, after the publication of 
the Clothier Report Evans Medical accepted the findings 
and deeply regretted the circumstances leading to it. 
Essential management changes were being made. 14 Thus 
after 4 months changes were still not complete. 
The Orange Guide and Sterile Products 
The Orange Guide emphasises the key role of an 
independent quality controller. Ideally, he should infuse 
his staff with a keen awareness of their responsibility -
responsibility to the users or consumers of the products 
as well as their responsibility to the organisation. At that 
time many hospital pharmacy departments manufactured 
some of their own products. For instance in 1972, there 
was an outbreak of hospital infection over many months 
due to contaminated autoclaved fluids .15 Tests of five 
autoclaved pharmaceutical products showed four 
contaminated, with 15 samples contaminated out of 109 
tested. In clinical areas, of 33 bottles of hospital-
manufactured infusion fluids which were in use on 
patients, ten were contaminated. The contamination was 
noticed because a rare organism was isolated from a 
number of patients. It appeared that stored water 
containing the organisms was used for cooling and this 
contaminated the outside of the bottles and was probably 
drawn into the bottles during the cooling cycle. 
A Health Ministry spokesman said that the Inquiry 
would look into the safety of solutions manufactured by 
hospitals: 16 six of twelve hospitals visited had been asked 
to suspend production of infusion solutions. 17 The 
Minister of Health said that all hospitals had been asked 
to examine their manufacturing procedures in the light of 
the Orange Guide and many stopped. 
After the 1966 incident, the Ministry inspectors had 
suggested that some bottles of each batch should be 
tested for sterility after a delay of a week. The Orange 
Guide suggested that some bottles of each batch should 
be kept until the expiry date. Phillips et al revealed a 
further hazard. 18 Only about one in six of undisturbed 
bottles in their sample was contaminated, but if the caps 
were banged on the bench, the number of contaminated 
bottles was doubled, to one third. Thus, the Orange 
Guide might be amended so that the bottles for testing 
should be inverted, banged firmly against a bench, left for 
48 hours and then tested. Half of the bottles kept to the 
expiry date should also be inverted and banged. 
Nationwide epidemic of septicaemia in 
the USA 
In April 1970 Abbott introduced a new elastomer-lined 
closure for its intravenous products and soon patients 
developed septicaemia while receiving them. Products 
by other manufacturers using Gilsonite closures were not 
involved. The outbreak was monitored by federal public 
health doctors at the Center for Disease Control (CDC) at 
Atlanta, Georgia in conjunction with epidemiologists and 
bacteriologists in 25 hospitals. The results were 
published in the free Morbidity and Mortality Weekly 
Report (MMWR) in 1971-1973 and in scientific papers in 
medical journals from 1972 on. 19 A massive review of the 
problem of infection control in intravenous therapy was 
published, with 266 references.20 
Experiments showed that the infecting organisms were 
Gram-negative bacteria usually associated with plants. 
The bacteria were of Enterobacter species including 
Enterobacter cloacae. The main contaminating organism 
had previously been called Etwinia and was better 
known as a plant pathogen: CDC renamed it 
Enterobacter agglomerans. 21 
In 1972 as part of its quality control programme, the 
Laboratory Licensure and Control Branch of CDC sent, 
as an unknown, a strain of E. agglomerans to hospital 
laboratories for identification. 
Septicaemia 
Septicaemia or blood poisoning is caused by the release 
of bacterial toxins into the blood from either an infection 
or from an outside source, e.g. a contaminated drip. In 
many infections there may be bacteria present in the 
blood and the blood may be cultured in the laboratory. 
Where the infection is sequestered in an abscess or the 
source is from a drip for example, there may be no 
bacteria in the blood - with a slow drip, the bacteria may 
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be killed and the toxin released. Where septicaemia is 
suspected, e.g. when a patient who has received a new 
drip develops a rise in temperature, the bottle should be 
replaced (and preserved for investigation) without 
waiting for laboratory tests. 22, 23 
Kelsey argued that the concept of sterility of operations 
is a myth and is misleading: he suggested that attention 
should be focussed on process control.24 In the UK, good 
process control is listed in the Orange Guide. However, 
it appears that, in practice, from four to ten per cent of 
fluids contain organisms, but the numbers are usually 
small and do not cause noticeable clinical reactions. Only 
a small number of organisms appear to grow in dextrose 
solutions: Klebsiel/a, Enterobacter and Pseudomonas 
species are the most common. Normal people have 
adequate humoral and cellular immunity to kill small 
numbers of these bacteria and any illness is likely to be 
caused by the infusion and release of endotoxin only. 
The 1972 Clothier and 197 4 Smallpox 
(Cox) Reports compared 
Jn 1974 a technician at the London School of Hygiene 
and Tropical Medicine (LSHTM) became infected with 
smallpox when visiting a research laboratory there. 
Smallpox was not suspected and she infected three other 
people while in hospital. This outbreak caused two 
deaths directly and another due to complications 
following more than four million vaccinations: an 
inquiry (The Cox Committee )25 followed, as many 
mistakes and omissions had occurred. 
Jn 1971, a survey of safety at the School had been made, 
the Schilling-Hall Report, and safety measures were 
introduced. 26 The Committee investigated these measures, 
which had not been sufficient to prevent the accident. The 
Clothier Committee had 'considered that it was no part of 
its task to investigate the 1966 incident' although the 
non-compliance of the measures proposed were vital to 
the understanding of their inquiry. 21 
The Cox Committee inspected laboratories at LSHTM 
and visited three others. 28 Ten photographs and plans of the 
laboratory were included in the report. A plan, Plate XI, of 
the hospital ward was included and the case notes and 
ward bed state books were examined. The Report included 
an Appendix N of new methods for the disinfection of 
books. There was a long review of smallpox prophylaxis 
by vaccination, immune globulin and antiviral agents.29 
Unlike the Clothier Committee, the Cox Committee listed 
the qualifications of all the 95 witnesses. The Report ended 
with six pages of specific recommendations,30 including a 
two-page code of practice, the setting up of a permanent 
committee of experts, details for the LSHTM and Public 
Health Laboratory Service (PHLS) staff, finance and 
outbreak control measures. 
Jn contrast, the Clothier Report listed ten matters to be 
referred to the Medicines Commission in eighteen 
lines.JI Evans Medical was not mentioned, but the DHSS 
was singled out for needing improvement in the 
arrangements for dealing with emergencies32 because 
' there was a slight delay in reaching the DHSS'.33 There 
is no indication in the Report that the Committee visited 
Evans Medical to inspect the autoclaves or that they 
initiated any experiments. 
Conclusions 
Although there had been reports of previous small 
outbreaks of hospital infections caused by contaminated 
autoclaved fluids,34 the two outbreaks in Devonport and 
the USA sparked a growing recognition of contaminated 
fluids and septicaemia, with contributions from many 
countries. The two incidents prompted widespread 
concern and the formation of journals, conferences and 
societies for the study of hospital infections. The Clothier 
Committee did not come to grips with the problems of 
contamination although a similar experience in the USA 
had possibly contributed to the deaths of at least 500 
hospital patients. A similar inquiry (the Cox Committee) 
in the UK made many sensible suggestions and work in 
the USA also produced improvements. No recom-
mendations of any worth were made by the Clothier 
Committee and the most glaring omission was the 
absence of any measures relating to the manufacturer. 
Governments may appoint committees to enquire into 
problems, or they may entrust enquiries to their own 
scientists, but the outcomes may depend on the quality of 
those appointed. 
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Appendix: Relevant sections of the 
Orange Guide. 
From the Orange Guide, 1971 , pages 15, 16: 
The Quality Controller should have the final responsibility to 
management for the approval or rejection of all items of ... 
materials in process, and finished products. Materials should 
not pass to the next stage of processing or, in the case of 
finished products, to distribution without the agreement of the 
Quality Controller. The Quality Controller should receive 
prior information on all changes and manufacturing 
procedures and written instructions. 
The Quality Controller should have the following 
principal duties: 
The approval of specifications for starting materials . . . and 
finished products. [If otherwise delegated, this must be 
recorded and the specifications approved]. Stability samples 
should be retained from representative production batches. 
The necessary revision of current control procedures and 
Specifications. 
The Quality Controller shall be empowered to take 
samples from any part of the premises at any time. 
Samples for quality control testing should be 
representative of the batch and be taken in accordance 
with sampling procedures which ensure that the results of 
the tests are significant. 
In the case. of finished products, reference samples 
should be retamed. The number of units retained should 
be sufficient to permit re-examination ... ( on previously 
unopened samples). Samples should be retained until the 
expiry date. 
The Quality Controller should keep and preserve the 
appropriate Analytical Reports concerning the exam-
ination of each batch on products manufactured ... to 
include a final evaluation of the product and a decision as 
to whether the batch does or not conform to the accepted 
specifications. 
From the Orange Guide. 1971, Appendix, pages 22, 
23 : 
The quality control department should maintain 
cumulative records of the testing specified in this 
appendix and should take into due account the results of 
such testing before releasing any batch of a sterile 
product for distribution. 
The quality control department should be responsible 
for the tests and for the assessment of the details on tests 
specified: 
records for sterile products should include details of duration 
and temperature of the sterilisation of the product. The charts 
on automatic recorders ... should constitute part on the records 
... [ marked to identify the batch]. 
Samples for quality control shall be taken by quality 
control staff. Regular checks should be made to verify the 
continuing efficiency of any sterilisation process. All 
such indicating and recording equipment should be ... 
checked periodically. 
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Pharmaceutical Lore in the Lapidary 
of Sidrac (13th century) 
Dr Christopher J. Duffin 
Natural History Museum, London SW? 5BD and 
146, Church Hill Road, Sutton, Surrey, 
The Book of Sidrac 
Le Livre de Sidrac, a work that has had scant attention in 
modem times, was a once highly popular text written in 
Old French by an unknown author some time during the 
last quarter of the 13th century (and certainly after 1268).1 
It defies classification by genre, containing elements of a 
novel, encyclopaedia and almanac. The volume is known 
by a number of titles, and is represented by around 70 
manuscripts, with translations from ancient French into 
Occitan, English, Catalan, Danish, Italian, Ripuarian, 
Middle low-German and Middle Dutch.2 Early copies 
have been recorded in the inventories of the libraries of 
Jean, Due de Berry (1340-1416), Charles V (1338-1380) 
and Charles VI (1368-1422) of France, and the Dukes of 
Bourgogne (1415).3 Careful analysis and classification of 
the extant manuscripts of The Book of Sidrac indicates 
that they fall into two main groups - long and short 
versions of the text, with much variation as to what has 
been included. The Editio Princeps appears to have been 
published in Paris in 1486 with at least one other 
incunabular version (1495), both published by the highly 
respected Antoine Verard (active 1485-1512); other 
versions followed during the 16th century. 
A Prologue is followed by an account of the life of the 
philosopher, Sidrac, whose name is modelled after the 
Biblical Shadrach. The bulk of the volume is taken up by 
a didactic section based upon a system of questions ( as 
many as 1225 in some versions) covering a vast range of 
subjects (including occasional medical references4), posed 
by a pagan Indian king, Boctus or Boccus, and answers 
given by Sidrac. In one of the most accessible versions of 
the text (fl Libra di Sidrac), 557 questions are presented, 
for which Question 454 states 'De quants manieres et de 
quel vertu sont les pierres precieuses et ou se trovent ells 
et combient sont?' (What manner of virtues are shown by 
precious stones, how many are there and where do you 
find them?). The answers that follow make up the text of 
what is generally referred to as The lapidary ofSidrac. 
English versions 
English versions of The Book of Sidrac also belong to 
two groups: verse translations and prose versions, none 
of which contain the lapidary section. There are only two 
extant complete manuscripts of the Middle English 
poem, both dating from the second half of the fifteenth 
century, plus a further 8 manuscript fragments.5 The 
English rhymed version was produced by Hugh of 
Campendene (Chipping Norton, Glos.), who supposedly 
lived during the reign of Henry VI and was believed to be 
a much travelled and highly skilled linguist.6 
Recorded remnants of an English prose version of the 
work are limited to a small volume whose opening words 
are 'Here be certayne Questyones Kynge Bocthus of the 
maners, tokyns, and condycions of man, with the 
answeres made to the same by Phylosopher Sydrac'. The 
volume was published by R. Wyer in London around 
1535 and contains only a specialised portion of the full 
text comprising 23 questions and answers. 7 Two further 
16th century publications are recorded in Typographical 
Antiquities, the historical account of publishing in 
England from 1471 to 1600 written by the bibliographer 
and antiquary Joseph Ames (1689-1759).8 The Bake of 
Demaundes, of the science of Phylosophye and Astro-
nomye, Betwene Kynge Baccus and the Phylosopher 
Sydracke was printed by Robert Wyer (1550), and A 
Booke of the Medicines of King Bacchus was printed by 
Robert Redman, a London printer who died in 1540. The 
former is known, but no copy of the second title is extant, 
so far as I am aware. 
Robert Wyer and 'a lyte/1 boke of the 
xxiiii stones pryncipalles' 
Few biographical details are available for Robert Wyer. 
He worked as a printer and bookseller during the second 
half of Henry VIII's reign, carrying out his profession 'at 
the sign of St. John the Evangelist, at Charing Cross', 
premises which he rented ( as part of the town house) from 
the Bishop ofNorwich, Richard Nykke (circa 1447-1535; 
Nykke was the last Roman Catholic to hold this office 
before Henry's reforms). Following the death of the 
Bishop, the town house was surrendered to Henry VIII in 
Figure 1. Printing device used by Robert Wyer in his 
Golden Pystle of Saint Bernard (1531 )(from Plomer 
1897).9 The device in the lytell booke of the. xxiiii. Stones 
pryncipalles is very similar but lacks the printer's name. 
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exchange for land in Norfolk; Henry passed the property to that representing the philosopher on the title page of the 
on to his brother-in-law, the 1st Duke of Suffolk, Charles unattributed The history of kyng Baccus & Sydracke. The 
Brandon ( circa 1484-1585), who retained it until his death. final page, however, features a printer's device which 
Robert Wyer was active as a printer at this location from plays on the location of the publishing house. St John the 
c.1530, through the period of transition, until 1556 when Evangelist is seated on a promontory of land, partly 
he was succeeded by Nicholas Wyer, perhaps his son. surrounded by water, with the towers and walls of a city in 
The change of landlord is reflected in the colophons the background He holds an eagle in his right hand; the 
used by Wyer, and is a useful means of giving some bird has an inkpot clasped in its beak. The device is 
relative dates to the 100 or so volumes which he closely similar to others from the 'Norwich' period, an 
produced; items printed before 1536 have the 'Norwich' example of which is given in Fig. 1, but no publisher is 
colophon, indicated by statements such as 'Irnprynted by indicated. The volume has consequently been suggested 
me Robert Wyre, dwellynge at the sygne of seynt lohan as having been printed for Robert Wyer, rather than 
euangelyft in seynt Martyns paryfihe in the felde befyde directly by him. The British Library catalogue entry for 
Charynge cro:ffe in the byflhop of Norwytche rentys'. the volume suggests that it was produced by the Lutheran 
Those published after 1536 possess the 'Sussex' printer, Thomas Godfray, for Wyer, possibly in 1535. 
colophon exemplified by Wyer 's address being given as Godfray flourished from around 1530-1536 and is known 
'in the Duke of Su:ffolkes rentes befyde charynge for his publication of propagandist literature associated 
Crosse", or 'befyde the Duke of Suffolkes place' .9 In with the Tudor revolution; his authors included such 
addition, some books omitting Wyer's name from the names as William Tyndale (c. 1494-1536) and John Frith 
colophon, but otherwise showing clear affinity to his (1503-1533), plus a number of other authors closely 
other publications, may represent volumes produced by associated with Thomas Cromwell, the 1st Earl of Essex 
other printers for him. ( c. 1485-1540), Henry VII's politically astute but 
Wyer has been characterised as: 10 ultimately ill-fated Privy Councillor. 
almost the first ofEnglishmen to make it his chief business as This book is the earliest printed lapidary in the English 
a printer and publisher to purvey cheap books for the language. Lapidaries are books about stones. They often 
uneducated ... The substance of the books is as characteristic contain much information on the supposed properties 
as the fonn. Some offer the appearance ofleaming without its and virtues of precious and semi-precious gems. 
difficulty, some appeal to current superstitions, but most are Particularly popular in medieval times, they are 
practical books, containing receipts, especially medical represented by numerous manuscripts and were the 
fonnulae and directions, and thus appealing to the desire of subject of numerous incunabulae_ 12 The question arises 
Everyman to be his own physician and save a fee. as to whether the volume under consideration can be 
Medicine is certainly prominent among his published Jinked to any of the popular western lapidaries from the 
works, most undated and often republished on several 11 th century onwards. The conclusion drawn here is that 
occasions with a variety of titles, and which include: The it represents a previously unknown English prose version 
questyonary of cyrurgyens (1542); an English translation of The Lapidary ofSidrac, extracted from one of the long 
of Macer Floridus 's Herbal (154 3 ); This bake doth treate manuscript versions of the original o Jd French work. The 
all of the beste waters artyfj;cialles and the vertues and bases of this conclusion are: 
properties of the same, moche projj;table for the poore 1. A careful direct comparison of the English text with 
sycke (attributed to Roger Bacon; 1530?); Thomas the most accessible published version.13 
Moulton's This is the glasse of helth (1547?); The 2. Direct comparison with the Old French text in a 
gouernaunce of good he/the (1549?); Andrew Boorde's manuscript version.14 
Dyetary ofhelth (1554?); This lyte/1 practyce of Johannes 3. The list of included stones, some of which are 
de Vigo in medycyne (1555?); and Here begynneth the unique to the Lapidary of Sidrac. 15 
seyng of urynes ( 1540?). 11 This conclusion also infers that an otherwise unknown 
There is a single extant small octavo volume held by the English prose translation of part or all of Le fivre de Sidrac 
British Library whose opening lines are 'Here begynneth was in circulation during the first half of the 16th century. 
a /yte/1 booke of the. xxiiii. Stones pryncipal/es that 
profj;teth most to mans body as ye dayand the nyght hath. Medical lore of the stones 
xxiiii. Hours so be there. xxiiii. Stones pryncipa/1 '. Toe Of the 24 stones cited in the text, 20 have medical 
book is clearly from Robert Wyer's publishing stable on applications associated with them; all have some magical 
the basis of the form of the opening words, the address of properties ascribed to them, including such marvellous 
publication, and the inclusion of characteristic woodcuts qualities as being able to counteract witchcraft and 
and devices. Three quarters of the title page is occupied by sorcery, to confer special personal characteristics to the 
a woodcut of two figures, each with an empty scroll above bearer, or to resist temptation. These special virtues are 
them. One image is of an older, bearded gentleman envisaged as originating from the grace of God and, 
dressed in a long cloak, emphasising a point of discussion invested in the stone, are appropriated by consecrated, 
with his raised left hand and carrying a scroll in his right righteous living. Indeed, a number of stones are asserted 
He faces a younger , clean-shaven man in a smaller cloak, as being derived, by floods of water, from 'Paradyse 
also with raised left hand but clasping a sword just below terrestre', a title which refers to the choice, central part of 
the hilt in his right. The image of the older man is identical the Garden of Eden. 16 Many of the virtues can be 
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interpreted in terms of sympathetic magic, where 
correspondence between some feature of the material 
(often shape or colour) and of the disease it was used to 
treat determined its mode of employ ( e.g. red gems used 
in the treatment of bleeding). 
It has been suggested that the Lapidary of Sidrac was 
partly inspired by the earlier lapidary of Marbode, Bishop 
ofRennes (c. 1035-1123), probably written around 1090, 
and possibly also by unspecified 'eastern sources' which 
influenced the remainder of the text of Le Livre de Sidrac. 17 
The exact identity of many of the stones considered in 
the lapidary is open to discussion, partly because the 
rudimentary means of identifying minerals in classical 
and medieval times depended upon often unreliable, 
highly variable characteristics (such as colour), and other 
qualities which were, at best, relative measurements. 
Much synonymy, as well as huge nomenclatural 
variation and etymological evolution, combined with 
occasional copying errors and fabrications from one 
author to another adds another layer of complexity. The 
most likely identifications will be given, where such 
suggestions can be made, in the discussion below. 
1. Sard: this translucent brown, unhanded mineral is a 
type of agate, which is a cryptocrystalline form of silica. 
Sidrac states that it is part of a group also containing 
'Granat' (garnet), Almandine (a reddish-purple mineral 
of the garnet group) and 'Jargonce' (usually taken to be 
yellow or green zircon). Sidrac indicates that it preserves 
youthfulness and is haemostatic (staunches bleeding). 
When worn as an amulet, the bearer 'nedeth nat to drede 
ttc~er,iff A,aac1>e. 4:apltlllo.c. 
latDe ano d15amae, 
ant a1manD111es , ano 
3ac1once be au con1 
' teen togpt~cr1butJae 
once 1,Jatl) tl)i bectui 
-of tl)crc ff ones , aaab 10 
·, t1Jrmoftfp11cft, ano 
t gpuctb.a 1cnrell cell 
,010.uc1am, anake. a ,nan mcip ant, glatv 
an& llcpetlJ bpm 1on1e 101, .Q'ttanb in gieac 
tcctutlJlanb maketl;J a man to flJ1,1Ct bas ti 
tr'aq,r.QRD atro at aaucl)ctr, bloDetauo r,c 
to·at. 1,erpt'IJJt 1Jpon ,;,pm, ncoetlJ nat ro 
b.Je~ to to11cbc no .a:upll becmpu • .acsb a1ro. }Je map paae au patellous places teU>lelp 
11>it-,out oaungee,anb m UJl.uu place tl)at 
l)e cometlJ to I to be lobgeb m 11Je ro,ur be 
11aDlp ceupueb, t,aae 1001> tbctc ( .am~ 
anp tl)pnr tl)at IJe aCketlJ tlJa t u1 of ieaC011 
~au nat IJc betsPeb JJpm11101 u,arn,11 ~ptn. 
Figure 2. Text entry for Sard (Cap. 1 of the lytell booke 
of the. xxiiii. Stones pryncipalles) from Plomer (1897).9 
to touche no evyll vermin' - it presumably protected 
from bites, venom and possibly picking up parasites. The 
text entry for this stone is illustrated in Fig. 2. 
2. Topaz: currently, this name refers to an alurnino-
silicate, but in the past it is possible that almost any 
yellow gem was meant. Sidrac indicates its use in cases 
of 'fye ', an ancient French term whose meaning is 
obscure. The phrase 'who so euer haue this fye and serue 
it about with a Topace stone it shall neuer growe more' 
suggests that it might be a tumour or other excrescence. 
The same disease is referred to as 'fyc' in Le Lapidaire du 
Roi Philippe, 'fis' in the London Lapidary, ' fey' in the 
Peterborough Lapidary and 'fyes' in the Sloane 
Lapidary.18 This may be the same as 'le fiel' in the 14th 
century lapidary of John Mandeville, 19 translated by one 
author as 'le maladie des bovins' - a cattle disease. 
3. Emerald: This gemstone variety of the alurnino-
silicate mineral beryl is coloured bright green by traces of 
chromium and sometimes vanadium in the crystal lattice. 
Sidrac explains that it heals otherwise unspecified 
diseases of the heart ('likenesse of the hert'), is effective 
against gout and 'longe sycknesse', by which protracted 
periods of illness is presumably meant. 
4. Ruby: This deep red gemstone variety of the 
aluminium oxide, corundum, is hailed by Sidrac as 'lorde 
of all stones'. It supposedly has a veterinary application 
- 'And if any beest be sycke & d.rynke of the water that 
the Rubye is put in it shall heale hym'. In addition, it 
contributed to a person's overall state of health in that it 
'fedeth a mans sight & cornfortheth the hert & the body'. 
5. Sapphire: This blue variety of corundum was 
esteemed by Sidrac as an antivenin, as well as being 
useful in the treatment of inflamed and festering sores 
('boches ' and 'rankles'), swellings, fevers, aches and 
pains (physical and mental), and jaundice. Treatment 
involved drinking the water in which the ruby had been 
steeped. In addition, if placed on the eye, it was believed 
to remove any 'fylth & make a bodyes iyen fayre & 
clere', as well as healing the condition known as Web-
Eye ( caligo - obscurity of the vision due to an opaque 
object in the tissues of the eye or eyelid). 
6. Jasper: This form of chalcedony comes in a wide 
variety of colours, but commonly red, brown and green. 
The red form was undoubtedly important, 'to staunche 
blode ofhym that bath good byleue in god and staunche 
a body also of the blody meneson [ dysentery J & of the 
feuers & of the Dropsye .... And also this stone is good 
and profitable for a woman that traueyleth with chylde'. 
7. Ligure: Also known as Lyncurium, Lapis Lincis or 
the Lynx Stone, this is a stone whose identity has been 
much debated: amber, tourmaline, zircon and sapphire 
have all been proposed as mineral candidates, while 
fossil belernnites appear under this name in geological 
material medica collections from the 18th centwy.20 
Sidrac asserts that carrying the stone is good for jaundice, 
gout, melancholy and stomach problems, as well as being 
an effective haemostatic, especially in cases of dysentery. 
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More generally, it 'stauncheth the bloode of mans 
membres in what place that ever it be on a man that 
bledeth'. In addition, it was believed to bring down high 
temperatures if placed in the mouth, and to cure diseases 
of the eye if touched against the eye itself. 
8. Agate: Agates are brightly coloured, banded or 
variegated varieties of cryptocrystalline silica, usually of 
chalcedony. Named by Theophrastus (c. 371- c. 287 BC) 
from specimens collected from the River Achates (now 
Dirillo) on Sicily, Sidrac recommended agate as a geriatric 
medicine: 'The verry fyne and trewe Acate saueth & 
comforteth an olde man and sleketh his thurste and maketh 
hym stronge agayne and kepeth a body from venym and 
from the bytyng of Serpentes and other wode bestes' . 
9. Amethyst: Sidrac gives only passing mention of the 
well-known property of this purple variety of quartz for 
preventing drunken-ness. 
10. Onyx: banded chalcedony was suggested by Sidrac 
as being generally efficacious for preserving good health. 
11. Beryl: This is a beryllium-rich alurninosilicate, one 
variety of which is emerald (see [3] above). Drinking the 
water in which this gem had been soaked was seen as 
being 'good and holsome for many dyuers syckenesses 
and who so be in good beleue and . . . specially for the 
feuers and for the heed and for the heate that is in a mans 
stomake of any syknesse'. 
12. Diamond: The impressive qualities of 'Dyamant', 
especially its hardness, led to the opinion that 'God gave 
unto this Diamante great grace and many vertues'. Sidrac 
summarised the perceived medical virtues as providing 
protection from poisons, and it 'kepeth a mans bones & 
his members hole & safe'. 
13. Dyane : This unidentified mythical stone is unique 
to Sidrac, who says it develops in the stomach of a fish 
over a period of 300 years before being cast upon the 
shore by the sea. The haemostatic qualities of the stone 
could be exploited by touching upon open and bleeding 
wounds and cases of nosebleed. If the patient were to 
drink water, wine or any other 'lycour' which this stone 
has come into contact with, he would be cured of internal 
bleeding and any haemorrhage associated with the 
passing of bladder stones. Touching the stone against the 
eyes would supposedly bring relief from bloodshot eyes 
associated with strokes or other sicknesses. 
14. Soryge: Another mythical stone unique to Sidrac, 
the Soryge originates in an animal that has much in 
common with the unicorn legend. Placing its head in the 
lap of a maiden, the animal is slaughtered for the stone, 
which is harvested from its mouth by hunters hiding 
nearby. Drinking only the water touched by this stone for 
a period of nine and a half days ensures freedom from the 
ravages of gout for a full year. Furthermore, it could be 
used 'for the syckenesse of the stomacke and for the 
humours of a mans body & against all wode beestes and 
the bytyngs of other vermyns and venomous beestes' . 
15. Crasnuf : A further stone found only in Sidrac; 
contemplating the Crasnuf both morning and evening 
preserved a man from suffering sudden death; 'And if a 
man be wounded and beare this stone upon hym his 
wounde shall neuer rankle nor haue euyll smell nor shall 
nat be in no peryll therof - the stone could also preserve 
wounds from festering and becoming gangrenous. 
16. Vermidor: Found only in Sidrac, this stone was 
supposedly 'good against all maner of maladyes & 
syckenesses of a mans body/ for al lemires markes/ that 
is serued with this stone it consumeth it/ and departeth it' . 
The Italian translation of the text indicates that the phrase 
rendered here as 'lemires markes ' refers to diseases of the 
heart and body.21 
17. Rejlambyne: The yellow colour of this stone 
indicated its efficacy in cases of jaundice, the treatment 
for which was drinking water touched by this stone twice 
a day for three days. The stone could also slake thirst and 
improve the strength and vitality of the bearer: ' it shall 
comforte greatly his members all that be on his body/ and 
shall gyue hym great force/ and strength a mans light 
greatly' . It has been suggested that Reflambyne, whose 
name is unique to Sidrac, is actually a misreading of 
'elambari ', the Arabic word for amber. 22 This proposition 
makes a great deal of sense considering the colour of the 
stone, its supposed virtues, and the fact that the author 
drew upon Arabic sources elsewhere in the volume. 
18. Cocrice: Another stone found only in Sidrac, 
specimens were supposedly collected by smearing pieces 
of goat meat with honey and then throwing them into the 
rocks below the mountains. Cocrice stones stuck to the 
honey-coated flesh and could then be retrieved by 
hunting the birds that descended into the valleys to collect 
the pieces of goat. If the stone was touched against the 
eye twice a day for three or four consecutive days, it 
would supposedly cure eyes afllicted by the presence of 
'perle that commeth often tymes of the poxes/ or of other 
diseases'. This could refer to cataracts or perhaps corneal 
cysts. In addition, the stone could expel poison from the 
body and protect the bearer from all types of vermin and 
'venymous beest' . 
19. Turquoise: The distinctively blue to green 'Turkays' 
stone is a hydrated copper phosphate. Carrying this stone 
ensured that 'shall neyther metes nor drynkes hurt hym 
nor do hym harme'. 
20. Magnetite: 'Adamounde', used for this entry in 
Sidrac, is a synonym for diamond. This entry differs 
somewhat from that for 'Dyamant' (see above) in terms 
of the therapeutic virtues indicated, however. Esteemed 
as being good for dropsy when taken in a drink, its most 
celebrated use was as an intensely magnetic ingredient in 
a weapon salve, a property indicating some confusion 
with the iron oxide mineral Magnetite, the Lodestone. 
The text runs as follows : 
Also surgyons that knoweth the virtue of this sayd stone/ doth 
breke it to powder when that a man is hurt with a spere/ 
quarell/ arrowe/ or gonne pellet/ that the yron or stele byde in 
their body/ then they make a tent/ & myxte the salue with the 
powder of the stone/ & put the tent into the hole/ where the 
yron or stele is in: & so by the great virtue that this powder 
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hath/ it draweth the yron or stele out/ & so they make the man 
hole. 
Conclusions 
In an attempt to identify the possible origins of some of 
the medical folklore contained in Sidrac, the entries were 
compared with a number of texts both predating the 
ancient French lapidary, and immediately following it. 
The older sources relevant to a discussion of the stones 
included in Sidrac include Dioscorides' first-century 
Materia Medica, Pliny the Eider's Historia Natura/is 
('Natural History', circa AD 77), Darnigeron's second 
century De Vzrtutibus Lapidum ('The Vrrtues of Stones'), 
the Etymologiarum oflsidore of Seville ('Etymologies', 
early 7th century), the Physica (12th century) of 
Hildegard von Bingen, Bartholomaeus Anglicus' De 
Natura Rerum ('On the Nature ofThings') written during 
the 1240s, Vmcent de Beauvais' Speculum Naturale 
('Mirror of Nature', mid-thirteenth century), the De 
Mzneralibus (circa 1242) of Albertus Magnus, and 
Alfonso X el Sabio's mid-thirteenth century work entitled 
n Lapidario. 23 It is obvious from Table 1 that there is no 
clear pattern of similarity between older works and the 
Lapidary of Sidrac; some of the therapeutic properties 
ascribed to certain stones have been cited by classical and 
early mediaeval authorities. The greatest similarity is 
shown between Sidrac and Marbode's Lapidary, De 
Mzneralibus and De Natura Rerum, especially in respect 
of Jasper, Ligure and Agate; these authorities had the 
greatest influence on the writer of Sidrac, but the 
correspondence is by no means exact, and numerous 
properties cited by these and other early authors are 
omitted entirely from the popular French work. Ligure, 
for example, was often cited as an effective treatment for 
kidney and bladder stones, while Topaz has been claimed 
as a useful remedy against haemorrhoids and lunacy. 
There are two lapidaries which are almost contem-
poraneous with Sidrac: Le Lapidaire du roi Philippe is 
known from around 11 manuscripts and is believed to 
date from the late 13th century, while the lapidary 
ascribed to the enigmatic John Mandeville is from the 
14th century. 24 The former of these two lapidaries is the 
closest match to Sidrac (Table 1 ). 
Potentially derivative works that have been examined 
are ~e various English medieval lapidaries; the London 
Lap~dary, North London Lapidary and Peterborough 
Lapidary all date to the 15th century, whilst the Sloane 
Lapidary is 16th century. Table 1 shows a much greater 
consonance between these lapidaries and Sidrac, but not 
all of the comments in Sidrac have been repeated. In 
some examples ( e.g. sapphire, jasper, ligure) the match is 
very good, and in some cases, the therapeutic properties 
are presented in a sequence almost identical to that in 
~idrac. Once again, however, additional qualities appear 
m the English lapidaries. 
Th~ most significant and accessible early medieval 
Arabic works on precious stones include the Kitab al-
Jamahir fi Ma 'rifat al-Jawahir ('The Book Most 
Com?re~ensive in Knowledge on Precious Stones') of 
Al-BllUill (Abu al-Rayhan Muhammad ibn Ahmad al-
Buuni, or Alberonius in Latin; 973- 1048), and the slightly 
later Azhar al Ajkar fi Djawahir al Ahdjar ('Best 
Thoughts on the Best Stones') by Ahmad ibn Yusuf al-
T1fachi (1184-1253).25 An examination of these texts for 
medical lore associated with precious stones has yielded 
no significant overlap with that in The Lapidary of Sidrac. 
Thus, the Lapidary of Sidrac is interesting for several 
reasons; ( l) like other lapidaries, it is a source of 
otherwise lost medical folklore, (2) it occupies an 
intermediate temporal position between the writings of 
classical authors plus early medieval encyclopaedists and 
the later, fully established, English lapidary tradition, (3) 
its content is likewise intermediate, containing some 
elements from earlier authors, but having much closer 
ties to contemporary and later lapidaries, whose content 
it might have influenced to some degree, (4) it contains 
some unique medical lore and information on a number 
of therapeutic stones exclusive to itself, reflecting the 
influence of other, as yet unidentified sources. 
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The story of diabetes mellitus is a remru:kable _chronicle 
covering around 3,500 years of medical history . . In 
medieval times Persian physicians carried out extensive 
literary and clinical research on the ~agnosis and 
treatment of diabetes. They tested vanous types of 
dosage forms to treat diabetic patients. In this '.111icle the 
most common diabetic formulations and therr general 
considerations which were repeatedly experienced by 
traditional Pe~ian scholars during 9th-18thcenturiesAD, 
are studied. These formulations are divisible into two 
categories: oral and non-oral forms. The most common 
oral dosage forms include tablets (Qors), soaked ~gs 
(Naqoo), decoctions (Matbookh or Tabikh), and ffilXed 
powders of drugs (Sofoof), while the most common non-
oral dosage forms include inhalant drugs ~Shomoo':l), 
solutions that the patient sits in (Abzan), omtment-like 
drugs (Zemad), enema solutions (Hoqneh) and 
suppositories (Shiaj). These findings reveal a part of the 
history of pharmacy in the medieval period. 
Interest in medicines has been universal and 
changeless since the beginning of man. 1 Traditional 
Persian Medicine (TPM) consists of the sum to_tal of ~ll 
the knowledge and practices used in diagnosis, 
prevention and elimination of diseases in Persia from 
ancient times to the present. It is based entirely on 
practical experience and observations passed_ down from 
generation to generation.2 It seems that Persian scholars 
first conceived the theory of humours and it later became 
a world-wide theme ofmedicine.3 This theory was based 
on the four humours (blood, phlegm, black bile and 
yellow bile), which were the basis of diagno~is and 
treatment at that time.4 Wherever civilisation anses we 
find 'pharmacy' because it fulfills one of hurnan's basic 
needs. s The history of pharmacy in Persia goes back 
many centuries. Among the oldest pharmacy documents 
of ancient Persia one can mention the holy book of 
Avesta as well ' as the Dinkard, the Vazidegiza-i-
Zadsperam, and the memories of some Greek historians. 
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It is interesting to mention that the term 'Drug' is 
probably derived from the Avestan ancient term 'Darav' 
meaning the stem of a plant (Dar in Persian means tree). 
This word later changed into 'Darug ' in ancient Persian 
and then to 'Droga ' in Latin, 'Drogue ' in French, 'Dru' 
in English and 'Daru' in Persian. According to Edward 
Brawn: 
The most cogent evidence for ancient Persian interest in 
pharmacy is the Persian origin of many drug names in 
medieval medicine. 6 
The most famous documents among pharmaceutical 
books written by the Persian scientists are Qarabadin 
books, which are traditional pharmacopeias describing 
the preparation methods and procedures of compound 
medications. They include lists of the names of drugs, 
formulations or prescriptions. 7 For example, one of the 
famous pharmacists in Jundishapur academic centre 
( one of the earliest Persian universities in the Sassanid 
era) was Shapur Sahl. He composed his Aqrabadin (or 
Qarabadin) Kabir (great pharmacopeia) in 869 AD; it 
became the first formulary to receive widespread 
acceptance and use in hospitals and pharmacies of the 
time.8•9 The design of the formulations in Qarabadins 
varies from author to author. Various dosage forms with 
different routes of administration were mentioned in 
those books,7 including diabetic drugs. 
The story of diabetes mellitus is a remarkable chronicle 
covering around 3500 years of medical history. The word 
'Diabetes' is derived from a Greek term, which was first 
used by Aretaeus (81-138 AD) in 138 AD. Later, Galen 
(129-199 AD) researched this disease and described it as 
a renal disease. Persian physicians have carried out 
extensive literary and clinical research about diagnosis, 
complications, treatments and drug dosages for diabetes. 
The term Ziabetes in Persian, was used by early Persian 
scholars to define and describe what is currently called 
diabetes. In the TPM view diabetes may result from an 
imbalance in the kidney temperament as well as the 
whole body. Regarding this abnormal temperament, the 
disorder was categorised into two main types as hot 
(Ziabites-e-har) and cold (Ziabites-e-barid). The hot type 
was significantly more prevalent than the cold one and 
caused by an abnormal hot and dry temperament in the 
kidneys and all the body. The most important signs of 
both types of diabetes were unusual and excessive thirst, 
frequent urination and weight loss. In the cold type, thirst 
was mildly less than the hot type. Persian traditional 
scholars explained several dosage forms of drugs and 
therapeutic methods for diabetes. 10.13 
In this study, these dosage forms along with their 
special formulations and general considerations in 
medieval Persia are represented and introduced to clarify 
pharmaceutical knowledge of the drugs and therapeutic 
methods for diabetes in the medieval period as a part of 
the history of pharmacy. 
Materials and Methods 
The research method employed in this article is based on 
the analysis of the main remaining manuscripts of 
medieval Persia from 9th to 18th century AD including 
medical and pharmaceutical textbooks of this era, 
including Al-Hawi fi al-Teb [Liber Continent] of Razes 
(860-925 AD), Hidiiyat al-Muta'alliminfi al-Tzbb [The 
Students' Handbook of Medicine] of Abubakr 
Akhawayni Bukhari (10th C AD), Qanoon fi al-Teb 
[Canon of Medicine] of Avicenna (980-1037 AD), 
Zakhireye Kharazmshahi [Treasure of the Khwarazm 
Shah] of Ismaiel Jorjani (1041-1136), Kholasat-al-
Tajarob of Baha-al-Dolah Razi (16th C), Tohfat-al-
Momenin of Mohmmad Momen Tonekaboni (17th C), 
Mofareh-al-Gholoob and Teb e Akbari of Akbar Arzani 
(17-18th C), Makhzan-al-Advieh and Qarabadin Kabir 
[Great pharmacopeia] of Mohammad Hossein Aghili 
Khorasani (18th C) and Exir Azam [Great Elixir] and 
Qarabadin Azam [ Azam Pharmacopeia] of Mohammad 
Azan Khan Chasti ( 18th C). 
The chapters containing information about diabetes 
were investigated and the data was collected, categorised 
and analysed. Then the types of dosage forms prescribed 
in diabetes by Persian scholars and their definitions and 
general considerations were researched. 
Results 
In Traditional Persian Medicine (TPM) references, 
especially in Qarabadins, there are several formulations 
and therapeutic methods for the treatment of diabetes. 
These formulations are divisible into two categories: oral 
forms and non-oral forms. The most common oral 
dosage forms include tablets (Qors), soaked drugs 
(Naqoo), decoctions (Matbookh or Tabikh), and mixed 
powders of drugs (Sofoo!J. The most common non-oral 
dosage forms include inhalant drugs (Shomoom ), 
solutions that the patient sits in (Abzan), ointment-like 
drugs (Zemad), enema solutions (Hoqneh) and 
suppositories (Shia/) 11 • 14 (Table 1 ). 
Oral forms 
Qors (Tablet) 
In Qarabadin books, Qors is usually defined as a storage 
dosage form; but sometimes (such as in the case of 
diabetic drugs) this term used for a pill (hab in Persian) 
and defined as a solid dosage form, prepared in a small 
round shape for a specific dose of drug. 15 When making 
this form of drug, traditional scholars triturated the 
ingredients together and mixed the powder with proper 
herbal extracts and then divided and formed the resulting 
paste into round-shaped tablets. 11 •13• 1&-17 Traditional 
scholars believed that the best time to use Qors was two 
years after date of production. After that, the drug would 
be expired 14 Qors is more potent than sofoof. 15 
Naqoo 
Naqoo are liquid dosage forms which are obtained by 
soaking drugs in water or other liquid and filtering them 
later without boiling. 14•18 Penetration of Naqoo in the 
body is more than for Matbookh and it is recommended 
that drugs and herbs used in the Naqoo should be 
semiground, not be broken roughly, and soaked in the 
water or other liquids for 2-3 days. 14 This point is 
emphasised in the preparation of Naqoo-e-Tamrehendi 
(tamarind) in diabetes.20 
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Table 1. Examples of diabetic dosage forms in TPM 
Type of dosage form Example 
Oral Qors Qors-e-Tabasheer: Common Purslane seed, Damask rose flower, Pomegranate flower, 
Indian Thorny Bamboo dried exudates on node and Lettuce seed are ground and sifted and 
then mixed with apple, cucumber or sour pomegranate juice. Then the paste obtained is 
divided and formed into round shape (pill) and dried. 11 -13 
Naqoo Naqoo-e-Tamrehendi: Tamarind soaked in water (19-20) 
Matbookh/ Mathookh by Yohanna ibn Miisawayh, ( one of the famous physicians of Jondishpour (9th century 
Tabikh AD): Myrtle seed, Damask Rose flower, Somac, Pomegranate flower, Barbeny, Azarole fiuit mixed 
with sour apple or sour pomegranate juice after decoction.21 
Non- Sofoof Sofoof-e-Ziabetus: Dried Coriander, Damask Rose flower, Indian Thorny Bamboo dried 
oral exudates on node, dried Purslane, Pomegranate flower, Lettuce seed, Arabic gum and 
Camphor are ground and mixed together. 11 
Shomoom Shomoom of Camphor. 12 
Abzan Abzan of cold water. 11 ,12 
Zemad Zemad for use on diabetic patients kidneys: Lentil flour mixed with Rose water.23 
Hoqneh Rectal Hoqneh: mixture of Almond oil, Pumpkin oil and fresh milk.11 ,12,16 
Shiaf Suppository of ice-24 
l\fatbookh/fabikh 
Table 2. Scientific names of herbal drugs mentioned. 
Matbookh and its synonym Tabikh are liquid dosage 
forms which are obtained from a decoction of herbal 
drugs. In Matbookh form, dregs of drugs should be 
filtered off immediately after decoction, or else the 
potency of Matbookh decreases. 14 
Persian Common name 
name 
Khorfa Common purslane 
Gol-e-Sorkh Damask rose flower 
Golnar Pomegranate (flower) 
Tabasheer Indian Thorny 
Bamboo ( dried exudate 
on node) 
Kahao Lettuce 
Tamrehendi Tamarind 
Moord Myrtle 
Somaq Sumac 
Amberbaris Barbeny 
Zaaroor Azarole 
Geshniz Coriander 
Samq-e- Arabic gum 
Arabi 
Kaphoor Camphor 
Adas Lentil 
Badam Almond 
Kadoo Pumokin 
98 
Scientific name 
Portulaca oleracea L. 
Rosa x damascena Mill. 
Punica granatum L. 
Bambusa bambos (L.) 
Voss 
Lactuca saliva L. 
Tamarindus indica L. 
Mvrtus communis L. 
Rhus coriaria L. 
Berberis vulgaris L. 
Crataegus azarolus L. 
Coriandrum sativum L. 
Acacia arabica (Lam.) 
Willd. 
Cinnamomum camphora 
(L.) J.Presl. 
Lens culinaris Medikus 
Prunus dulcis (Mill.) 
D.A.Webb 
Cucurbita pepo L. 
Sofoof 
Sofoof is a dry mixture of triturated drugs. In TPM, it is 
the best dosage form for kidney and liver disorders. 14-15 
Thus it was commonly used in diabetes, which was 
believed to be an abnormal temperament of the kidneys. 
In making sofoof, the ingredients were ground into very 
fine and powdery particles and then prescribed for 
diabetic patients to eat with proper fruit juice. 11 
Traditional scholars believed that the best time to use 
Sofoof was 2-6 months after the production date. After 
that, the drug would have expired. 14 
Non-oral forms 
Shomoom 
Shomoom are inhaled drugs, either solid or liquid.22 
Abzan 
Abzan is a basin full of water or decocted herbal drugs in 
which the patients sits. Traditional scholars believed that 
the water of diabetic Abzan should surround the kidneys 
of patients.22 They also said that sitting in cold Abzan 
strengthens bladder muscles and chills abnormally hot 
kidneys of diabetic patients. 12 
Zemad 
Zemad are soft thick liquid dosage forms which are 
daubed on various parts of a patient's body depending on 
the type of disease. 14,15 In diabetic Zemad form, after 
daubing on the kidneys, the effective and potent part of 
the drug penetrates and influences the kidneys. 12 
Occasionally Zemad was prescribed for patients who 
could not tolerate oral drugs.25 
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Hoqneh 
Hoqneh is one of the therapeutic procedures in which a 
liquid form drug is introduced into the rectum and colon 
via anus or into the uterus via vagina (rather like an 
enema).22 In TPM, Hoqneh is one of the safest and most 
efficacious therapeutic methods; it is used to excrete waste 
and unnecessary materials from the body and affects 
gastrointestinal and kidney diseases. Hoqneh should not 
be performed in very hot weather12 or when the patient is 
hungry or very tired. 25 The liquid drug introduced into the 
rectum, should be moderately warm; its composition was 
different in various disorders. It was used with cold 
temperament herbs and drugs in diabetic Hoqneh. 11-12 
Shiaf 
Shiaf(suppository) is defined as a solid dosage form that 
is prepared in a biconvex shape for insertion in the 
rectum_ 12, 14 
Conclusions 
History reveals that diabetes has always been a part of 
medical research and discussion, although in a very 
primitive form in the ancient ages. In the medieval ages 
the Persian physicians carried out extensive literary and 
clinical research on the diagnosis and treatment of 
diabetes. Various diabetic formulations were used in 
medieval Persia from the 9th to 18th century. The 
number of diabetic formulations was increased during 
that time but dosage presentations remained the same. It 
seems that the emphasis on the properties of drugs and 
adverse or toxic effects following the use of these 
formulations was not neglected by Persian scholars, and 
it is not possible that the formulations could have been 
used continuously throughout history with no therapeutic 
effects. Accordingly the pharmaceutical existence of 
diabetic formulations in the medieval era cannot be 
denied. 
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